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Gene expression is regulated at both the transcriptional and post-transcriptional levels. While transcription
controls only the rate of RNA production, numerous and diverse mechanisms regulate the processing,
stability and translation of RNAs at the post-transcriptional level. At the heart of this regulation are RNA-
binding proteins (RBPs) and their RNA targets. Thousands of RBPs are encoded in mammalian genomes,
each with hundreds to thousands of RNA targets. Therefore, cataloging these interactions represents a
significant challenge. Recent advances in high-throughput sequencing technologies have greatly expanded the
toolkit that researchers have to probe RNA-protein interactions, but these technologies are still in their
infancy and thus new methods and applications are required to move our understanding forward.
We developed a novel, high-throughput approach to globally identify regions of RNAs that interact with
proteins throughout a transcriptome of interest. We applied this technique to human HeLa cells and provide
evidence that our approach captures both known and novel RNA-protein interaction sites. We identified
global patterns of RNA-protein interactions, found evidence for co-binding of functionally related genes, and
revealed that disease associated single-nucleotide polymorphisms are enriched within protein interaction
sites.
We also performed detailed analysis of the RNA targets for two specific RBPs; Poly(A)-binding protein
cytoplasmic 1 (PABPC1) and Argonaute (AGO). First, we used CLIP-seq to generate a transcriptome-wide
map of PABPC1 interaction sites in the mouse transcriptome. This analysis revealed that PABPC1 binds
directly to the highly conserved polyadenylation signal sequence and to translation initiation and termination
sites. We also showed that PABPC1 binds to A-rich regions in the 5’ untranslated region of a subset of
messenger RNAs (mRNAs) and negatively regulates their gene expression.
Finally, we applied a recently developed approach to isolate and sequence AGO-bound microRNA precursors
(pre-miRNAs). We uncovered widespread trimming and tailing, identified novel intermediates and created an
index for pre-miRNA processing efficiency. We discovered that numerous pre-miRNA-like elements are
embedded within mRNAs, but do not produce functional small RNAs. In total, these studies provide several
advances in our understanding of the global landscape of RNA-protein interactions and serve as a foundation
for future mechanistic studies.
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ABSTRACT 
 
IDENTIFYING RNA-PROTEIN INTERACTION SITES THROUGHOUT EUKARYOTIC 
TRANSCRIPTOMES 
 
Ian Michael Silverman 
Brian D. Gregory, Ph.D. 
Gene expression is regulated at both the transcriptional and post-transcriptional levels. 
While transcription controls only the rate of RNA production, numerous and diverse mechanisms 
regulate the processing, stability and translation of RNAs at the post-transcriptional level. At the 
heart of this regulation are RNA-binding proteins (RBPs) and their RNA targets. Thousands of 
RBPs are encoded in mammalian genomes, each with hundreds to thousands of RNA targets. 
Therefore, cataloging these interactions represents a significant challenge. Recent advances in 
high-throughput sequencing technologies have greatly expanded the toolkit that researchers have 
to probe RNA-protein interactions, but these technologies are still in their infancy and thus new 
methods and applications are required to move our understanding forward.  
 We developed a novel, high-throughput approach to globally identify regions of RNAs 
that interact with proteins throughout a transcriptome of interest. We applied this technique to 
human HeLa cells and provide evidence that our approach captures both known and novel RNA-
protein interaction sites. We identified global patterns of RNA-protein interactions, found evidence 
for co-binding of functionally related genes, and revealed that disease associated single-
nucleotide polymorphisms are enriched within protein interaction sites. 
 We also performed detailed analysis of the RNA targets for two specific RBPs; Poly(A)-
binding protein cytoplasmic 1 (PABPC1) and Argonaute (AGO). First, we used CLIP-seq to 
generate a transcriptome-wide map of PABPC1 interaction sites in the mouse transcriptome. This 
analysis revealed that PABPC1 binds directly to the highly conserved polyadenylation signal 
sequence and to translation initiation and termination sites. We also showed that PABPC1 binds 
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to A-rich regions in the 5’ untranslated region of a subset of messenger RNAs (mRNAs) and 
negatively regulates their gene expression.  
Finally, we applied a recently developed approach to isolate and sequence AGO-bound 
microRNA precursors (pre-miRNAs). We uncovered widespread trimming and tailing, identified 
novel intermediates and created an index for pre-miRNA processing efficiency. We discovered 
that numerous pre-miRNA-like elements are embedded within mRNAs, but do not produce 
functional small RNAs. In total, these studies provide several advances in our understanding of 
the global landscape of RNA-protein interactions and serve as a foundation for future mechanistic 
studies. 
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This section refers to work in: 
 Silverman IM*, Li F*, Gregory BD. 2013. Genomic era analyses of RNA secondary 
structure and RNA-binding proteins reveal their significance to post-transcriptional regulation in 
plants. Plant Science. 205-206:55-62  
Abstract: 
The eukaryotic transcriptome is regulated both transcriptionally and post-transcriptionally. 
Transcriptional control was the major focus of early research efforts, while more recently post-
transcriptional mechanisms have gained recognition for their significant regulatory importance. At 
the heart of post-transcriptional regulatory pathways are cis- and trans-acting features and factors 
including RNA-binding proteins (RBPs) and their recognition sites on target RNAs. Recent 
advances in genomic methodologies have significantly improved our understanding of RBPs and 
their regulatory effects within the eukaryotic transcriptome. In this section, I will introduce these 
regulatory factors and describe the approaches for studying RNA-protein interaction sites, with an 
emphasis on recent methodological advances that produce transcriptome-wide datasets. 
 
1.1 THE REGULATION OF GENE EXPRESSION 
In the 1950’s, Francis Crick proposed the central dogma of molecular biology, which in its 
simplest form states that genetic information flows from DNA to RNA through transcription, and 
from RNA to protein through translation (Figure 1.1) [1]. This elegant model serves as a basis for 
our understanding of molecular biology and gene expression in general.  
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Figure 1.1 The central dogma of molecular biology. Genomic DNA is transcribed into mRNA by 
RNA polymerase II (RNAPII) and mRNA is translated into protein by the ribosome. 
 
While Crick’s model holds true for much of molecular biology, it gives us a static view of 
the complex and dynamic systems that are living biological organisms. How do organisms 
determine when to initiate and terminate transcription? Specifically, how do cells respond to 
changes in their environment? In 1961, Jacques Monod, discovered that E. coli lactose 
metabolism enzymes were only expressed in the presence of lactose and in the absence of 
glucose [2]. This seminal discovery of the lac operon was the first demonstration of transcriptional 
gene regulation and set a new paradigm in molecular biology. 
Simple models of transcriptional gene regulation were sufficient to explain many 
observations in bacteria, but higher eukaryotes present a unique challenge to Monod’s model. 
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How do organisms with billions of cells and hundreds of distinct cell types, each with highly 
specialized functions, regulate gene expression? The full answer to this question is outside the 
scope of this dissertation. Briefly stated, higher eukaryotes have evolved tens of thousands of 
proximal and hundreds of thousands of distal regulatory elements, which work in concert with 
regulatory proteins (transcription factors) to regulate the spatiotemporal expression of the 
approximately 20,000 protein coding genes encoded in mammalian genomes [3].  
 
1.2 POST-TRANSCRIPTIONAL GENE REGULATION 
Transcription of RNA is only the first process regulating gene expression (Figure 1.1). 
Once RNA is transcribed, numerous mechanisms exist that control the abundance, timing and 
even the sequence of proteins that are ultimately produced. Post-transcriptional regulatory 
processes allow cells to diversify their proteome, respond to environmental cues, and fine tune 
gene expression. This regulation can occur at any step of the RNA “life cycle” including 
maturation (e.g. 5’ capping, splicing, polyadenylation, etc.), transport from the nucleus, 
localization within subcellular compartments, molecule stability, as well as the initiation, 
elongation, and termination of protein translation (Figure 1.2). The integration of transcriptional 
and post-transcriptional processes ultimately determines the amount of each individual protein 
that is produced. Importantly, the stability and activity of proteins is subject to further regulation, 
but this is outside the scope of this discussion. 
 
1.2.1 Alternative pre-mRNA splicing 
 Transcription results in the production of a pre-mRNA molecule that contains exons 
separated by long intervening sequences, called introns (Figure 1.2). In order for pre-mRNAs to 
mature into protein coding units, exons must be spliced together by the action of a multi-subunit 
macromolecular machine known as the spliceosome. Components of the spliceosome, including 
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the small nuclear ribonucleoproteins (snRNPs), recognize sequence elements in the exons and 
introns and catalyze the joining of exons to form mature mRNAs. However, it was observed in the 
late 1970’s that the same pre-mRNA can give rise to multiple distinct isoforms, which are 
generated through alternative splicing reactions [4]. Depending on which exons are included and 
in which order, alternative mRNA isoforms can code for distinct proteins, contain regulatory 
sequences, or even contain premature stop codons leading to rapid decay [5]. This is one of the 
mechanisms by which higher eukaryotes diversify their limited set of 20,000 protein coding 
genes. We now understand that these alternative splicing events are mediated by specific 
regulatory sequences and structures in exons and introns, known as splicing enhancers and 
silencers, which interact with RBPs to promote or repress exon splicing. The complex rules which 
govern alternative splicing have only just begun to be elucidated [6, 7] 
 
1.2.2 Alternative Polyadenylation 
 Polyadenylation of pre-mRNA represents another step by which the mature mRNA 
sequence can be altered. Polyadenylation of mRNAs is a key step in their maturation and is 
required for the transport, stability and productive translation of almost all mRNAs [8]. During 
transcription, RNA polymerase II (RNAPII) continues transcribing RNA through the end of the last 
exon. The polyadenylation machinery assembles on the 3’ end of the pre-mRNA by interacting 
with specific sequence elements; most notably, the cleavage and polyadenylation specificity 
factor (CPSF), which binds to the polyadenylation signal (PAS; AAUAAA) approximately 20-25 
nucleotides upstream of the eventual cleavage sites [9]. Another complex, the cleavage 
stimulation factor (CSTF), assembles downstream of the cleavage site and together with CPSF 
promotes cleavage, followed by subsequent polyadenylation of the mRNA. Consequently, a 5’ to 
3’ exoribonuclease, Rat1, chases down the transcribing RNAPII and terminates transcription [10]. 
It later was noted that mRNAs contain multiple PAS sequences in their 3’ UTRs, and more recent 
evidence suggests that ~75% of genes are subject to alternate polyadenylation (APA) [11]. If APA 
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occurs, the resulting mRNA sequences may vary not only in length, but also by the presence or 
absence of specific regulatory elements in the 3’ UTR [8]. These regulatory elements may dictate 
the stability or translation efficiency, among other post-transcriptional processes.  
 
1.2.3 Cytoplasmic Regulation of mRNA Stability and Translation 
 Once mature mRNA in exported into the cytoplasm, its lifespan and productivity are 
determined by the cohort of cis-regulatory elements and by the abundance of cognate trans-
factors that it interacts with. Properly processed mRNAs will emerge from the nucleus carrying a 
protective 5’-7-methyguanlate (m7G) cap and a 3’ poly(A) tail. These features recruit protein 
factors, which aid generally in the stability and translation of the mRNA. However, a large amount 
of variation exists in both the stability and translation efficiency of mRNAs [12, 13]. For example 
the β-globin mRNA is much more stable than housekeeping mRNAs in erythrocytes [14, 15]. It is 
now well understood that RBPs and microRNAs interact with mRNAs through sequence and 
structure-specific interactions to regulate these two processes [15].  
The mechanisms by which mRNA stability and translation are regulated are diverse. For 
example, in plants miRNAs generally cleave mRNA targets, leaving behind unprotected 5’ and 3’ 
ends that are rapidly degraded by the general degradation machinery [16]. In mammals, this 
mechanism is less often utilized, and rather miRNAs are thought to recruit deadenylation factors, 
which remove protective elements leading to decay [17]. Interestingly, many factors involved in 
mRNA turnover and miRNA mediated decay, accumulate in cytoplasmic processing bodies (p-
bodies), possibly facilitating these functions (Figure 1.2) [18]. P-bodies are also thought to be a 
depot of transnationally repressed mRNAs, inhibiting translation by removing mRNAs from the 
translatable pool. Alternatively, numerous soluble factors can bind to the 5’ UTR and inhibit 
ribosome scanning, which is a critical step in mRNA translation. While the processes I have 
described here are diverse, they are all controlled by a limited number of cis- and trans-acting 
elements. These include RBPs, microRNAs and their RNA recognition sites on mRNAs. We will 
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discuss these regulatory elements and the methods used to identify these regions in the 
transcriptome. 
 
Figure 1.2 RNA-binding proteins mediate post-transcriptional gene regulation. RNAs are 
regulated by a variety of processes after transcription that are mediated by RBPs. White bars 
indicate coding exons. Green and purple bars indicate 5’ UTR and 3’ UTR, respectively. 
 
1.3 RNA-BINDING PROTEINS 
 RNA-binding proteins (RBPs) are a group of trans-acting regulatory factors that are integral 
to the post-transcriptional regulation of eukaryotic transcriptomes. Cellular RNA is involved in a 
multitude of complex interactions with numerous RBPs from the initial processing of a transcript in 
the nucleus to its final translation and decay in the cytoplasm [19-21] (Figure 1.2). Recent 
experimental and bioinformatic analyses have suggested that >1,300 RBPs are encoded in the 
8	  
	  
human genome [22-24]. These proteins interact with mRNAs and form dynamic multi-component 
ribonucleoprotein (mRNP) complexes, which are the functional forms of mRNAs [25]. It is only 
through their proper formation that transcripts are correctly regulated and precisely produce the 
required amount of protein in a eukaryotic cell [19, 21, 25, 26]. Thus, RNA-protein interactions are 
necessary for the functionality, processing, and regulation of mRNA molecules.  
 
1.3.1 RNA-Binding Domains 
RBPs are a ubiquitous and heterogeneous class of proteins found in all organisms and 
characterized by the presence of one or more RNA-binding domains (RBDs). These proteins 
interact with single-stranded or double-stranded regions of RNA molecules through their binding 
domains, as well as with other cellular components through auxiliary domains. There are dozens 
of described RBDs, each with a distinct RNA-interaction interface. For instance, the RNA 
Recognition Motif (RRM) is the most abundant RNA-binding domain in mammalian cells (Table 
1.1). The RRM is characterized by having a βαββαβ secondary structure, with the two α-helices 
packed against a 4-stranded β-pleated sheet. Canonically, the β-sheet is responsible for 
recognition of ssRNA (2-8 nucleotides), and the outward facing amino acid side chains in turn 
dictate the sequence specificity. The double-stranded RBD (dsRBD) is a common RBD that 
interacts with structured regions of RNA (Table 1.1). These RBDs are characterized by a ~65 
amino acid domain in an αβββα structural arrangement in which the two α-helices overlap and 
pack against the antiparallel tri-β-sheet [27]. This structure allows the RBD to recognize the 
phosphate backbone and clamp onto a double-stranded RNA in lieu of a sequence motif. Other 
common RBDs include the K homology (KH) domain, cold-shock domain (CSD), several types of 
zinc finger (ZnF) domains (the most abundant being C-x8-X-x5-X-x3-H), DEAD/DEAH box, 
PIWI/Argonaute/Zwille (PAZ), and like-SM (LSM) (Table 1.1) [25, 28, 29]. Based on recent 
studies of RNA-interacting proteins, it is likely that many more RBDs are yet to be discovered [22-
24].  
9	  
	  
 
1.3.2 Auxiliary Domains 
RBPs are highly modular and may contain a single binding domain (e.g. DAZL), multiple 
copies of the same domain (e.g. PABPC1 and PCBP2), or a collection of different domains (e.g. 
IGFBP1) [24]. Together, the collection of RBDs in an RBP determines the affinity for target RNAs 
and increase specificity over a single RBD. Many RBPs possess auxiliary domains that carry out 
a variety of functions, such as facilitating protein-protein interactions or acting as substrates for 
post-translational modifications. Glycine-rich and arginine-serine-rich domains are common 
auxiliary domains observed in plants and metazoans [30, 31]. Auxiliary domains can have vast 
impacts on the mRNA target repertoire and regulatory potential of an RBP. For example a 
protein-protein interaction domain in GW182, a core component of the RNA induced silencing 
complex, interacts with Poly(A) binding proteins to recruit deadenylases to microRNA targeted 
mRNAs [32]. The presence or absence of a nuclear localization signal determines the subcellular 
localization and therefore the target RNA repertoire and functional outputs of an RBP. Therefore, 
the rules that govern RBP-RNA interactions are complex and understanding the in vitro 
specificities of an individual RBD does little to enhance our understanding of the true biological 
targets of a given RBP, in vivo. 
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Table 1.1 Known RNA-binding domains and the number of RBPs in humans containing these 
domains 
 
 
1.3.3 Recurring Themes in RBP Biology 
Detailed studies of RBPs have pointed to several recurring themes in RBP-mediated 
regulation. First, these proteins generally participate in multiple post-transcriptional processes, 
making the functional categorization of RBPs difficult. A prominent example of an RBP with 
multiple roles is SF2/ASF, which was originally identified as an essential splicing factor, and has 
now been implicated in translational control [33] and miRNA processing [34]. Second, a number 
of RBPs bind to and auto-regulate their own mRNAs, including DGCR8, RBFOX, TDP-43 and 
HuR [35-38]. Auto-regulation can occur via any of the mechanisms described in the previous 
section. Finally, mRNAs interact with multiple RBPs, which in turn bind to functionally related sets 
of mRNAs, suggesting a combinatorial network for control of gene expression at the RNA level 
[39]. Thus, the final fate of an mRNA is determined by the entire complement of bound RBPs. 
These themes point to a highly coordinated and controlled system of gene regulation by RBPs. 
 
RNA-binding domain Human RBPs (Pfam)
RRM 597
KH 113
CSD 18
DS-RBD 50
ZnF (C-x8-C-x5-C-x3-H) 64
DEAD/DEAH box 200
PPR 8
RGG box 152
PUF 8
PAZ 12
LSM 35
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1.3.4 Poly(A)-Binding Proteins 
The poly(A)-binding proteins (PABPs) are an important class of RBPs with global and 
gene-specific roles in regulating mRNA stability and translation efficiency. Canonically, PABPs 
exert their function by binding to the poly(A) tail, a post-transcriptional modification that is found 
on the 3’ end of nearly all mRNAs (Figure 1.3A). Through this binding, PABPs are thought to 
physically protect the mRNA from 3’ to 5’ exonucleolytic decay and to interact with other trans-
factors that bind to the mRNA 5’ cap to promote translation [40]. Paradoxically, PABPs have also 
been shown to participate in negative regulation of mRNA stability through direct interaction with 
components of the RNA induced silencing complex (Figure 1.3B) [32]. More limited evidence 
suggests that PABPs interact with genomically encoded A- and AU-rich sequences in specific 
mRNAs to exert mRNA-specific regulation (Figure 1.3C) [41]. This mRNA-specific regulation can 
promote or repress translation, depending on the position of the binding [40]. Thus, PABPs can 
exert their function through a variety of mechanisms and through a number of cis- or trans-
regulatory elements.  
In mammals, there are six defined PABP isoforms; a single nuclear isoform, PABPN1, 
that impacts the addition of poly(A) tails in the nucleus and five cytoplasmic PABPs; ePAB, 
PABPC1, PABPC2, PABPC4, and PABPC5, that are thought to play roles in regulating mRNA 
stability and translation in the cytoplasm [42-44]. The overall structures and RNA binding 
specificities of the five cytoplasmic PABPs are highly conserved [45, 46]. They each contain four 
RNA Recognition Motifs (RRMs). RRMs 1 and 2 are primarily responsible for the high affinity 
binding to homopolymeric adenosines (Kd = 1.8 nM) [47], while RRMs 3 and 4 can bind to non-
homopolymeric AU sequences (Kd= 2.9 nM) [47]. However, the levels of functional specificity 
and/or redundancy of the mammalian cytoplasmic PABPs remain unexplored.  
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Figure 1.3 Mechanisms of PABPC1-mediated post-transcriptional gene regulation. A) PABPC1 
plays a role in global mRNA regulation protecting mRNA from 3’ end degradation factors and by 
interacting with EIF4G. B) PABPC1 participates in miRNA-mediated gene silencing by interacting 
with AGO proteins through GW182 to promote degradation. C) PABPC1 regulates specific 
mRNAs by disrupting ribosome scanning in the 5’ UTR or promoting association with EIF4G from 
the 3’ UTR. 
	  
PABPC1 is the major cytoplasmic PABP isoform in adult somatic cells and is abundantly 
expressed in all tissues [48]. The interaction of PABPC1 with mRNA poly(A) tails is well 
documented in multiple contexts [42, 49]. The corresponding functions of the PABPC1/poly(A) tail 
complex are primarily mediated in pathways of mRNA stabilization and translation enhancement 
(Figure 1.3A) [50-52]. These functions are linked to the interactions of PABPC1 with the 5’ cap-
binding complex (CBC) via heterodimerization with eIF4G [53, 54]. Through this interaction, 
PABPC1 is inferred to facilitate mRNA circularization, although this model has not been fully 
elucidated.  
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PABPC1 also plays a role in mRNA-specific gene regulation via two main mechanisms. 
PABPC1 interacts with GW182, which in turn interacts with Argonaute (AGO), the central 
mediator of RNA silencing [55]. Through this interaction, PABPC1 helps to recruit deadenylation 
and decay factors directly to the RNA, resulting in turnover (Figure 1.3B). Limited evidence also 
points to specific binding sites and functions for PABPC1 within genomically encoded regions of 
the eukaryotic mRNA transcriptome. For example, PABPC1 has been shown to bind to an A-rich 
element in the 5’ untranslated region (UTR) of its own mRNA in mouse and human, and repress 
translation, establishing an auto-regulatory translational control circuit (Figure 1.3C) [41, 56, 57]. 
Due to the central role of PABPC1 in regulating global mRNA stability and translation, the impact 
of its auto-regulation on the transcriptome and proteome are vast. Analysis of the PABPs in the 
plant model system Arabidopsis thaliana suggests that this interaction is conserved in multiple 
organisms, representing an ancient RBP-mediated regulatory circuit [58]. The extent to which 
PABPC1 directly regulates other mRNAs in a similar fashion has not been explored. 
A recent study in Saccharomyces cerevisiae using a photoactivatable-ribonucleoside-
enhanced crosslinking immunoprecipitation approach (PAR-CLIP) demonstrated in vivo binding 
of yeast poly(A) binding protein Pab1 to AU-rich elements in mRNAs [59], including binding to the 
efficiency element (UAUAUA) of the yeast polyadenylation signal [60, 61]. The downstream 
effects of Pab1 binding to the polyadenylation efficiency element in yeast remains undefined, as 
does any generalization of these findings to higher eukaryotic organisms. Based on its 
participation in global and mRNA-specific regulation through a variety of pathways, PABPC1 
represents one of the most important RBPs in the mammalian genome. However, identification of 
PABPC1 targets in mammalian cells has not been performed to date. 
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1.4 MICRORNA BIOGENSIS 
In addition to directly regulating mRNAs, RBPs also serve as biogenesis factors and 
effectors of microRNAs (miRNAs), another important class of post-transcriptional regulatory 
molecules. MiRNAs are short ~22 nucleotide small RNAs that function as sequence-specific 
guides to repress mRNA translation or stability. MiRNAs are conserved from plants to mammals; 
however distinct biogenesis pathways suggest that the miRNA system evolved at least twice [16]. 
The human genome encodes thousands of miRNAs, each of which can bind to and regulate 
hundreds of mRNAs [62]. In humans, specific miRNAs have been implicated in numerous 
biological pathways, are misregulated in disease, and have conserved functional roles in 
eukaryotes [63-65]. Thus, understanding the biogenesis, regulation and function of these small 
RNA molecules is critical to our understanding of gene regulation.  
 
1.4.1 Nuclear Processing 
In mammals, miRNAs are transcribed by RNA polymerase II (RNAPII) as primary miRNA 
(pri-miRNA) genes or as pieces of larger parent RNA molecules. In fact, the majority of human 
miRNAs reside within introns, with only a handful of miRNAs identified within mRNA exons [66]. 
Regardless of their origin, miRNA stem-loops are processed into miRNA precursors (pre-
miRNAs) by the microprocessor complex, which is comprised of the type III ribonuclease Drosha 
and the dsRBD-containing RBP, DGCR8 [67, 68] (Figure 1.4). The microprocessor complex binds 
to stem-loop structures in the nucleus and cleaves a ~65 nucleotide (nt) pre-miRNA molecule ~11 
nucleotides from the base of the stem with a 2nt 3’ overhang, which enhances Dicer processing 
[69]. Recent studies have found that pre-miRNA biogenesis can occur in a microprocessor-
independent fashion whereby pre-miRNAs are directly generated by the spliceosome [70, 71]. 
After these initial processing steps, pre-miRNAs are transported into the cytoplasm by the nuclear 
transport protein Exportin-5 to be further processed [72, 73].  
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1.4.2 Cytoplasmic Processing 
In the cytoplasm, pre-miRNAs interact with the miRNA loading complex (miRLC), which 
consists of the miRNA effector protein Argonaute (AGO), another Type III endonuclease called 
Dicer, and dsRBD-containing TRBP [74-76] (Figure 1.4). Dicer is responsible for cleaving the pre-
miRNA on the stem-loop side of the duplex, leaving a ~22nt miRNA-miRNA* duplex, with 2 nt 3’ 
overhangs on both ends. Dicer is able to cleave pre-miRNAs in the absence of AGO and TRBP. 
However, recent evidence suggests that the miRLC is the major pre-miRNA maturation pathway 
in mammals in vivo [77]. Interestingly, Dicer-independent pathways have also been discovered 
for mammalian miRNA maturation [78]. For instance, the erythrocyte specific pre-miR-451 
contains a short stem loop that is a poor substrate for Dicer processing. Instead, AGO2, which is 
the only AGO in mammals with catalytic activity for RNA cleavage, cuts pre-miR-451 as part of 
the miRNA precursor deposit complex (miPDC), promoting 3’ to 5’ exonucleolytic decay by the 
poly(A) ribonuclease, PARN, resulting in a mature and active miR-451 [79, 80] (Figure 1.4). 
AGO2-cleaved pre-miRNAs (ac-pre-miRNAs) function as an alternative biogenesis mechanism 
for several other pre-miRNAs, although the extent to which pre-miRNAs can be processed along 
this pathway has not been addressed [78]. 
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Figure 1.4 Mammalian microRNA biogenesis and function. Pre-miRNAs are processed from 
primary miRNAs (pri-miRNA) or from other host RNA species in the nucleus by the 
DGCR8/Drosha microprocessor complex. Once in the cytoplasm the pre-miRNAs interact with 
the miRLC to be processed by DICER. Alternatively, some pre-miRNAs (ac-pre-miRNAs), are 
cleaved by AGO2 and trimmed by PARN to produce functional miRNA (miPDC). Only one strand 
is loaded and used as a guide for RNA silencing. 
 
1.4.3 AGO-Loading and miRNA Function 
 Canonically, one of the strands in the liberated miRNA-miRNA* duplex is selectively 
loaded into one of four AGO proteins to make a functional RNA-induced silencing complex 
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(RISC) (Figure 1.4). However, there is some evidence that the miRNA* (passenger strand) may 
serve other functions in the cell and miRNA strand switching has been observed between cell 
types [81, 82]. miRNA-RISC binds to target mRNAs through complementary base-pairing 
interactions, which in mammals are primarily dependent on the miRNA seed sequence 
(nucleotides 2-8 from the 5’ end of the miRNA) [83]. More recent evidence has demonstrated that 
sequences outside the seed are important for miRNA target recognition, and that in vivo miRNA-
mRNA target pairs do not always follow seed pairing rules [84, 85]. 
It is clear that miRNAs negatively regulate their target mRNAs, although the exact 
mechanisms by which they exert their regulatory function remains controversial [16] (Figure 1.4). 
Evidence suggests that some combination of translation inhibition and mRNA degradation 
contribute to the decreased mRNA and protein abundance of miRNA target mRNAs [86-88]. The 
exact means of miRNA-mediated repression may depend on numerous factors, including 
sequence complementarity, binding site accessibility, and the presence of other factors including 
specific RBPs. 
 
1.5 METHODS TO STUDY RNA-PROTEIN INTERACTIONS  
 How do RBPs recognize their RNA targets? As described earlier, the β-sheet in each 
RRM is responsible for recognition of a specific sequence element. However, given the variety of 
RBDs, and the multitude of these domains in each RBP, recognition of RNA targets is governed 
by complex rules. Further complications arise when one considers that some such domains (i.e. 
dsRBD) do not recognize specific sequence elements but rather specific RNA structures. A prime 
example of this is the recognition of miRNA stem loop by DGCR8. This protein binds to a specific 
structural arrangement found in thousands of miRNA stem-loops rather than a clearly defined 
sequence motif [89]. In actuality, both the primary sequence and secondary structure of RNA 
targets are important for target recognition. Therefore, multiple approaches are required to gain 
an understanding of the features that dictate RBP-RNA interactions. Here, I will review classical 
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approaches and discuss more recent methodologies that directly identify RNA-protein interaction 
sites in cells. 
 
1.5.1 Classical Approaches 
A comprehensive analysis of bound RNA targets is necessary to understand the role of 
RBPs in post-transcriptional gene regulation. This information is needed to determine the specific 
binding sites as well as the sequence and structural preferences (interaction motif(s)) of each 
RBP. Initially, in vitro approaches were developed to identify these interacting motifs. Such 
approaches include RNA Electrophoretic Mobility Shift Assays (EMSAs), RNA-affinity 
chromatography, UV-crosslinking studies, Systematic Evolution of Ligands by Exponential 
Enrichment (SELEX), and RNACompete [90-95]. Although these studies have proven useful in 
identifying RBP interacting motifs and cis-elements, they are performed in vitro and thus may not 
reflect biologically relevant sequence specificities in cells.  
RNA EMSAs utilize in vitro binding and non-denaturing gel electrophoresis to identify 
changes in gel mobility due to binding events of protein and nucleic acids [92]. While effective in 
demonstrating strong protein-nucleic acid interactions (especially DNA-protein), EMSAs may not 
be sensitive enough to capture weak or transient binding events. UV-crosslinking experiments, in 
which covalently linked RNA-protein complexes are interrogated by SDS polyacrylamide gel 
electrophoresis (SDS-PAGE), can be utilized to increase sensitivity [91]. In RNA-affinity 
chromatography, a specific RNA sequence is used to capture an interacting RBP(s) from a total 
protein cell lysate [90]. This approach is commonly used when trying to identify protein partners of 
known cis-regulatory sequences, but highly abundant or promiscuous RBPs may confound 
results. Conversely, SELEX provides an approach to identify specific protein-interacting 
sequences for a particular protein of interest [93]. SELEX reduces investigator bias but 
systematic biases may also exist due to the in vitro nature of the methodology. Recent advances 
in SELEX-like approaches have enabled more high-throughput analyses and generated a 
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valuable resource of RNA-binding site sequence preferences for a few hundred RBPs [94, 95]. 
While all of these approaches can reveal RNA-protein interactions, each method has 
disadvantages and the most reliable results are those confirmed by multiple methods. 
Furthermore, most of these approaches can only be performed on one RNA or protein at a time, 
and may not consider RNA secondary structure, severely limiting their usefulness.  
 
1.5.2 Genomic Era Approaches 
More recently, in vivo approaches have been developed to directly study RNA-protein 
interactions in cells (Figure 1.5). All of these methods rely on the same general scheme, whereby 
RBPs are co-immunoprecipitated with their RNA targets, followed by identification and 
quantitation of bound RNAs. For instance, RNA immunoprecipitation (RIP) followed by RT-PCR, 
microarray (RIP-chip), or high-throughput sequencing (RIP-seq) have been used extensively to 
identify mRNA targets of RBPs from a variety of organisms [96]. RIP can also be performed in the 
presence of formaldehyde to stabilize interactions between RNAs and their interacting proteins. 
This method allows for more stringent washing and reduces the levels of RBP association with 
non-biologically relevant targets after cell lysis [97]. One caveat of this approach is that 
formaldehyde also crosslinks proteins to one another, and therefore the identified interactions 
may be indirect. However, revealing indirect associations may also be informative and biologically 
relevant given the complex nature of mRNPs in eukaryotic cells. 
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Figure 1.5 Global approaches to Identify RNA-protein interaction sites. In RIP, whole mRNAs are 
immunoprecipitated and quantified by qPCR, microarray, or sequencing. In CLIP-seq, RNA 
fragments are immunoprecipitated and sequenced to identify clusters. In PAR-CLIP RNA 
fragments are immunoprecipitated and sequenced and T>C transversions are used to identify 
single-nucleotide binding sites. 
 
A more specific approach for defining RNA-protein interactions is the Crosslinking and 
Immunopreciptiation (CLIP) approach (Figure 1.6 and 1.7). This approach relies on the 
crosslinking specificity of UV (254 nm) light, which covalently attaches RNAs to their interacting 
proteins (Figure 1.5) [98]. A ribonuclease (RNase) digestion is performed during the isolation of 
the RNA-protein complexes, thereby revealing the specific interaction regions of RNA targets 
(Figure 1.6). This improves the resolution of CLIP by isolating only RBP interacting sites in 
contrast to the full length RNA molecule that is isolated in RIP-based studies (Figure 1.5). CLIP 
followed by high-throughput sequencing-based analysis of protein-bound RNA sites (CLIP-seq or 
HITS-CLIP) and several variant protocols (e.g. Photoactivatable-Ribonucleoside-Enhanced 
Crosslinking and Immunoprecipitation (PAR-CLIP)) have been widely used to study RBPs in a 
diverse set of metazoan cell types (Figure 1.6) [99-101]. In PAR-CLIP, 4-thiouridine is introduced 
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into the cell media and longer wave UV light (365 nm) is used to specifically crosslink this non-
natural nucleotide. Cross-linking events create transversion mutations (T(U)>C) and algorithms 
are subsequently used on the resulting sequencing data to identify single-nucleotide resolution 
binding sites. These methods reveal the entire complement of binding sites for a given RBP, and 
have provided enormous insight into the role of these proteins in pre-mRNA splicing [102, 103], 
stability [104], and translation [105].  
 
Figure 1.6 Overview of the CLIP-seq approach. In CLIP-seq, RNA-protein complexes are 
crosslinked with UV light (254 nm). RNAs are digested through an RNase treatment and a protein 
of interest is immunoprecipitated. Crosslinks are reversed by proteinase digestion followed by 
strand-specific library preparation and high-throughput sequencing. 
 
While CLIP-seq and PAR-CLIP are powerful approaches to identify in vivo RNA-protein 
interaction sites, they can only identify the binding sites of a single protein at a time. Therefore, 
their impact is limited due to the large number of RBPs encoded in genomes as well as the labor-
intensive nature of these assays. Therefore, there is a need for more global approaches for 
defining RNA-protein interaction sites. The work discussed in Chapter 2 describes the 
development of one such assay by our laboratory (Figure 1.7). Concurrent with this work, other 
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RNA-centric approaches were developed. For instance, a photoactivatable-ribonucleoside 
enhanced crosslinking (PAR-CL) and oligo-dT affinity purification coupled with RNase (RNase I) 
digestion was used to comprehensively reveal the binding sites of RBPs along mature mRNAs in 
human and yeast (Figure 1.8) [22, 106]. These approaches are an RNA-centric means to define 
RNA-protein interaction sites across eukaryotic transcriptomes without the need for antibodies to 
specific proteins. We and others have since used these approaches to investigate nuclear RNPs 
and compare RBP-RNA interaction profiles in different cell types [107, 108]. Future studies are 
necessary to address RNA-protein interaction dynamics during important biological processes in 
order to advance our understanding of post-transcriptional gene regulation. 
 
Figure 1.7 RNA-centric approaches to study RBP-RNA interactions. In PAR-CL, cells are 
supplemented with 4-thiouridine, and crosslinked with UV (365 nm). mRNA-protein complexes 
are enriched by oligo-dT selection and RNase/proteinase digestion is performed to liberate 
complexes. In PIP-seq, RNA-protein complexes are stabilized with formaldehyde followed by 
differential RNase digestion. Protein binding sites are identified by comparative analysis. 
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1.6 OUTLINE OF DISSERTATION 
 In Chapter 2, I describe the development of a novel, high-throughput approach to globally 
identify regions of RNA-protein interaction throughout a transcriptome of interest. As a proof-of-
principle, we applied this technique to human HeLa cells and provide evidence that our approach 
captures both known and novel RNA-protein interaction sites. We identified global patterns of 
RNA-protein interactions, found evidence for co-binding of functionally regulated genes, and 
revealed that disease associated single nucleotide polymorphisms (SNPs) are enriched within 
RBP interaction sites. 
 In Chapter 3, we used CLIP-seq to create a transcriptome-wide map of poly(A)-binding 
protein (PABPC1) interaction sites in the mouse transcriptome. This analysis revealed that 
PABPC1 binds to mammalian mRNAs outside of its canonical role in poly(A) tail binding. We 
showed that PABPC1 binds directly to the highly conserved polyadenylation signal sequence and 
to translation initiation and termination sites. We also showed that PABPC1 binds to A-rich 
regions in the 5’ untranslated region of a subset of mRNAs, including its cognate mRNA, and 
negatively regulates their translation and stability. 
 In Chapter 4, we applied a recently developed approach to isolate and sequence Ago-
bound pre-miRNAs in the human transcriptome. Using a novel bioinformatics pipeline, we 
uncovered widespread trimming and tailing of pre-miRNAs and identified novel AGO2-cleaved 
pre-miRNAs. We created an index for pre-miRNA processing efficiency and discovered that 
numerous pre-miRNA-like elements are embedded within mRNAs. Some of these represent 
novel miRNAs but the majority, including the iron-responsive element of ferritin genes, are 
inefficiently processed into mature small RNAs. The function of these poorly processed pre-
miRNA-like sequences will be the focus of future investigations. 
 In Chapter 5, I discuss the implications of these studies, and delineate future experiments 
to address new questions that have arisen from this work. 
 
24	  
	  
 
 
 
Chapter 2: RNASE-MEDIATED PROTEIN 
FOOTPRINT SEQUENICNG 
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This section refers to work from: 
• Silverman IM*, Li F*, Alexander A, Goff L, Cole T, Rinn JL, Gregory BD. 2014. RNase-
mediated protein footprinting reveals protein-binding sites throughout the human 
transcriptome. Genome Biology. 15:R3 
• Silverman IM and Gregory BD. Transcriptome-wide Ribonuclease footprinting to identify 
RNA-protein interaction sites. Methods. 72:76-85 
 
Abstract: 
 RNAs are continuously associated with RNA-binding proteins (RBPs), and these 
interactions are necessary for many key cellular processes ranging from splicing to chromatin 
regulation. Although numerous approaches have been developed to map RNA-binding sites of 
individual RBPs, few methods exist that allow assessment of global RBP-RNA interactions. Here, 
we describe a universal, high-throughput, ribonuclease-mediated protein footprint sequencing 
approach that reveals RNA-protein interaction sites throughout a transcriptome of interest. We 
apply this method to the HeLa transcriptome and compare RBP binding sites found using 
different cross-linkers and ribonucleases. From this analysis, we identify numerous putative RBP 
binding motifs, reveal novel insights into co-binding by RBPs, and uncover a significant 
enrichment for disease-associated polymorphisms within RBP interaction sites. 
 
Contributions: 
 The contents of this section were generated by in collaboration with Fan Li. I performed 
all experimental analyses with technical assistance from Anissa Alexander. Fan Li provided 
bioinformatic support for the computational aspects of the work and assisted in the drafting of the 
first manuscript. 
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2.1 INTRODUCTION  
 RNA-protein interactions are central to all of the post-transcriptional regulatory processes 
that control gene expression. From the initial processing of a protein-coding transcript in the 
nucleus to its final translation and decay in the cytoplasm, cellular mRNAs are involved in a 
complex choreography with various trans-acting RNA-binding proteins (RBPs) [19-21]. RBPs are 
also required for the processing and function of the thousands of non-coding RNAs (ncRNAs), 
both large and small, encoded by eukaryotic genomes. These RNAs have a variety of cellular 
functions, including chromatin regulation and control of cell fate [109, 110]. Thus, RNA-protein 
interactions represent a vast, diverse, and critical layer of transcriptome regulation. 
 Eukaryotic genomes encode a large collection of RBPs that interact with mRNAs to form 
dynamic multi-component ribonucleoprotein complexes (RNPs) [111, 112]. These RNPs often 
constitute the functional forms of mRNAs, and it is only through their proper formation that 
transcripts are correctly regulated to precisely produce the required amounts of each protein in a 
cell [19, 21, 26, 112]. Intriguingly, recent evidence suggests that post-transcriptional regulation of 
mRNAs encoding functionally related proteins likely requires mRNP assembly by specific sets of 
co-occurring RBPs, an idea that was originally postulated by the post-transcriptional operon 
hypothesis [39, 113]. Thus, the precise composition and formation of RNPs in eukaryotic cells is 
critical for proper gene expression regulation. 
 The essential nature of RNA-protein interactions to eukaryotic biology has led to the use 
of numerous biochemical, genetic, and computational approaches being utilized, alone and in 
combination, to identify and validate RBPs and their specific RNA-binding sites [20, 114, 115]. 
These approaches have proven useful in characterizing a number of RBPs [89, 103, 105, 116-
126]. However, all of these earlier approaches investigated RNA-protein interactions one protein 
at a time, limiting the ability to monitor the global landscape of RNPs and to reveal insights into 
the combinatorial binding and regulation by the cellular milieu of RBPs. This observation points to 
a major gap between the significance of cellular RNA-RBP interactions and the difficulty in 
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establishing a comprehensive catalogue of these interactions in a single experiment.  
Recently, several groups have established experimental approaches to interrogate RNA-
protein interaction sites on a more global scale. These approaches utilize 4-thiouridine and 
ultraviolet (UV) cross-linking to identify RNA-protein interactions by uncovering sites of T>C 
transversion (representing RNA-protein cross-linking events) [127, 128]. However, these studies 
have been limited by several factors. Specifically, they rely on treatment with synthetic 
nucleotides and UV cross-linking, which can be used for cell culture but not tissues or whole 
organisms. Furthermore, UV cross-linking only identifies sites of direct RNA-protein contact and 
may not capture the larger multi-protein complexes that comprise the overall RNP architecture in 
vivo. Finally, these studies have focused on poly-adenylated (polyA) transcripts, reducing their 
ability to monitor RBP binding in non-polyA and nascent RNAs.  
To address the limitations of the currently available methodologies, we report here a 
ribonuclease (RNase)-mediated protein footprint sequencing approach that we call protein 
interaction profile sequencing (PIP-seq). This approach identifies RNA-protein interaction sites 
within both unprocessed and mature RNAs in a mostly unbiased manner and on a transcriptome-
wide scale. We describe the use of multiple cross-linking techniques to capture both direct and 
indirect RNA-protein interactions. We also show that both single-stranded and double-stranded 
RNases uncover distinct but overlapping sets of RNA-protein interaction sites. Using this 
approach, we find PIP-seq to be a reproducible approach that reveals both previously known and 
novel RBP interaction sites. We demonstrate the utility of PIP-seq by uncovering enriched 
sequence motifs within the complement of identified RBP interaction sites. We also investigate 
the interactions among protein-binding sites and provide evidence for co-binding of RNAs by 
specific sets of RBPs, some of which bind to groups of transcripts encoding functionally related 
proteins. These results reveal novel insights into networks of post-transcriptional gene regulation 
mediated by specific groups of RBP-bound sequence motifs. Finally, we identify a significant 
enrichment for disease-associated variants within RBP interaction sites, and demonstrate the 
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effects of some of these single nucleotide polymorphisms (SNPs) on RNA-protein interactions. 
Overall, our approach provides an RNA-centric global assessment of RNA-RBP interactions that 
directly identifies RNA-protein interaction sites and is applicable for use in all organisms and 
sample types. 
 
2.2 RESULTS AND DISCUSSION 
2.2.1 RNase-mediated protein footprinting identifies sites of RNA-protein interaction 
 To obtain an unbiased, genome-wide view of RNA-protein interactions for both 
unprocessed and mature RNAs in eukaryotic transcriptomes, we developed an RNase-mediated 
protein footprint sequencing approach, referred to herein as PIP-seq, by performing our nuclease-
sensitivity sequencing assays [129, 130] on cross-linked RNA-protein complexes from HeLa cells 
(Figure 1A). Previous investigations of RNA-protein interactions have assayed stable 
endogenous interactions as well as those captured by the use of UV (254 nm), which cross-links 
only direct protein-nucleic acid contacts, and formaldehyde, which cross-links protein-nucleic acid 
and protein-protein contacts with longer range [131-133]. Therefore, to generate a 
comprehensive and multifaceted view of RBP interaction sites, we used both cross-linking 
techniques and no cross-linking when performing PIP-seq.  
 We had previously used nuclease-sensitivity sequencing assays on purified RNAs to 
determine RNA base-pairing probabilities by treating RNA with either single-stranded or double-
stranded RNase (ss- or dsRNase, respectively) and sequencing the resulting populations. We 
reasoned that by using both of these RNases on cross-linked RNA-protein complexes, we would 
be able to both comprehensively map RBP binding sites and also investigate RNA base-pairing 
probabilities in vivo. However, for the purposes of this manuscript we focus our analysis 
specifically on the identification of protein-interaction sites, which we refer to as Protein-Protected 
Sites (PPSs). 
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 To perform PIP-seq, we started with adherent HeLa cells cross-linked by one of the 
methods described above (UV or formaldehyde) or used cells that had not been cross-linked. The 
resulting cell lysates were then split into experimental and background samples. Due to the 
structure-specific nature of the RNases used, it was essential to have a background sample to 
control for RNase insensitive regions. Therefore, a ‘footprint sample’ (experimental) was directly 
treated with either a single- or double-stranded RNase (ssRNase [RNaseONE] or dsRNase 
[Rnase V1], respectively). In contrast, the ‘RNase digestion control’ sample was first denatured in 
SDS and treated with Proteinase K prior to RNase digestion. In this way, regions that were 
protein-protected in the footprinting sample became sensitive to RNase digestion in the control 
sample and regions that were unbound but insensitive to one of the nucleases due to their 
structural status, remained that way. For both samples, cross-links were subsequently reversed 
(heating for formaldehyde cross-links and extensive Proteinase K treatment for UV cross-links) 
and followed by strand-specific library preparation (Figure 2.1). Highly abundant RNA species 
(e.g. ribosomal RNAs) were depleted from each library based on their rapid re-annealing rates 
using a duplex-specific thermostable nuclease (DSN) protocol (see Materials and Methods for 
more details). 
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Figure 2.1 PIP-seq strategy and design. Tissue culture cells are cross-linked with formaldehyde 
and split into two samples. RNase footprinting samples are subjected to RNase treatment with 
either an ssRNase (RNase One) or dsRNase (RNase V1). RNases are then inhibited and cross-
links reversed. RNase digestion control samples are subjected to protein denaturation and 
digestion first, followed by RNase treatment (ssRNase or dsRNase). The RNA fragments are then 
ligated between RNA sequencing adapters and subjected to strand-specific library preparation. 
DSN treatment is used to remove highly abundant RNA species and the resulting library is 
sequenced on an Illumina HiSeq2000. Examples of PPSs identified in TARDBP (top panel) and 
FUS (bottom panel) by replicates from ssRNase and dsRNase PIP-seq experiments. Color scale 
indicates CSAR enrichment score for footprint library compared to digestion control library (as 
indicated at the bottom of the figure). 
 
 
 We then sequenced the resulting libraries (4 total for each replicate) using the Illumina 50 
base pair (bp) single-end sequencing protocol, and obtained ~31-60 million raw reads per library 
(Table 2.1). To identify PPSs, we used a Poisson distribution model based on a modified version 
of the CSAR software package [134]. Specifically, read coverage was calculated for each base 
position in the genome and a Poisson test was used to compute an enrichment score for footprint 
versus RNase digestion control libraries (Table 2.1). PPSs were then called as described for 
ChIP-seq analysis [134] with a false discovery rate (FDR) of 5% (Figure 2.1). Using this approach 
we identified a total of ~1,011,000 PPSs over 7 experiments, comprising ~430,000 non-
overlapping sites (Table 2.1).  
 We found PPSs identified by both cross-linking strategies and with no cross-linking to be 
widely distributed across both exonic and intronic regions, with a particular enrichment for distal 
intronic binding in the formaldehyde cross-linked experiments (Figures 2.2). Closer examination 
of PPSs broken down by genic features (e.g. 5’ and 3’ UTR, CDS, and intron) or RNA type 
(mRNA and lncRNA) revealed that > 50% of all human mRNAs contained multiple binding events 
across all transcript regions except the 5’ UTR (average of ~1 PPS in only 28.8% of total 
transcripts) in HeLa cells (Figure 2.3). Strikingly, an average of ~26 PPSs were found in the 
introns of each transcript in the formaldehyde cross-linked PIP-seq experiments, compared with 
~3 and ~2 intronic PPSs with the UV and non-cross-linked experiments, respectively (Figure 2.3). 
These results suggest that formaldehyde cross-linking captures more transient and/or weak RBP-
RNA interactions within intronic (especially distal (> 500 nucleotides (nt) from a splice site)) 
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portions of mRNAs. We also found that ~2 – 6% of all known human lncRNAs could be identified 
as containing an average of 2.5 PPSs in HeLa cells using PIP-seq with the various cross-linking 
strategies (Figure 2.3). The limited number of PPS-containing lncRNAs uncovered by our 
experiments is likely due to the low expression and tissue-specific nature of these transcripts. To 
address a possible dependence of our approach on RNA expression levels, we assessed the 
relationship between RNA steady state abundance and number of PPSs per transcript and found 
that RNA levels explained only a small fraction (R2 = 0.11) of the total variation in PPS counts 
between transcripts (Figure 2.4). Overall, these results suggest that PIP-seq provides a 
comprehensive and mostly unbiased view of global RNA-protein interaction sites in eukaryotic 
transcriptomes. 
Table 2.1 PIP-seq library characteristics 
 
 
Table2.1: PIP-seq library characteristics
Cross-linker Rnase Replicate Library Type raw reads trimmed reads
trimmed 
reads (%)
mapped 
reads
mapped 
reads (%) PPS (FDR=5%)
Footprint 60,880,156 42,030,874 69.04% 30,639,721 72.90%
Control 77,929,058 65,922,052 84.59% 53,512,731 81.18%
Footprint 103,702,805 89,989,687 86.78% 74,858,669 83.19%
Control 88,842,812 75,858,871 85.39% 67,295,403 88.71%
Footprint 66,398,039 59,750,511 89.99% 51,968,442 86.98%
Control 77,342,721 59,282,909 76.65% 52,909,099 89.25%
Footprint 70,747,816 51,183,479 72.35% 45,281,100 88.47%
Control 67,705,765 40,019,397 59.11% 36,112,186 90.24%
Footprint 70,546,971 58,144,499 82.42% 51,232,318 88.11%
Control 62,663,571 48,642,460 77.62% 45,222,199 92.97%
Footprint 64,725,704 46,067,911 71.17% 40,107,905 87.06%
Control 79,466,145 60,612,150 76.27% 56,223,519 92.76%
Footprint 31,019,360 27,834,338 89.7% 25,654,498 92.2%
Control 39,136,707 35,069,030 89.6% 30,905,190 88.1%
Footprint 24,604,010 21,458,724 87.2% 18,832,305 87.8%
Control 32,977,185 29,400,832 89.2% 22,126,579 75.3%
Footprint 31,248,062 25,230,672 80.7% 23,381,804 92.7%
Control 29,411,398 24,114,686 82.0% 22,983,479 95.3%
Footprint 30,371,337 25,984,739 85.6% 24,337,412 93.7%
Control 27,442,306 21,546,936 78.5% 20,412,845 94.7%
Footprint 33,186,168 31,303,968 94.3% 29,057,193 92.8%
Control 34,912,635 32,291,230 92.5% 27,402,521 84.9%
Footprint 32,691,777 28,246,801 86.4% 26,881,380 95.2%
Control 29,148,805 24,234,319 83.1% 23,072,655 95.2%
Total 1,267,101,313 1,024,221,075 900,411,153 1,011,025
Average 52,795,888 42,675,878 83% 37,517,131 89% 42,126
Formaldehyde
double-
stranded
1 70,371
2 88,060
3 122,277
single-
stranded
1 190,654
2 289,984
3 143,631
UV (254 nm)
double-
stranded
1 6,642
2 2,871
single-
stranded
1 42,878
2 24,635
None
double-
stranded 1 2,428
single-
stranded 1 26,594
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Figure 2.2 Absolute distribution of PPSs throughout RNA species for formladehyde PIP-seq 
experiments. 
 
Figure 2.3 Average PPS count per RNA molecule (classified by RNA type (mRNA and lncRNA) 
and transcript region (e.g. 5’ UTR)) for formaldehyde PIP-seq experiments. Percentages indicate 
the fraction of each RNA type or region that contains PPS information. 
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Figure 2.4 Average expression (y-axis) of human mRNAs separated by total number of PPSs 
identified in their sequence (x-axis) for formaldehyde cross-linking identified PPSs. 
 
In general, we found that formaldehyde cross-linking revealed the highest number of 
PPSs, whereas UV and no cross-linking yielded many fewer sites (Table 2.1). This is not 
surprising, given that formaldehyde both has longer range than UV and also can stabilize more 
transient and indirect interactions. Thus, the use of formaldehyde cross-linking gives a more 
comprehensive view of RNA-protein interaction sites, while the use of UV likely increases the 
specificity of PPSs to more tightly associated RBP-bound targets. We also observed that 
ssRNase treatment yielded twice as many unique PPSs as compared to dsRNase digestion 
(Table 2.1). There are several explanations for this, none of which are mutually exclusive. For 
example, the ssRNase may have higher activity in the reaction conditions used in our 
experiments, the dsRNase may have lower accessibility to protein-bound dsRNA regions, or 
human RBPs may prefer non-structured regions within target RNAs for interaction. Together, 
these results show that the choice of cross-linking reagent or RNase can have a profound effect 
on RNA-protein interaction site identification and that these effects likely apply to the other 
technologies that address this same experimental question [127, 128]. 	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2.2.2 PIP-seq is a reproducible approach known and novel RBP interaction sites 
 To assess the reproducibility of PIP-seq, we first determined the correlation of 
sequencing read abundance between biological replicates of footprinting and RNase digestion 
control libraries (Figure 2.5). Using a sliding window approach, we observed high correlation in 
read counts between individual replicates of formaldehyde cross-linked, ssRNase-treated 
footprinting and RNase digestion control libraries (Pearson correlation r = 0.88 and 0.84, 
respectively) (Figure 2.5A). Similar results were also found for the dsRNase treated libraries 
(Pearson correlation r = 0.84 and 0.76, footprinting and RNase digestion control, respectively) 
(Figure 2.5B). This high reproducibility of PIP-seq libraries was also observed between replicates 
of the UV cross-linked libraries (data not shown). Together, these data indicate that PIP-seq 
experiments and controls are reproducible across replicates using various RNases and cross-
linkers.   
 We next investigated the reproducibility of exact PPS identification between paired 
biological replicates. With formaldehyde cross-linking, we observed 68% and 42% (for ssRNase 
and dsRNase, respectively) overlap between PPSs identified in two replicates (Figure 2.6A). 
Similarly, 73% and 64% (ssRNase and dsRNase, respectively) of the PPSs identified by UV 
cross-linking were replicated in a second, larger data set (Figure 2.6B). This degree of overlap 
between PPSs is relatively high when compared to the more modest reproducibility of the 
identified RBP binding sites in CLIP-seq and PAR-CLIP experiments [120]. In total, these results 
indicate that our novel approach is a reproducible means of identifying the protein-bound 
component of the eukaryotic transcriptome. 
 
36	  
	  
Figure 2.5 Correlation of PIP-seq replicates. A-B) Correlation in read counts between two 
formaldehyde cross-linked (A) ssRNase-treated PIP-seq replicates (footprinting sample on left, 
RNase digestion control on right). (B) As in (A), but for formaldehyde cross-linked dsRNase-
treated replicates.   
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Figure 2.6 Overlap in PPS calls between formaldehyde (A) and UV-cross-linked (B) ssRNase-
treated (top, blue), and formaldehyde cross-linked dsRNase-treated (bottom, green) PIP-seq 
replicates.  
 
 We also interrogated the relationship between PPSs identified by different RNases. We 
compared the use of RNaseONE, which preferentially cleaves single-stranded RNA, to RNaseV1, 
which preferentially cleaves paired bases (Figure 2.7). We found high overlap between 
formaldehyde PPSs (72%) identified by each RNase, as compared to UV (32%) or non-cross-
linked (37%) PPSs. This is unsurprising, given the larger number (Table 2.1) of formaldehyde 
identified PPSs as compared to UV or non-cross-linked experiments. In total, these results 
revealed that both RNases uncovered a set of overlapping and unique PPS sequences, 
demonstrating that the use of an ss- and dsRNase is needed for comprehensive identification of 
RNA-protein interaction sites in eukaryotic transcriptomes.  
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Figure 2.7 Overlap in PPS calls between formaldehyde (A), UV- (B) and non-cross-linked (C) 
ssRNase and dsRNase treated PIP-seq samples. 
 
 To validate that PIP-seq identifies bona fide RNA-protein interaction sites, we overlapped 
PPSs with known RBP binding sites from HeLa and HEK293T cells [89, 103, 116-127], and found 
that a significant number (all p-values < 2.2e-16) of the PPSs coincided with numerous RBPs 
previously tested by single protein immunoprecipitation approaches (e.g. HITS-CLIP, PAR-CLIP, 
etc.) as compared to an expressed transcriptome background (see Materials and Methods for 
more details) (Figure 2.8). This is noteworthy given our analysis of PPSs in HeLa cells, whereas 
the majority of the CLIP-seq and PAR-CLIP datasets were generated using HEK293T cells.  
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Figure 2.8 Overlap between PPSs identified from formaldehyde cross-linking treated PIP-seq 
samples and various CLIP datasets. Values are shown as log2 enrichment over shuffled 
background distributions. *** denotes p-value < 2.2e-16, Chi-squared test.  
 
We also compared our data with previously published global PAR-CLIP (gPAR-CLIP) 
data from HEK293T cells [127], in which protein-binding sites were identified on the basis of T>C 
transversions (Figures 2.8 and 2.9). We observed a significant (p-value < 2.2e-16) enrichment of 
the previously identified transversion events within our identified PPSs relative to the expressed 
transcriptome background, suggesting that at least some fraction of binding events are cell type 
independent (~38% overlap between HeLa and HEK293T, Figures 2.8 and 2.9). Furthermore, we 
analyzed the number of T>C transversions per PPS and found that on average 6.3 T>C 
transversions were observed per PPS for the formaldehyde cross-linked PPSs (Figure 2.10). 
These data revealed that there are often numerous gPAR-CLIP T>C transversions per RNA-
protein binding event identified by PIP-seq, and suggest that many of our identified PPSs 
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represent sites of multi-RBD and/or multi-RBP interactions. Additionally, our findings demonstrate 
that PIP-seq can identify the full footprint of RBP-RNA interaction sites, underscoring its utility in 
studying these events.  
 
Figure 2.9 Overlap between cross-linked PPSs from HeLa cells and 40 nt T>C transversion 
event-containing loci from the gPAR-CLIP dataset generated from HEK293T cells (T>C 
transversion events less than 40bp apart were merged to generate a data set comparable to 
PPSs).  
  
Figure 2.10 Number of T>C transversion events per PPS identified by formaldeyde cross-linking 
(purple) versus shuffled regions (gray). Values for the number of events per shuffled region are 
the average from ten random shuffles. 
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It is also worth noting that PIP-seq identified a total of 428,713 ~40 nt protein protected 
regions, while gPAR-CLIP yielded 706,586 loci of similar length (Figure 2.10). There are multiple 
explanations for this discrepancy. For instance, PIP-seq involves the use of a background control 
library (RNase digestion control (Figure 2.1)) whereas gPAR-CLIP does not. This control is likely 
important for distinguishing between noise and true protein binding events, and may account for 
the identification of fewer sites by PIP-seq. Alternatively, PIP-seq may be less sensitive due to the 
lack of a stringent RNA-protein purification step. In total, our results indicate that PIP-seq 
captures a significant population of human RNA-protein interaction regions in a single 
experiment, further validating its reliability and robustness.  
 
2.2.3 PIP-seq reveals an in-depth view of the protein-bound transcriptome 
 Two outstanding questions in the field of RNA biology are the extent and patterning of 
RBP binding across genic regions. We set out to address these questions using PIP-seq data 
from the various cross-linkers and RNases. We first determined the size distribution of PPSs 
identified by each RNase and cross-linker (Figure 2.11). We found that the median PPS sizes for 
formaldehyde cross-linked ss- and dsRNase treatments were ~40 and ~35 nt, respectively. 
Importantly, this variation in size between the two RNases was consistent across cross-linkers 
(Figure 2.11), suggesting that ssRNase treatment reveals larger protein footprints and/or longer 
stretches of RBP interactions across RNA regions.  
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Figure 2.11 Distribution of ssRNase-treated (light blue bars) and dsRNase-treated (green bars) 
PPS sizes from formaldehyde treated samples. Dashed lines represent mean PPS sizes 
(ssRNase, blue line and dsRNase, green line).  
  
 To assess the genomic distribution of protein binding events, we calculated the 
enrichment of PPSs in specific regions of the human transcriptome (e.g. coding sequence [CDS], 
5’UTR, 3’UTR, intron, etc.) relative to their expression levels in the RNase digestion control 
sample (Figure 2.12). This analysis revealed a consistent enrichment between RNases and 
cross-linkers for protein-binding in the 3’UTR, proximal (< 500 nt from a splice site) introns, as 
well as within the CDS (Figure 2.12). These results are unsurprising given the role of these 
regions in post-transcriptional regulation and translation. We also found that distal (> 500 nt from 
a splice site) intronic regions were enriched for protein binding in the formaldehyde treated 
samples only (Figure 2.12), suggesting a high level of transient, weak, and/or non-specific RNA-
binding activity occurs in these non-coding areas. Our results support the idea that the large 
interior regions of introns may serve as sinks for RBPs in human cells [121]. 
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Figure 2.12 Genomic distribution of PPS density for formaldehyde crosslinked (C) samples, 
measured as PPS base coverage normalized to RNase digestion control read counts per 
genomic region. Proximal intron refers to 500 nt at the 5' and 3' ends of introns.  
 
 In contrast to protein-coding mRNAs, we found that long non-coding RNAs (lncRNAs) 
were consistently depleted for protein-binding (Figure 2.12). Therefore, we closely examined 
protein binding to the 100 most highly expressed lncRNAs compared to expression-matched 
mRNA 3’ UTRs in the three different cross-linking conditions. These analyses revealed that the 
fraction of identified lncRNA and 3’UTR base pairs bound by proteins was similar for the 
formaldehyde cross-linking experiments using both RNases. Conversely, for UV and no cross-
linking, lncRNAs demonstrated a significant depletion in protein binding compared to the 
expression-matched mRNA 3’ UTRs (Figure 2.13). This depletion was consistent for both 
RNases, suggesting that this finding is not a consequence of structural differences between 
mRNAs and lncRNAs. In total, these results support the hypothesis that lncRNAs are more 
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weakly and/or transiently bound by interacting proteins as compared to protein-coding mRNAs, 
which may be a distinguishing feature of these two types of eukaryotic RNAs.  
 Given the fundamental role of RBP-RNA interactions in the regulation of eukaryotic gene 
expression, we hypothesized that many of the identified PPSs would be evolutionarily conserved 
within vertebrates. To test this, we compared SiPhy-π conservation scores for PPSs versus 
same-sized neighboring regions (Figure 2.14). Using this approach, we found that PPS 
sequences were significantly (p-value < 2.2e-16) more evolutionarily conserved than flanking 
regions (Figure 2.14A-C). Importantly, this was true for PPS sequences in both exonic and 
intronic portions of human mRNAs, but not for lncRNAs (Figures 2.14D and G), and was 
consistent for PPSs identified with every cross-linking approach (Figures 2.14E-F and H-I). These 
results support the notion that the ability to interact with RBPs is functionally important to mRNA 
sequences, and that this trait has undergone selection during vertebrate evolution. Furthermore, 
the lack of conservation of PPSs within lncRNAs is consistent with their low conservation rates 
across vertebrate species.  
 
Figure 2.13 Fraction of base pairs covered by PPSs in 100 most highly expressed lncRNAs 
(orange bars) and expression-matched control mRNA 3’UTRs (purple bars) for PIP-seq libraries 
made with ssRNase (ss) or dsRNase (ds) under the three different cross-linking conditions (as 
specified). 
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Figure 2.14 PPSs are highly conserved. (A-C) Cumulative distribution of average SiPhy-π scores 
in formaldehyde (A), UV- (B) and non-cross-linked (C) identified PPSs (red line) versus similarly-
sized flanking sequences (gray line). (D-F) Comparison of average SiPhy-π scores between 
formaldehyde (D), UV- (E) and non-cross-linked (F) identified PPSs (red bars) and flanking 
sequences (gray bars) for various genomic regions. (G-I) Average SiPhy-π score profiles across 
the first and last 25 nt of formaldehyde (G), UV- (H) and non-cross-linked (I) identified PPSs as 
well as 50 nt upstream and downstream of exonic (green line), intronic (blue line), and lncRNA 
(orange line) PPSs. *** denotes p-value < 2.2e16, NS = not significant, Chi-squared test. 
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2.2.4 RBP binding densities across unprocessed and mature mRNAs 
 Given the importance of RBP binding within different regions of mRNAs, we decided to 
determine the density of protein-binding sites within specific regions of protein-coding transcripts 
(Figure 2.15). To do this, we first identified PPSs within each annotated CDS, 5’ UTR, 3’UTR, and 
intronic region and calculated the relative distribution of binding sites across these regions 
(Figures 2.15A-C). We corrected for average length of each region to obtain a global view of 
relative binding between regions. We also calculated PPS coverage on a per nucleotide basis for 
specific sub-regions of protein-coding mRNAs (Figures 2.15D-I). 
 Applying this approach to PPSs identified with formaldehyde cross-linking, we observed 
similarly high levels of binding within the entirety of the CDS and 3’ UTR of protein-coding 
transcripts with an enrichment for binding events occurring at and near the start and stop codons 
(Figures 2.15A and D). This enrichment was particularly evident when interrogating the PPS 
density over the start and stop codons on a per nucleotide basis (Figure 2.15D). Similar 
enrichments leading to the start of the CDS were identified when defining PPS densities in the 5’ 
UTR. We also found that the overall protein binding density was lower in the 5’ UTR when 
compared to the CDS and 3’ UTR (Figures 2.15A). The observed enrichment of PPSs at the CDS 
start and stop codon regions likely reflects ribosome binding, as was previously observed by 
others [127, 128].  
 Overall similar patterns of RBP binding were also observed for the UV and no cross-
linking experiments (Figures 2.15B-C). The two exceptions were that UV and non-cross-linked 
RBP binding density across the 3’ UTR peaked near the middle of this region (Figures 2.15B-C), 
and the interaction profile directly over the start codon displayed a minor depletion in protein 
binding in these experiments (Figures 2.15E-F). These results likely reflect the differential cross-
linking specificities of formaldehyde and UV, and support the use of multiple cross-linkers in the 
comprehensive identification of RBP binding sites. 
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Figure 2.15 PPS coverage across mRNAs. (A-C) Average PPS density for formaldehyde (A), UV- 
(B) and non-cross-linking (C) experiments across 100 equally spaced bins in various genic 
regions. Values are normalized separately for each genic region (e.g. intron). (D-F) Average PPS 
density for formaldehyde (D), UV- (E) and non-cross-linking (F) experiments within 50 nt of CDS 
ends. (G-I) Average PPS density for formaldehyde (G), UV- (H) and non-cross-linking (I) 
experiments within the first and last 50 nt of introns. Dotted lines in (D-I) represent the remaining 
(unanalyzed) length of each element. 
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base resolution, we located the beginning of this enrichment starting 40 nt away from each splice 
site, consistent with the binding location of RNA splicing factors (Figures 2.15G-I). In total, our 
results indicate that PIP-seq gives a comprehensive view of RNA-protein interaction site densities 
in all portions of mature as well as unprocessed mRNAs, especially when multiple cross-linking 
agents are employed. 
  
2.2.5 PIP-seq provides evidence for the post-transcriptional operon hypothesis  
 Given that PPSs correspond to protein-bound RNA sequences (Figure 2.8), we sought to 
gain insights into the sequence elements that are enriched within RNA-protein interaction sites in 
the HeLa transcriptome. To do this, we employed the MEME (Mulitple EM for Motif Elicitation) 
algorithm [135] on PPSs partitioned by specific region (e.g. 5’ UTR, 3’ UTR, CDS, and intron). 
Because we could not rule out ribosome binding at start and stop codons, we additionally 
removed the first and last exon of each CDS. Using this approach, we identified previously known 
binding motifs including sequences similar to the LIN28 binding motif [124] and U-rich sequences 
(accessible at gregorylab.bio.upenn.edu/PIPseq). We also identified numerous putative RBP 
binding motifs, some of which are particularly interesting because they are long (~20 nt) and 
contain multiple strong consensus sequences flanked by weaker ones (3’UTR motifs 4 and 31 
and intron motifs 1 and 13) (accessible at gregorylab.bio.upenn.edu/PIPseq). These motifs may 
correspond to binding by multiple RNA-binding domains (e.g. RRM) of a single protein or by a 
complex of multiple RBPs. Importantly, motifs with this signature have not been previously 
reported in CLIP-seq and PAR-CLIP data. In addition, we identified at least one sequence that 
displayed a high degree of self-complementarity (3’ UTR motif 1). This is surprising, given that 
MEME does not use RNA secondary structure as a search feature while identifying motifs from a 
set of given sequences. These findings underscore the utility of PIP-seq and its use of multiple 
structure-specific nucleases to uncover hidden features of the protein-interacting transcriptome. 
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Figure 2.16 PPS analysis reveals evidence for post-transcriptional operons. (A) MDS analysis of 
RBP-bound motif co-occurrence in human mRNAs. The motifs used for this study were identified 
by a MEME-based analysis of PPS sequences. Sequences for all of the motifs used in this 
analysis can be found in Additional File 10. Colors indicate cluster membership as defined by k-
means clustering (k = 5). (B) The most significantly enriched biological processes (and 
corresponding p-value) for target transcripts, where the specified clusters of motifs identified in 
(A) are co-bound.  
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Although RNAs are thought to be bound and regulated by multiple RBPs, very little is 
known about these interactions and the relationships between specific RBPs and their 
corresponding sequence motifs. To address this, we interrogated the interactions between 
putative RBP binding motifs (Figure 2.16A) discovered by our PIP-seq approach, since these are 
protein-bound sequences in HeLa cells. To do this, we first identified all instances of each motif 
within the global set of identified PPSs on target RNAs using FIMO [136]. We collapsed motifs 
with similar sequences and excluded those that were long (~20 nts) and non-degenerate because 
these likely represent repetitive sequences instead of true binding motifs. We then quantified the 
co-binding of the remaining motifs (~40) within all protein-coding mRNAs by counting the number 
of transcripts on which each pair of motifs was jointly found within PPSs. We then used k-means 
clustering of the resultant weighted adjacency matrix and identified 5 clusters of motifs that 
interact on highly similar sets of target mRNAs (Figure 2.16A). These findings indicate that many 
mRNAs contain numerous RBP interacting motifs within their sequences and that coordinated 
binding of RBPs to specific target transcripts may represent a general phenomenon of cellular 
RNA-protein interactions, as was previously proposed by the post-transcriptional operon 
hypothesis [39, 113].  
We also used DAVID [137] to interrogate over-represented biological processes for RNAs 
that contained binding events for each motif from the five clusters identified in the k-means 
analysis (Figure 2.16A, Clusters 1, 3 – 5). It is of note that the motifs in Cluster 2 did not co-occur 
in a large enough group of bound transcripts to allow meaningful Gene Ontology (GO) analysis. 
We found that the most highly over-represented functional terms for the RNAs that contained 
these co-occurring sequence motifs in HeLa Clusters 1, 3 – 5 were related to distinct processes, 
including developmental processes and immunity (Cluster 1), caspase activity and apoptosis 
(Clusters 4 and 5, respectively), as well as regulation of transcription and RNA metabolic 
processes (Cluster 3) (Figure 2.16B). These results suggest that there are distinct groups of RBP 
recognition motifs that are involved in the post-transcriptional regulation of various collections of 
mRNAs encoding functionally related proteins.  
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2.2.6 Disease-linked SNPs correlate with protein-bound RNA sequences 
 A growing set of evidence suggests that multiple RNA-level mechanisms, some of which 
depend upon RNA-protein interactions, are the means by which particular single nucleotide 
polymorphisms (SNPs) in mRNAs effect human disease phenotypes [138-141]. In support of this 
concept, we found PPSs to be enriched in disease-associated SNPs from dbSNP build 137 and 
the NHGRI GWAS Catalog (Figure 2.17A). Furthermore, the ratio of synonymous to non-
synonymous SNPs was also significantly higher within PPSs compared with the expressed 
transcriptome background (Figure 2.17B, p-value = 9.8e-04), lending further support to the notion 
that disruption of RNA-protein interactions underlies the disease mechanism of the 
polymorphisms in question.  
 
Figure 2.17 PPSs are enriched within disease-associated SNPs. (A) Enrichment of disease-
associated SNPs from dbSNP build 137 and the NHGRI GWAS Catalog in PPSs versus 
background. *** denotes p-value à 0 and ** denotes p-value < 0.001, Chi-squared test. (B) Ratio 
of synonymous to non-synonymous SNPs in PPSs versus background. ** denotes p-value < 
0.001, Chi-squared test. (C – D) Two examples of disease-related SNPs found in UROD (C) and 
PARK7 (D) that overlap with PPSs identified by PIP-seq in HeLa cells using ssRNase treatment 
(SSase). The UROD and PARK7 SNPs (as indicated in Flagged SNPs track) are used in the 
analyses in E – F, respectively. A blue line below the transcript model denotes the regions used 
for the analyses in E – F. (E – F) UV cross-linking analysis of normal compared to disease-related 
SNPs using probes with only the specific base pair substitution specified in parentheses next to 
disease label and protein lysates from HeLa cells. The rs121918066 (E) and rs74315352 (F) 
SNPs associated with Porphyria Cutanea Tarda and early-onset Parkinson’s disease, 
respectively, were used in this analysis. Representative images for three replicate experiments. ** 
denotes p-value < 0.001. p-values were calculated by a one-tailed t-test. 
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 To verify that disease-related human SNPs could affect RBP-RNA interactions, we used 
UV cross-linking analyses with 38 nt RNA probes containing either the normal or disease-
associated variant at their center. For these analyses, we focused on two specific SNPs that are 
associated with Porphyria Cutanea Tarda and early-onset Parkinson’s disease (rs121918066 and 
rs74315352, respectively). We found that both disease-associated SNPs tested had significant 
effects on specific RBP-RNA interactions (p-values < 0.001) (Figures 2.17C – D). In fact, we 
found that rs121918066 disrupted while rs74315352 enhanced specific interactions with an RBP 
complex. These findings revealed that disease-associated SNPs that reside within RBP binding 
sites can affect the interaction between proteins and their target RNAs. In total, these results 
suggest that modulation of RBP interactions may be a significant RNA-level disease mechanism 
in humans. 
 
2.3 CONCLUSIONS 
In general, the global architecture of RNA-protein interactions within the population of 
both unprocessed and mature RNA molecules is still poorly characterized [20, 114, 115]. Here, 
we described a novel RNase-mediated protein footprint sequencing approach (PIP-seq) that 
allows global identification of RNA-protein interactions for numerous RBPs in the human 
transcriptome with a single experiment (Figure 2.1). Our approach is similar to other recently 
published methodologies [127], but in addition to polyA-containing, mature mRNAs we also 
provide a view of RNA-protein interaction sites in unprocessed mRNAs (i.e. introns). Additionally, 
our approach is widely applicable to all samples and organisms since it is not dependent on the 
incorporation of non-natural nucleotides or UV cross-linking. 
Analysis of the PPSs uncovered by our approach allowed us to identify significant levels 
of known and novel RNA-protein interaction sites and sequence motifs. By comparing across 
cross-linkers and RNases, we demonstrated that each uncovers specific subsets of protein-
bound sequences and support the use of multiple reagents when obtaining a comprehensive 
analysis of the protein-bound transcriptome in eukaryotic organisms. 
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Using the RNA sequences identified as being protein-bound in the HeLa cell 
transcriptome by PIP-seq, we uncovered a large set of putative RBP-binding motifs. Based on 
their size and sequence characteristics, it is likely that many of these motifs correspond to binding 
sites for RBPs that interact with target RNAs through multiple RNA-binding domains or 
complexes of multiple RBPs. We used these identified RBP-bound motifs to investigate the 
interaction between RBPs within target mRNAs and offer insights into mRNP organization in the 
human transcriptome. This study is one of the first to comprehensively examine the co-binding by 
RBPs with specific target mRNAs. In fact, our findings provide an important resource for 
investigation into the idea that groups of RBPs bind to collections of mRNAs encoding proteins 
functioning in specific biological processes. These sequences can be used for identification of the 
interacting proteins so that their effects on post-transcriptional regulation can be further studied.  
Finally, we observed a significant overlap of PPSs with disease-linked SNPs obtained 
from two different sources (dbSNP build 137 and NHGRI GWAS Catalog [142]), and validated 
these results using UV cross-linking experiments that demonstrated disease-linked SNPs could 
both disrupt or enhance RBP-RNA interactions. Thus, determining the molecular details behind 
each disease-associated SNP that affects an RNA-RBP interaction will be an important future 
research endeavor. It is also worth noting that our findings point to the intriguing possibility that 
PIP-seq could be used in conjunction with genome-wide association studies to screen for 
synonymous mutations that may be causal via altering of any number of RNA-protein interactions 
in affected tissues. Such a tool would be extremely valuable in mechanistic, pharmacogenomic, 
and therapeutic studies of disease-associated polymorphisms. In summary, we present a 
powerful method that will be important for future studies of RNA-protein interaction site dynamics 
in multiple eukaryotic organisms and in important biological contexts. 
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2.4 MATERIALS AND METHODS 
Cell lines  
For these experiments, HeLa cells were seeded in 15 cm Corning Standard tissue-culture 
treated culture dishes (Sigma, St. Louis, MO), grown to 90% confluence (~18 million cells) in 
DMEM media (Life Technologies, San Diego, CA) supplemented with L-glutamine, 4.5 g/L D-
Glucose, 10% FBS serum (Atlanta Biologics, Atlanta, GA), and Pen/Strep (Fisher Scientific, 
Waltham, MA).  
 
Cross-linking experiments 
 For formaldehyde cross-linking, 37% formaldehyde solution (Sigma, St. Louis, MO) was 
added drop-wise with mixing directly to cell culture dishes containing 90% confluent cells to a final 
concentration of 1% and incubated at room temperature for 10 minutes. Next, 1M glycine (Sigma, 
St. Louis, MO) was added to a final concentration of 125 mM and incubated for an additional 5 
minutes with mixing. Then, cells were washed twice with ice cold PBS and collected. Finally, cells 
were pelleted and frozen until the PIP-seq digestions were performed. For UV cross-linking 
experiments, 90% confluent cells were washed twice with ice cold PBS and resuspended in 5 ml 
of PBS. Cell culture dishes were placed in a UV Stratalinker 2400 (Agilent Technologies, New 
Castle, DE) with the lid removed and irradiated with UV-C (254 nm) once with 400 mJ/cm2. The 
cross-linked cells were collected by scraping, pelleted, and then frozen until used. 
 
PIP-seq library preparation 
To begin, we lysed the cell pellets in RIP buffer (25 mM Tris-HCl, pH = 7.4; 150 mM KCl, 
5 mM EDTA, pH = 7.5; 0.5% NP40; 10 µM DTT; 1 tablet protease inhibitors/10 ml) and manual 
grinding (850 µl of RIP is used per 10 million cells). The resulting cell lysate was treated with 
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RNase-free DNase (Qiagen; Valencia, CA). Subsequently, these DNA-depleted lysates were split 
and treated with either 100 U/ml of a single-stranded RNase (ssRNase) (RNaseONE (Promega; 
Madison, WI)) with 200 µg/ml BSA in 1X RNaseONE buffer for 1 hour at room temperature, or 2.5 
U/ml of a double-stranded RNase (dsRNase) (RNaseV1 (Ambion; Austin, TX)) in 1X RNA 
structure buffer for 1 hour at 37°C as previously described ([129, 130], see Figure 2.1 for a 
schematic description). Proteins were then denatured and digested by treatment with 1% SDS 
and 0.1 mg/ml Proteinase K (Roche; Basel, Switzerland) for 15 minutes at room temperature. It is 
worth noting for clarity that we had two cell lysates for these experiments: one treated with the 
ssRNase and the other with dsRNase. For formaldehyde cross-linking experiments, proteinase 
digestion was followed by a 2-hour incubation at 65°C to reverse the cross-links, whereas for UV 
cross-linking experiments, RNA was liberated from protein by retreating the lysates with 1% SDS 
and 1 mg/ml Proteinase K for 30 minutes.  
To determine whether nuclease resistant regions in RNAs are due to protein binding or 
specific secondary structures, we also determined the digestion patterns of ds- and ssRNases in 
the absence of bound proteins. To do this, we performed the identical treatments as described 
above except that the cross-linked cellular lysates were treated with 1% SDS and 0.1 mg/ml 
Proteinase K (Roche; Basel, Switzerland) and ethanol precipitated prior to being treated with the 
two RNases. In this way, the SDS and Proteinase K solubilized and digested the proteins 
allowing us to deduce PPSs within all detectable RNAs in the cells of interest (see Figure 2.1 for 
schematic). 
The digested RNA was then isolated using the Qiagen miRNeasy RNA isolation kit 
following the included protocol (Qiagen; Valencia, CA). Finally, the purified RNA was used as the 
substrate for strand-specific sequencing library preparation, as previously described [129, 130], 
with the exception that we also include DSN library normalization per manufacturer instructions 
(Illumina; San Diego, CA). Briefly, 100 ng of the final library was denatured at 95°C and then 
annealed for 5 hours at 68°C. 2 µl of DSN enzyme (1U/µl) was used to deplete re-annealed 
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duplexes. All of the RNase footprinting libraries (a total of 4 for each replicate (ss- and dsRNase 
treatments, footprint and RNase digestion controls)) were sequenced on an Illumina HiSeq2000 
using the standard protocols for 50 base pair (bp), single read sequencing. 
 
Read processing and alignment 
PIP-seq reads were first trimmed to remove 3’ sequencing adapters using cutadapt 
(version 1.0 with parameters -e 0.06 -O 6 -m 14). The resulting trimmed sequences were 
collapsed to unique reads and aligned to the human genome (hg19) using Tophat (version 2.0.9 
with parameters --read-mismatches 2 --read-edit-dist 2 --max-multihits 10 --b2-very-sensitive --
transcriptome-max-hits 10 --no-coverage-search --no-novel-juncs). PCR duplicates were 
collapsed to single reads for all subsequent analyses. 
 
Identification of PPSs 
PPSs were identified using a modified version of the CSAR software package [134]. 
Specifically, read coverage values were calculated for each base position in the genome and a 
Poisson test was used to compute an enrichment score for footprint versus RNase digestion 
control libraries. PPSs were then called as described [134] with an FDR of 5%. 
 
PPS saturation analysis 
 Mapped reads from chromosome 9 of formaldehyde cross-linked ssRNase treated PIP-
seq replicate 1 libraries were randomly subsampled at 10%-90% by a custom perl script. CSAR 
was used to identify PPSs as described and total number of PPSs was plotted as a function of 
subsample size. 
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Validation by comparison with CLIP-seq, PAR-CLIP and gPAR-CLIP data 
iCLIP, PAR-CLIP, and CLIP-seq datasets were compiled from sources as referenced and 
overlapped with PPSs. Significance of overlaps with PPSs was assessed using a Chi-squared 
test compared to an expressed transcriptome background. To compute a background distribution 
for the number of T>C transversions, we generated 10 random sets of genomic intervals with the 
same size distribution as PPSs. These random intervals were selected from a background of 
actively transcribed regions (defined using bgrSegmenter [143] with parameters threshold=10 
maxGap=10 minRun=15). 
 
Functional analysis of PPSs 
Gene annotations were downloaded from the UCSC Genome Browser (RefSeq Genes, 
wgRna, rnaGene, lncRNA), and miRBase release 18 was used for microRNA annotations. PPS 
annotation was done ‘greedily’, such that all functional annotations that overlapped with a given 
PPS were counted equally. Conservation was assessed by computing average SiPhy-π log-odds 
[144] scores within PPSs and in equally-sized regions immediately upstream and downstream of 
each PPS. 
 
Motif and co-occurrence analysis 
MEME [135] was used to identify enriched RBP interaction motifs with parameters –dna –
nmotifs 100 –evt 0.01 –maxsize 100000000. Motif co-occurrence was defined at the transcript 
level, and k-means clustering of the resultant weighted adjacency matrix was used to identify 
modules of co-occurring motifs. We set k=5 based on manual inspection of clusters on a 
multidimensional scaling (MDS) plot of the adjacency matrix. Gene Ontology (GO) analysis was 
performed using DAVID [137]. 
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Analysis of SNPs and disease associations 
Clinically associated SNPs (snp137Flagged) were downloaded from the UCSC Table 
Browser. We also downloaded the NHGRI GWAS Catalog [142] of disease-linked SNPs. 
Background distributions refer to the incidence of each dataset within the same genic regions as 
those of the PPSs in each analysis. Significance was assessed using a Chi-squared test. 
 
UV Cross-linking analysis of disease-associated SNPs 
We generated asymmetric oligonucleotide hybrids for in vitro transcription by annealing 
T7 sense DNA oligonucleotides (TAATACGACTCACTATAGGG) to antisense probe sequences 
fused to the antisense T7 (aT7) sequence (rs74315352 normal: 
CTTGTAAGAATCAGGCCGtCTTTTTCCACACGATTCTC(aT7), rs74315352 disease: 
CTTGTAAGAATCAGGCCGgCTTTTTCCACACGATTCTC(aT7), rs121918066 normal: 
CCCAGGTTGGCAATGTAGcGATGTGGTCCAAAGTCATC(aT7), rs121918066 disease: 
CCCAGGTTGGCAATGTAGtGATGTGGTCCAAAGTCATC(aT7)) (IDT; San Jose, CA). Each 
hybrid reaction was incubated at 95°C for five minutes and cooled to 25°C by step-wise 
increments of 1°C/minute. 
 In vitro transcription reactions were performed by adding 1 µg of the asymmetric 
oligonucleotide hybrids (see above) to a 25 µL transcription reaction comprising 1X T7 RNA 
Transcription buffer (NEB, Cambridge, MA), 36 µM UTP (for rs74315352) or 36 µM CTP (for 
rs121918066), 264 µM each of ATP, CTP and GTP (for rs74315352) or 264 µM each of ATP, 
UTP and GTP (for rs121918066), 0.04 mCi 32P UTP (for rs74315352) or 0.04mCi 32P CTP (for 
rs121918066), 10 nM DTT, 40 U RNaseOUT (Invitrogen; Carlsbad, CA), and 75 U of T7 RNA 
Polymerase. The reactions were incubated at 37°C for two hours. DNA was digested with 4 units 
of Turbo DNase (Invitrogen; Carlsbad, CA) at 37°C for 20 minutes. RNA probes were chloroform 
extracted and precipitated. The amount of labeled RNA probe was determined by 15% TBE-Urea 
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gel electrophoresis followed by phosphorimaging and densitometry. Normal and disease RNA 
probes were normalized to equal activities and used for subsequent analysis. 
Equal concentrations of each RNA probe (~10% of total from in vitro transcription) were 
added to separate 10.2 µL binding reactions comprising 0.2 mM Tris pH 7.5, 0.02 mM EDTA, 40 
mM KCl, 1.3% polyvinyl alcohol, 25 ng/µl tRNA, 3 mM MgCl2, 1 mM ATP, 50 mM creatine 
phosphate, and 1.5 µg/µl HeLa whole cell lysate in RIP buffer (25 mM Tris-HCl, pH = 7.4; 150 
mM KCl, 5 mM EDTA, pH = 7.5; 0.5% NP40; 10 µM DTT; 1 tablet protease inhbitors/10mL) and 
incubated at 30°C for 20 minutes. The binding reaction was then subjected to UV cross-linking for 
20 minutes using a 254nm UV lamp (Mineralight Lamp Model R-52G (UVP; Upland, CA)). To 
digest unbound RNA, each reaction was incubated with 20 U RNase T1 and 8 µg RNase A at 
37°C for 20 minutes. RNA bound proteins were denatured in 1X SDS sample buffer and 1 mM β-
mercaptoethanol and boiled for 5 minutes. Samples were separated on NuPAGE 3-8% Tris-
Acetate gel (Invitrogen; Carlsbad, CA) at 130V for 1.5 hrs. Phosphorimaging and densitometry 
were used to visualize and quantify protein-bound RNA, respectively. 
 
Accession Numbers 
All PIP-seq data from our analyses were deposited in GEO under the accession 
GSE49309. All of our data (i.e. files of all identified PPSs, complete lists of overrepresented 
motifs, GO analyses, etc.) can also be accessed at http://gregorylab.bio.upenn.edu/PIPseq/. Web 
browsers for visualization of all PPSs and our analyzed and raw sequencing data can be found at 
http://gregorylab.bio.upenn.edu/jbrowse/?data=data/HeLa_PIPseq for jbrowse, and at 
http://genome.ucsc.edu/cgi-
bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=pipseq&hgS_otherUserSessionN
ame=PPS for the UCSC genome browser. 
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This section refers to work from: 
• Kini H*, Silverman IM*, Ji X, Gregory BD, Liebhaber SA. Cytoplasmic poly(A) binding 
protein-1 binds to genomically encoded sequences within mammalian mRNAs. RNA  
 
Abstract: 
 The functions of the major mammalian cytoplasmic poly(A) binding protein, PABPC1, 
have been characterized predominantly in the context of its binding to the 3’ poly(A) tails of 
mRNAs. These interactions play important roles in post-transcriptional gene regulation by 
enhancing translation and mRNA stability. Here, we performed transcriptome-wide CLIP-seq 
analysis to identify additional PABPC1 binding sites within genomically encoded mRNA 
sequences that may impact on gene regulation. From this analysis, we found that PABPC1 binds 
directly to the canonical polyadenylation signal in thousands of mRNAs in the mouse 
transcriptome. PABPC1 binding also maps to translation initiation and termination sites 
bracketing open reading frames, exemplified most dramatically in replication-dependent histone 
mRNAs. Additionally, a more restricted subset of PABPC1 interaction sites comprised A-rich 
sequences within the 5’ UTRs of mRNAs, including Pabpc1 mRNA itself. Functional analyses 
revealed that these PABPC1 interactions in the 5’UTR mediate both auto-regulatory and trans-
regulatory translational control. In total, these findings reveal a repertoire of PABPC1 binding that 
is substantially broader than previously recognized with a corresponding potential to impact on 
and coordinate post-transcriptional controls critical to a broad array of cellular functions. 
 
Contributions: 
 The contents of this section were generated by in collaboration with Hemant Kini. I 
performed all computational analyses on experimental data generated by Hemant Kini. We 
contributed equally to the drafting of the manuscript.  
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3.1 INTRODUCTION 
The biogenesis of eukaryotic messenger RNAs (mRNAs) is tightly linked to the post-
transcriptional addition of polyadenylate (poly(A)) tails to their 3’ ends. These poly(A) tails 
contribute to regulation of mRNA transcription, transport, stability, and translation [42, 145]. PolyA 
tail-dependent functions are mediated in large part via the association of one or more poly(A) 
binding proteins (PABPs). In mammals, there are six defined PABP isoforms; a single nuclear 
isoform, PABPN1, that impacts on the addition of poly(A) tails in the nucleus and five cytoplasmic 
PABPs, ePAB, PABPC1, PABPC2, PABPC4, and PABPC5 that are thought to play roles in 
regulating mRNA stability and translation in the cytoplasm [42-44]. The overall structures and 
RNA binding specificities of the five cytoplasmic PABPs are highly conserved [45, 46]. They each 
contain four RNA Recognition Motifs (RRMs). RRMs 1 and 2 are primarily responsible for the 
high affinity binding to homopolymeric adenosines (Kd = 1.8 nM) [47], while RRMs 3 and 4 can 
bind to non-homopolymeric AU sequences (Kd= 2.9 nM) [47]. The levels of functional specificity 
and/or redundancy of the mammalian cytoplasmic PABPs remain unexplored. 
PABPC1 is the major cytoplasmic PABP isoform in adult mouse somatic cells and is 
abundantly expressed in all tissues [48]. The interaction of PABPC1 with the poly(A) tails is well 
documented and defined in multiple contexts [42, 49]. The corresponding functions of the 
PABPC1/poly(A) tail complex are primarily mediated in pathways of mRNA stabilization and 
translation enhancement [50-52]. These functions may be linked to the interactions of PABPC1 
with the 5’ cap-binding complex via heterodimerization with eIF4G [53, 54]. Limited evidence 
points to additional binding sites and functions for PABPC1 within the eukaryotic mRNA 
transcriptome. For example, PABPC1 has been shown to bind to an A-rich element in the 5’ 
untranslated region (UTR) of its own mRNA (mouse and human), establishing an auto-regulatory 
translational control circuit [41, 56, 57]. A recent study in Saccharomyces cerevisiae using a 
photoactivatable-ribonucleoside-enhanced crosslinking immunoprecipitation approach (PAR-
CLIP) demonstrated in vivo binding of yeast poly(A) binding protein Pab1 to AU-rich elements in 
63	  
	  
mRNAs [59], including binding to the efficiency element (UAUAUA) of the yeast polyadenylation 
signal [60, 61]. The impact of Pab1 binding to the polyadenylation efficiency element in yeast 
remains undefined, as does any generalization of these findings to higher eukaryotic organisms.  
The extent to which PABPC1 binds to genomically encoded sequences in the 
mammalian transcriptome remains undetermined. The presence of such interactions could have 
broad implications to the understanding of post-transcriptional gene regulation. To address this 
gap, we comprehensively mapped PABPC1 binding to sites throughout the mouse transcriptome. 
This analysis revealed robust PABPC1 occupancy within the 3’ untranslated region (3’ UTR) that 
is predominantly localized to the canonical polyadenylation signal (PAS). A distinct set of 
PABPC1 interactions, lacking a defined binding site motif, were mapped to 5’ and 3’ boundaries 
of the open reading frame (ORF), exemplified most clearly in the replication-dependent histone 
mRNAs. A third, and more restricted subset of PABPC1 binding sites, was identified at AU-rich 
sites within the 5’ UTRs of a small group of mRNAs and was demonstrated to impact on 
translation regulation. These studies substantially expand the known repertoire of PABPC1 
interactions within the eukaryotic transcriptome and link a subset of these interactions to 
pathways of posttranscriptional control.  
 
3.2 RESULTS 
3.2.1 CLIP-seq identifies genomically encoded PABPC1 binding sites 
We performed crosslinking immunoprecipitation coupled to high-throughput sequencing 
(CLIP-seq) to map PABPC1 binding sites within the transcriptome of mouse erythroleukemia 
(MEL) cells (see work-flow; Figure 3.1A). PABPC1 RNP complexes were captured by in vivo UV-
crosslinking, followed by limited RNase I digestion, 32P-labeling of RNA in the complexes, and 
immunoprecipitation with an isotype-specific anti-PABPC1 antibody. The immunoprecipitated 
PABPC1 RNP complexes were resolved on an SDS-PAGE gel and complexes migrating in close 
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proximity to the PABPC1 band (blue line, Figure 3.1B) were excised for analysis. The slower 
running complexes were excluded from library preparation as they were assumed to represent 
PABPC1 multimers bound to poly(A) (red line, Figure 3.1B). RNA fragments were isolated from 
the PABPC1 RNP complexes and used as templates for the construction of high-throughput 
sequencing libraries (see Methods). 
Sequencing of the libraries generated from the PABPC1-bound RNA fragments yielded 
14.8 million unique sequences across three biological replicates (Table 3.1). The mean size of 
the unique sequences protected from the RNase I treatment was 24 nucleotides (nts). These 
unique sequences were mapped to the mouse genome (mm10) with Novoalign, resulting in 7.5 
million uniquely mapping CLIP tags that were used for downstream analysis (see Methods) 
(Table 3.1). We first examined the correlation of CLIP tags per gene between biological replicates 
and found a high level of reproducibly between experiments (Spearman correlation coefficient; R 
> 0.96 for all comparisons) (Figure 3.2A). This consistency between replicates allowed us to 
merge the biological samples for subsequent analyses. We also determined the correlation 
between PABPC1 CLIP-seq and mRNA-seq data that we generated from MEL cells (see 
Methods; Figure 3.2B). The relatively high correlation coefficient between this CLIP-seq and 
mRNA-seq comparison (Spearman correlation coefficient; R2 = 0.79) suggested that the PABPC1 
may recognize genomically encoded sequences shared by most mRNAs in the transcriptome. 
Overall, the high reproducibility of CLIP-seq replicates supported successful enrichment of 
PABPC1 bound fragments and warranted further investigation. 
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Figure 3.1 Overview of PABPC1 CLIP-seq. (A) Schematic of PABPC1 CLIP workflow showing 
immunoprecipitation and library preparation of PABPC1 bound RNAs for sequencing (see 
Methods). (B) Isolation and 32P-labeled PABPC1-RNP complexes. Autoradiograph (left) and 
western blot (right) with antibody against PABPC1. 
 
 
 
Table 3.1 Summary of PABPC1 CLIP-seq libraries. 
 
 
 
 
 
 
 
Table& .1&Summary&of&PABPC1&CLIP7seq&libraries
PABPC%CLIP(seq Unique%Tags
Tag%
Length
Uniquely%
Aligned%Tags Deletions
Deletions%
(%)
CIMS%
Sites
CIMS%sites%
(P<.001)
5'%UTR%Clusters%
(mFDR%<0.01)
rep1 3,715,048 22.93 1,817,709 135,014 7.43% 72,099
rep2 6,767,526 24.70 3,575,653 279,770 7.82% 127,748
rep3 4,350,106 23.21 2,121,739 144,472 6.81% 74,005
Merged 14,832,680 23.82 7,515,101 559,256 7.44% 213,817
11,907 2,824
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Figure 3.2 PABPC1 CLIP-seq libraries are reproducible. (A) Correlation of PABPC1 CLIP-seq 
replicates. PABPC1 CLIP-seq tags per gene are plotted for three independent biological 
replicates (Spearman correlation coefficient, R > 0.96 for all comparisons). (B) Correlation of 
PABPC1 CLIP-seq and RNA-seq from MEL cells. RPKM per gene is plotted for CLIP-seq and 
RNA-seq (Spearman correlation coefficient, R = 0.792).  
 
3.2.2 PABPC1 binds predominantly to the 3’ UTR of mRNAs 
We next examined the distribution of PABPC1 CLIP tags across the mouse 
transcriptome. The great majority (73.89%) of CLIP tags mapped to the 3’ UTR, with the next 
highest amount of tags (19.63%) mapping to the coding sequence (CDS) (Figure 3.3A). Since the 
average genomic length of 3’ UTRs is shorter than that of the CDS, this distribution indicates a 
strong enrichment of PABPC1 binding in 3’UTRs. The remainder of the CLIP tags mapped to 
annotated 5’ UTRs, introns, long intergenic non-coding RNAs (lincRNAs), and microRNAs 
(miRNAs). A meta-analysis of PABPC1 CLIP tags across mature mRNA transcripts, 
demonstrated a marked enrichment of CLIP tag density in proximity to annotated 3’ termini of 
mRNAs (Figure 3.3B). This is in agreement with the majority of CLIP tags mapping to the 3’ UTR. 
Visual inspection of specific mRNAs revealed numerous CLIP tags clustering along the 3’ UTR 
with the most prominent peak occurring close to the 3’ termini (examples in Figure 3.3C). 
Together, these data indicate that PABPC1 binds to genomically encoded sequences in 
numerous mRNAs, that most binding events occur in the 3’UTR, and that the preponderant 
localization of the PABPC1 binding occurs in close proximity to the 3’ terminus of mRNAs. 
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Figure 3.3 Distribution of PABPC1 CLIP tags. (A) Pie chart of the distribution of PABPC1 CLIP-
tags within the transcriptome. (B) Relative distribution of PABPC1 CLIP tags along spliced mRNA 
transcripts. Gencode mRNAs were binned into 100 evenly sized regions and the coverage at 
each bin was used to create a composite profile. (C) Screenshots of the UCSC genome browser 
for two representative mRNAs (Slc25a1 and Pcbp1), showing distribution of PABPC1 CLIP-tags 
along the length of the primary transcript. Note: Pcbp1 is encoded by an intronless gene. 
 
3.2.3 PABPC1 binding is enriched at the termini of 3’ UTR  
To enable closer inspection of PABPC1 binding sites, we mapped direct binding events 
at single-nucleotide resolution by crosslink induced mutation site (CIMS) analysis [146, 147]. This 
analysis takes advantage of the propensity for reverse transcriptase to skip nucleotides with 
protein adducts that remain after proteinase K treatment of RNP complexes. In agreement with 
previous studies, we found that deletions, but not insertions or substitutions were enriched within 
the body of CLIP tags (Figures 3.4A-C). CIMS analysis of PABPC1 CLIP tags identified 11,907 
significant (False Discovery Rate (FDR) < 0.001) direct binding sites within the mouse genome 
(Table 3.1). Within the transcriptome, 86% of CIMS sites were located in 3’ UTRs, 9% in the 
CDS, and the remaining 5% distributed across other regions (Figure 3.4D). To examine the 
distribution of CIMS sites in more detail, regions of mature mRNAs (5’ UTR, CDS, and 3’ UTR) 
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were binned into 100 discrete units, and CIMS coverage across each bin was calculated (Figure 
3.5). We did not observe any positional enrichment within the 5’ UTR, whereas an increase in 
binding events was observed towards the 3’ end of the CDS leading into the beginning of the 3’ 
UTR. While numerous binding sites were distributed throughout the 3’UTR, the most robust sites 
of enrichment for PABPC1 binding localized to the terminal segments of 3’ UTRs. This distribution 
of CIMS sites is consistent with the distribution of CLIP tags toward the 3’ terminus of mRNAs 
(Figure 3.3) and is indicative of direct PABPC1 binding to these regions. 
 
Figure 3.4 CIMS analysis of PABPC1 CLIP tags. (A) Absolute distribution of deletion events 
within the length of CLIP tags. (B) Absolute distribution of insertion events within the length of 
CLIP tags. (C) Absolute distribution of substitution events within the length of CLIP tags. (D) 
Distribution of CIMS sites in the mouse transcriptome.  
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Figure 3.5 Relative distribution profile of CIMS sites along mRNAs. Position-specific coverage 
was calculated by parsing each region (UTRs and CDS) into 100 distinct bins and calculating 
CIMS coverage per bin.  
 
3.2.4 PABPC1 binding sites are enriched for A/U-rich and A-rich motifs  
We next determined the binding site sequence preference for PABPC1 within the mRNA 
population using multiple approaches. First, we analyzed the sequence content at each position 
surrounding CIMS sites. To do this, we anchored the analysis at CIMS sites and identified the 
base composition at each position +/- 10 nt from the CIMS site (Figure 3.6A). This approach 
revealed a strong preference for Adenosines interspersed with less frequent Uridines (denoted as 
T’s on the logo). Uridine was the most commonly cross-linked base (position 11), consistent with 
analyses of UV-induced cross-links for other RBPs [148] and most likely reflecting preferential 
formation of UV-induced cross-linking of proteins with Uridine over other ribonucleosides [149]. 
We also calculated the enrichment of hexanucleotide sequences in the region +/- 15nt from each 
CIMS sites relative to all mRNA sequences. We selected the top 20 most enriched 
hexanucleotides and created a position weight matrix and motif logo to represent the sequence 
content (Figure 3.6B). A strong enrichment for Adenosine and Uridine was observed using this 
approach. Finally, using a de novo motif discovery algorithm (MEME) [135], we identified an A/U-
rich sequence that had a striking resemblance to the canonical mammalian polyadenylation 
signal sequence (AAUAAA) (Figure 3.6C). The presence of this abundant and conserved 
sequence element may overshadow the identification of other true motifs. Therefore, to search for 
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a secondary motif, we eliminated all sequences that contained the top 10 mammalian PAS 
sequences (corresponding to 55% of all CIMS sequences) and re-ran the MEME analysis [150]. 
This secondary search revealed a purely A-rich sequence which was derived from ~170 CIMS 
sites (Figure 3.6D). Together, these orthogonal approaches led us to conclude that PABPC1 
binds directly to both the PAS-like as well as to purely A-rich sequences within the mammalian 
transcriptome. 
 
Figure 3.6 Motif analysis of PABPC1 CIMS sites. (A) Logo representing the average nucleotide 
sequence +/- 10 nt proximal to the CIMS sites (position 11 represents the CIMS site). (B) Z-score 
distribution of hexanucleotide analysis of CIMS sites (+/- 15 nt) and a logo representing the 20 
most enriched hexanucleotides. (C) Motif logo uncovered by MEME analysis of CIMS sites +/- 15 
nt flanking sequence. (D) Motif logo uncovered by MEME analysis on CIMS sites +/- 15 nt 
flanking sequence after removing all possible PAS signal sequences.  
 
3.2.5 PABPC1 binds directly to the cleavage and polyadenylation signal 
Due to the predominant binding of PABPC1 to 3’ terminal poly(A) tails, we considered the 
possibility that the observation of enriched binding at the PAS might reflect ‘bleed-over’ from 
canonical poly(A) tail binding. Positional analysis of CIMS sites revealed that a preponderance of 
the PABPC1 CIMS sites mapped 20-25nt upstream of the annotated 3’ terminus of mRNAs 
(Figure 3.7A). This location coincides precisely within the positioning of the PAS and argues 
against bleed-over from the poly(A) tail. Furthermore, alignment of the CIMS relative to the 
canonical PAS sequence (AAUAAA) revealed a sharp enrichment for CIMS sites specifically at 
this element (Figure 3.7B). To confirm that CIMS sites were localized to active PAS elements, we 
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used our mRNA-seq data generated from MEL cells to identify functional poly(A) addition sites in 
the MEL cell transcriptome (see Methods). We examined the distribution of active poly(A) addition 
sites relative to CIMS sites (Figure 3.7C). This analysis revealed that active poly(A) addition sites 
were located 20-25nt downstream of CIMS sites. These various approaches were internally 
consistent in demonstrating that PABPC1 binds directly to bona fide mRNA PAS elements. This 
binding to the PAS on mRNAs throughout the transcriptome is consistent with the high level of 
correlation between CLIP-seq and RNA-seq datasets and with the predominance of CLIP tags 
mapping to the 3’ terminus of the 3’UTR (Figure 3.3). In summary, these data support the 
conclusion that PABPC1 binds directly to PAS elements and to genomically encoded A-rich 
mRNA sequences, in addition to its canonical role in binding to mRNA poly(A) tails. 
 
Figure 3.7 CIMS sites occur at the PAS. (A) Absolute distribution of CIMS relative to the end of 
annotated 3’ UTRs. (B) Absolute distribution of CIMS sites relative to the PAS signal sequence 
(AAUAAA). (C) Absolute distribution of experimentally determined poly(A) addition sites relative 
to CIMS sites. 
 
3.2.6 PABPC1 clusters are enriched in close proximity to the translation initiation and 
termination codons 
As expected based on the correlation between mRNA abundance and PABPC1 CLIP 
tags, we found that the RNAs with the most CLIP tags were highly expressed mRNAs encoding 
the protein components of the ribosome and proteins that comprise the translation machinery. 
Surprisingly, we also observed that a number of replication-dependent histone mRNAs were 
represented among the top 1000 transcripts with highest CLIP tag density. Given that this class of 
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mRNAs is unique in lacking a PAS and poly(A) tail, we chose to examine the corresponding 
pattern of PABPC1 binding in detail. The distribution of CLIP tags across histone mRNAs (Figure 
3.8A; as in Figure 3.3B) was prominently enriched at the 5’ and 3’ ends of transcripts. This 
distribution contrasts strongly with the 3’ enrichment observed in the remainder of the mRNA 
transcriptome (compare Figs. 3.8A and 3.3B, examples in Figs. 3.8B and 3.3C). Detailed 
mapping of PABPC1 CLIP tags in replication-dependent histone mRNAs revealed that they were 
highly enriched over the translation initiation and termination sites (Figures 3.9A-B). Multiple 
analytic approaches failed to reveal any corresponding enriched primary sequence motif 
corresponding to these binding events. The pattern of binding within the replication-dependent 
histone mRNAs at start codons was similar to, although more sharply defined than that of the 
overall transcriptome (Figure 3.9C). PABPC1 binding in the vicinity of the stop codon of histone 
mRNAs similarly displayed a sharp peak (Figure 3.9B), whereas binding to the stop codon of all 
other detectable mRNAs in general peaked over the stop codon and remained high throughout 
the 3’ UTR (Figure 3.9D). This difference in the contour of the CLIP tag mapping to the stop 
codon may reflect, at least in part, the high frequency of PABPC1 binding at the PAS in 
polyadenylated mRNAs. Together, these results suggest that PABPC1 interacts with the 
translation initiation and termination sites in a poly(A) and PAS-independent fashion.  
 
Figure 3.8 PABPC1 binds to histone mRNAs. (A) Distribution of PABPC1 CLIP tags along histone 
mRNA transcripts. Histone mRNAs were binned into 100 evenly sized regions and the CLIP-tag 
coverage in each bin was used to create a composite profile. (B) Screenshots from the UCSC 
genome browser for two representative histone genes showing CLIP tags proximal the 5’ and 3’ 
end of the CDS. Green and Red boxes indicate annotated start and stop codons, respectively.  
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Figure 3.9 PABPC1 CLIP tags are enriched at start and stop codons. (A) Absolute distribution of 
CLIP tags proximal to the start codon of histone genes. (B) Absolute distribution of CLIP tags 
proximal to the stop codon of histone genes. (C) Absolute distribution of CLIP tags proximal to the 
start codon of all mRNAs. (D) Absolute distribution of CLIP tags proximal to the stop codon of all 
mRNAs. 
 
3.2.7 PABPC1 binds to A-rich sequences within a subset of 5’ UTRs. 
 Our initial analysis revealed a small subset of PABPC1 CLIP tags localized within 5’ 
UTRs (Figure 3.3A). Interestingly, we found a relatively low correlation between number of CLIP-
seq tags in 5’ UTRs and mRNA abundance (mRNA-seq) (Figure 3.10, Spearman correlation 
coefficient; R = 0.356). This low correlation suggested that the binding of PABPC1 to the 5’ UTR 
is heterogeneous across the population of mRNAs in MEL cells and occurs at determinants that 
are specific to subset(s) of transcripts. The number of CIMS sites within 5’ UTRs (Figure 3.4D; 79 
sites across 39 genes) was insufficient to identify a 5’ UTR specific motif. However, analysis of 
Position relative to Histone CDS Start
CL
IP
-ta
g 
de
ns
ity
−100 −50 CDS Start 50 100
0
20
0
40
0
60
0
80
0
10
00
12
00
Position relative to Histone CDS Stop
CL
IP
-ta
g 
de
ns
ity
−100 −50 CDS Stop 50 100
0
20
0
40
0
60
0
80
0
10
00
12
00
A B
C D
Position relative to all CDS Stop
−100 −50 CDS Stop 50 100
0
50
00
0
10
00
00
15
00
00
20
00
00
25
00
00
Position relative to all CDS Start
CL
IP
-ta
g 
de
ns
ity
−100 −50 CDS Start 50 100
0
50
00
10
00
0
15
00
0
20
00
0
25
00
0
CL
IP
-ta
g 
de
ns
ity
74	  
	  
the 5’UTR CLIP tags by a low stringency approach (Pycioclip implementation of the modified 
false discover rate (mFDR) approach [151]), identified ~ 2,800 PABPC1 CLIP-tag clusters located 
in 5’ UTRs (see Methods). Although 5’ UTRs are generally G-C rich [152], MEME analysis of 
PABPC1 5’ UTR cluster sites revealed an A-rich sequence motif that mapped to ~ 300 unique 5’ 
UTR clusters (Figure 3.11A). We examined the correlation of CLIP tags from A-rich motif 
containing 5’ UTRs with the mRNA-seq dataset and found an even weaker correlation (Figure 
3.11B, Spearman correlation coefficient; R = 0.186) than what was observed for all 5’ UTR CLIP 
tags (Fig. 4A). This lower correlation coefficient suggests that PABPC1 interactions with A-rich 
motifs in the 5’ UTR are further uncoupled from mRNA steady state expression levels. A gene 
ontology analysis (DAVID; [137]) on this subset of mRNAs revealed enrichment for gene function 
terms involved in the regulation of transcription, DNA binding, nuclear processes, and cell cycle 
control (Figure 3.11C). Together, these results suggest that PABPC1 may coordinately regulate 
mRNAs involved in these basic cellular processes through binding to a shared 5’ UTR motif. 
 
Figure 3.10 Correlation analysis of PABPC1 CLIP tags in 5’ UTRs of protein-coding transcripts 
and mRNA-seq RPKM per gene values (Spearman correlation coefficient, R = 0.356).  
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Figure 3.11 PABPC1 binds to A-rich motifs in the 5’ UTR of mRNAs. (A) Motif logo uncovered by 
MEME analysis of PABPC1 CLIP-tag clusters in the 5’ UTRs of mRNAs. (B) Correlation analysis 
of PABPC1 CLIP tags in 5’ UTRs of transcripts containing the A-rich motif (A) and RNA-seq 
RPKM per gene values (Spearman correlation coefficient, R = 0.186). (C) Gene ontology analysis 
of genes with A-rich motifs within CLIP-tag clusters in the 5’ UTR. 
 
Interestingly, we found that the top A-rich PABPC1 binding site in the 5’ UTR 
corresponds to Pabpc1 mRNA (Figure 3.12A). This is of note, because it has been previously 
reported that PABPC1 represses the translation of its own mRNA via binding to a 5’UTR A-rich 
determinant [153, 154]. Among other transcripts with significant PABPC1 binding to the A-rich 
sequence in the 5’ UTR were, cell cycle control protein Cyclin D2 (Ccnd2) (Figure 3.12B), 
Scaffold Attachment Factor B (Safb) an RNA binding protein that impacts on both transcription 
and splicing [155], and Adenosylmethionine Decarboxylase 1 (Amd1), a protein associated with 
cell and tumor growth [156], metabolism and obesity [157]. These observations led us to 
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hypothesize that PABPC1 binds to an A-rich determinant within the 5’ UTR of a subset of mRNAs 
and this binding may be of particular importance to the regulation of their translation.  
 
Figure 3.12 Screenshot of PABPC1 CLIP tags from the UCSC genome browser for two 
transcripts with PABPC1 binding within their 5’ UTRs (Pabpc1 (top) and Ccnd2 (bottom)). 
 
3.2.8 PABPC1 auto-regulates its expression by binding to an A-rich element 
PABPC1 was previously found to repress its own translation by binding to a 5’ UTR A-
rich determinant [56, 158]. Interestingly, we identified two distinct clusters of PABPC1 binding 
sites in the Pabpc1 mRNA 5’ UTR (Figure 3.13A, red and green bars, respectively), a more 5’ 
cluster, overlapping with the previously identified A-rich element (‘5’ cluster’, red bar), and a 
second, larger cluster of unknown function (‘3’ cluster’, green bar). To determine if these clusters 
have overlapping or unique roles in regulation of PABPC1 expression we cloned the intact 
PABPC1 5’ UTR into a Firefly Luciferase reporter plasmid and separately inserted derivative 
5’UTRs specifically lacking each of the two individual PABPC1 CLIP-tag clusters (Figure 3.13B). 
Each of these plasmids were transfected into NIH-3T3 cells. NIH-3T3 cells were chosen because 
they are more effectively transfected than MEL cells. Firefly Luciferase protein and RNA 
expression were quantified 48h post transfection (Figure 3.13C). Luciferase protein was 
significantly (C1-5’ UTR vs Luc; P < 0.01; two-tailed T-test) repressed in the presence of native 
Pabpc1 5’ UTR in the absence of an appreciable impact on mRNA accumulation (Figure 3.13C). 
This impact on expression was fully consistent with a mechanism of translation inhibition by 
PABPC1. Deletion of the 5’ interaction site resulted in a significant increase in protein expression 
as compared to the intact Pabpc1 5’ UTR (red cluster in Figure 3.13C, Mut1 vs. C1-5’UTR; P < 
0.001; two-tailed T-test) while deletion of the 3’ cluster had a statistically significant but marginal 
Pabpc1
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impact on protein output (Mut 2 vs. C1-5’UTR; P < 0.001; two-tailed T-test). These data, based 
on luciferase reporter assay, suggest that the more 5’ cluster mediates the translation repression 
activity of the intact 5’ UTR, while the function of the more 3’ cluster, if any, remains to be defined 
(see below).  
 
 
Figure 3.13 PABPC1 regulates the expression of its own mRNA. (A) Screenshot from UCSC 
genome browser of PABPC1 CLIP tags in the 5’ UTR for Pabpc1 mRNA. Red and Green bars 
highlight two major PABPC1 CLIP-tag clusters (5’ and 3’ clusters, respectively). (B) Insertion of 
the Pabpc1 5’ UTR and three derivatives in an expression vector in frame with the Firefly 
luciferase ORF. Mutants represent deletion of either one or both of the CLIP-tag clusters denoted 
in (A). (C) Quantification of Firefly luciferase mRNA levels (qRT-PCR; light grey bars) and 
luciferase enzymatic activity levels as a proxy for protein abundance (luciferase assay; dark grey 
bars).  
 
While PABPC1 has been reported to auto-regulate its protein expression by binding to 
the 5’ UTR A-rich sequence, this was not clearly delineated from the luciferase assays as deletion 
of the 5’ cluster also resulted in a significant (Mut 1 vs. C1-5’ UTR; P < 0.05; two-tailed T-test) 
increase in luciferase reporter mRNA expression (Figure 3.13C). Also of interest, we found that 
the 3’ cluster, whose deletion did not impact upon the reporter expression (Figure 3.13C), 
overlapped the start of a predicted upstream open reading frame (uORF) and co-localized with 
initiating ribosomes as determined by ribosome profiling with Harringtonin-treated mouse ES cells 
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[159] (Figure 3.14). Therefore, this region may regulate more complex translational control 
mechanisms not evident from these reporter assays.
 
Figure 3.14 PABPC1 and initiation ribosomes bind to the same region of the Pabpc1 5’ UTR. 
UCSC genome browser screenshot showing the region of overlapping PABPC1 CLIP tags and 
initiating ribosome tags within the Pabpc1 5’ UTR. Arrow denotes the canonical start codon 
(AUG).  
 
To address these discrepancies, we chose to examine the in vivo function of Pabpc1 5’ 
UTR binding clusters by ablating them in cell lines with CRISPR/Cas9 mediated site-directed 
deletion. Two guide RNAs (gRNAs) corresponding to sites flanking the Pabpc1 5’ UTR binding 
clusters were cloned into separate vectors expressing the Cas9 nuclease. These two vectors 
were co-transfected into the mouse myoblast cell line C2C12 and Puromycin-resistant clones 
containing a heterozygous deletion of this region were identified (Figure 3.15A). Analysis of 
Pabpc1 5’ UTR Mut +/- cells revealed that deletion of the Pabpc1 5’ UTR clusters resulted in a ~ 
2 fold (P < 0.01; two-tailed T-test) increase in PABPC1 protein levels in the absence of an 
alteration in steady state mRNA levels (Figures 3.15B-C). These in vivo results strongly support 
the model in which PABPC1 binding within the 5’ UTR of its encoding mRNA is critical for the 
homeostasis of PABPC1 protein expression. Deletion of the PABPC1 binding site in the 5’ UTR 
results in increased levels of PABPC1 protein expression in vivo in the absence of an alteration in 
mRNA levels.  
 
5’  UTR
PABPC1 CLIP-tags
Initiating ribosome (Harringtonin)
 AUG
79	  
	  
 
Figure 3.15 CRISPR analysis of Pabpc1 5’ UTR. (A) Agarose gel of genomic DNA PCR showing 
Pabpc1 5’ UTR region for WT cells (untransfected C2C12 cells), cells transfected with a vector 
expressing Cas9 without guide RNAs (Cas9), and cells transfected with vectors expressing Cas9 
and gRNAs targeting sites flanking both of the PABPC1 CLIP-tag clusters (Cas9/gRNA). Upper 
and lower arrows denote WT and mutant loci respectively. (B) Quantification of Pabpc1 mRNA 
levels (qPCR) for mutant clones relative to WT cells. (C) PABPC1 immunoblot of WT C2C12 cells 
and mutant clones. PABPC1 levels were quantified by densitometry and normalized to b-actin. ** 
= P < 0.01, *** = P < 0.001; Two-tailed T-test. 
 
3.2.9 PABPC1 inhibits synthesis by binding to 5’ UTR A-rich elements 
We next sought to determine if PABPC1 binding to 5’ UTR A-rich elements mediated 
regulatory control over additional mRNAs. Three mRNAs with prominent PABPC1 binding 
clusters at A-rich sites within their 5’ UTR were chosen for study; Safb, Amd1, and Ccnd2 
(Figures 3.16A, C, and E). The full 5’ UTR of each of these mRNAs was cloned into the Firefly 
Luciferase reporter plasmid and its impact was compared with the corresponding 5’ UTRs lacking 
the PABPC1 binding site Figures 3.16B, D, and F). Deletion of the PABPC1 binding region from 
both the Safb and Amd1 5’ UTRs significantly enhanced luciferase expression levels (Amd1: P < 
0.05 and Safb: P < 0.01; two-tailed T-tests) without altering corresponding mRNA levels (Figure 
3.17). A significant (P < 0.01; two-tailed T-test) increase in luciferase activity was also observed 
upon deletion of the PABPC1 binding site from the Ccnd2 5’ UTR (Figure 3.17) although in this 
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case there was a corresponding increase in mRNA levels (P < 0.05; two-tailed T-test). This 
increase in mRNA levels was similar to what was observed for deletion of the Pabpc1 5’ cluster 
region (Figure 3.13C). These results demonstrate that PABPC1 binding to A-rich sites within the 
5’ UTR of specific mRNAs can repress protein expression by repressing mRNA levels and/or by 
impeding effective translation. Thus, PABPC1 is involved in post-transcriptional control of gene 
expression in mammalian cells via an array of mechanistic pathways.  
 
Figure 3.16 Screenshots and schematic of PABPC1 5’ UTR targets. (A, C, and E) Screenshots 
from the UCSC genome browser of PABPC1 CLIP tags in the 5’ UTR for Safb (A), Amd1 (D), and 
Ccnd2 (G) mRNA. (B, D, and F) The native Safb (B), Amd1 (D), and Ccnd2 (F) 5’ UTRs (top) or 
mutant derivatives lacking the A-rich PABPC1 binding site cluster (bottom) were separately 
inserted in-frame with the Firefly luciferase ORF in a standard expression vector. The PABPC1 
binding site, corresponding to the CLIP-tag cluster in (A), (C), and (E), is represented by the black 
rectangle within the 5’ UTR.  
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Figure 3.17 PABPC1 5’ UTR binding sites regulate translation. Quantification of Firefly luciferase 
mRNA levels (qRT-PCR; light grey) and luciferase enzymatic activity levels (luciferase assay; 
dark grey) for the Safb, Amd1, and Ccnd2 5’ UTR constructs. * = P < 0.05, ** = P < 0.01; Two-
tailed T-test. 
 
3.3 DISCUSSION 
PABPC1 is an abundant cytoplasmic RNA-binding protein that is expressed in all somatic 
cells. The functions of PABPC1 are best understood in the context of its binding to the 
homopolymeric poly(A) tails of mRNAs. This PABPC1/poly(A) tail complex has been linked to 
pathways that control mRNA stability and translation activity and exerts significant impact on 
multiple cell functions [42, 145, 160]. In Saccharomyces cerevisiae deletion of its single poly(A) 
binding protein, Pab1p, is incompatible with cell viability [161] and in Drosophila melanogaster, 
homozygosity for P-element disruption of the cytoplasmic PABP gene results in embryonic 
lethality [162]. The impact of PABPC1 depletion or ablation in mammalian cells remains 
undefined.  
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Limited in vitro studies suggest that PABPC1 can bind to mRNAs at sites other than the 
poly(A) tail [47]. In vivo analysis in yeast provided further evidence that Pab1p binds to 
genomically encoded A and A/U rich sequences in mRNAs [59, 61]. In the present report, we 
performed CLIP-seq on PABPC1 in MEL cells with the goal of revealing the extent and role of 
PABPC1 binding to genomically encoded sequences in mammalian. These studies reveal that 
PABPC1 binds to complex sequences within different regions of annotated mRNAs and that 
subsets of these interactions have a defined impact on gene expression. 
 
3.3.1 PABPC1 binds to the PAS of mRNAs throughout the mammalian transcriptome 
A key observation from our study is that the majority of the PABPC1 CLIP tags cluster 
within mRNA 3’ UTRs (73.89%, Figure 3.3A). This is not surprising as proteins that bind to the 
CDS are generally susceptible to displacement by the elongating ribosome and stably assembled 
RNP complexes are preferentially localized to the 3’ UTR ‘sanctuary’ [163, 164]. As PABP’s are 
well characterized for their strong association to mRNA poly(A) tails it was necessary to 
rigorously demonstrate that the enrichment within 3’ UTRs reflected direct binding rather than 
‘bleed over’ from binding to the adjoining poly(A) tails. Mapping of PABPC1 binding at single 
nucleotide resolution by a CIMS analysis (Figures 3.4 – 3.7) unambiguously identified that 
PABPC1 binds directly within the mRNA 3’ UTR’s (Figure 3.5). Coupled with two orthogonal 
approaches, we were able to further determine that the majority of these binding interactions are 
localized to the canonical cleavage and polyadenylation signal sequence (AAUAAA) (Figures 3.6-
3.7). These observations are consistent with the prior analysis of Pab1p PAR-CLIP studies in 
yeast in which binding was mapped to the AU-rich efficiency element within the 3’ UTR region 
[59]. These results lead us to conclude that binding of cytoplasmic PABPs to polyadenylation 
elements has been conserved from yeast to mammalian cells.  
While the function(s) of non-poly(A) tail PABP RNP complexes in the cytoplasmic 
compartment remains unclear, related binding activities have been functionally linked to post-
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transcriptional pathways of gene regulation. For example, the cytoplasmic polyadenylation 
element binding (CPEB) protein binds to an A-rich element (CPE) within the 3’ UTR where it 
recruits the cleavage and specificity factor (CPSF) to the PAS with consequent cytoplasmic 
extension of the poly(A) tail and translational enhancement [165]. CPEB can also recruit proteins 
such as Maskin to regulate mRNA translation in Xenopus oocytes [165] and mouse hippocampus 
[166]. It is plausible that PABPC1, once bound to the PAS, can recruit other trans-acting factors 
that modulate translation. Furthermore, these mechanisms might reflect direct actions on 
translation or mRNA stability, or alternatively, the impact may be indirect, reflecting an impact on 
the length and/or function of the poly(A) tail. Based on our mapping data, these and related 
models can now be fully explored. 
 
3.3.2 PABPC1 binds in close proximity to the translation initiation and termination 
codons 
The mapping of CLIP tags within the MEL cell transcriptome revealed robust binding to 
replication-dependent histone mRNAs. These mRNAs are unique amongst polymerase II 
transcribed mRNAs in that they lack PAS elements and poly(A) tails. Analysis of the histone 
mRNAs thus allowed us to focus on PABPC1 interactions in the absence of the predominant 
poly(A) tail and PAS binding activities. Intriguingly, the CLIP tags within histone mRNAs localized 
to the sites of translation initiation and termination (Figures 3.8 – 3.9A-B). We observed similar 
enrichment for CLIP tags at the start codons throughout the transcriptome while the signal at stop 
codons was somewhat overshadowed in the bulk of mRNAs by PAS binding (Figures 3.9C-D). 
Importantly, the small number of CIMS sites and lack of any enriched sequence motif for 
PABPC1 binding at sites flanking ORFs, suggests that enrichment of CLIP tags bracketing the 
open reading frame may reflect indirect association of PABPC1. This indirect positioning of 
PABPC1 is consistent with the model proposed by others that PABPC1 remains associated with 
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the elongating ribosome during translation [167, 168]. Further study will be necessary to 
understand the role and functional consequences of PABPC1 binding to these regions.  
 
3.3.3 PABPC1 binds to A-rich sites within the 5’UTR of a restricted subset of mRNAs 
with resultant post-transcriptional repression of gene expression 
 The binding of PABPC1 within 5’ UTRs appears to be limited to a highly restricted subset 
of mRNAs (Figures 3.10-3.12). This specificity is indicated by the lack of correspondence 
between mRNAs bound in this region by PABPC1 and overall mRNA representation in the 
transcriptome (Figures 3.10 and 3.11B). MEME analysis of 5’UTR clusters revealed enrichment 
for a predominantly A-rich motif, consistent with the binding site preference of the PABPs (Figure 
3.11A). Interestingly, the highest ranked PABPC1 binding target within this mRNA subset was 
Pabpc1 mRNA. PABPC1 has been previously reported to auto-regulate its own translation by 
binding to an A-rich domain within the 5’ UTR [153]. This translational control domain is 
coincident with a prominent PABPC1 CLIP-tag cluster identified in the current study (5’ cluster, 
highlighted in red, Figure 3.13A). Remarkably, this analysis also revealed an adjacent and even 
more prominent cluster of CLIP tags (3’ cluster, highlighted in green, Fig. 5A) that did not impact 
on translation (Figure 3.13C, C1-5’ UTR vs. Mut 2). Interestingly, this second PABPC1 binding 
region tracks with the positioning of the initiating ribosome in mouse ES cells as mapped by 
ribosomal profiling with Harringtonin treatment and was predicted to encode the start of a uORF 
[159] (Figure 3.14). Thus, this PABPC1 binding element within the 5’ UTR may yet play a role in 
translational control not captured by the luciferase assay (Figure 3.13C).  
To validate the in vivo function of Pabpc1 5’ UTR clusters in translational control, we 
deleted the region of the Pabpc1 5’ UTR spanning both of the PABPC1 CLIP-tag clusters via 
Crispr/Cas9 endonuclease targeting. The 2-fold increase in PABPC1 protein expression in cells 
heterozygous for the 5’UTR deletion in the absence of any alteration in mRNA stead state levels, 
confirmed that this region acts to auto-regulate Pabpc1 translation (Figure 3.14C). Importantly, 
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PABPC1 overexpression has been associated with defective spermiogenesis in mice [169], 
deadenylation and translation inactivation in Xenopus oocytes, and with variations in cell cycle 
and apoptosis in certain leukemias [170]. Thus, this auto-regulatory feature of the Pabpc1 5’ UTR 
mediates a regulatory pathway relevant to critical aspects of cell differentiation and proliferation.  
The potential for PABPC1 to control gene expression was further extended by the 
analysis of additional mRNAs identified with 5’UTR PABPC1 CLIP-tag clusters. Deletion of these 
binding site regions enhanced the translation of reporter expressing Safb and Amd1 mRNA 5’ 
UTR’s (Figure 3.17). Protein expression was also enhanced by similar deletion within the 5’UTR 
of the Ccnd2 mRNA, although in this case there was a concomitant increase in the steady state 
mRNA levels (Figure 3.17). We note that deletion of the 5’ cluster (Mut 1) in the PABPC1-5’ UTR 
(Figure 3.13C) also enhanced mRNA levels, although to a lesser extent than the corresponding 
protein expression. These data underline the potential for the 5’ UTR binding of PABPC1 to 
impact on a variety of mechanisms that repress gene expression, including both mRNA stability 
as well as translational control. The relative importance of each of these pathways may reflect 
specifics of the binding site, including interaction with other trans-factors and/or adoption of 
specific RNA secondary structures. Overall, we reveal that PABPC1 regulates a repertoire of 
gene regulatory pathways and establish a foundation for the exploration of additional targets and 
cellular functions mediated by PABPC1 binding to genomic mRNA sequences. 
 
3.5 MATERIALS AND METHODS  
Cell culture and CLIP-seq analysis 
MEL and NIH-3T3 cells were grown under standard conditions in minimal essential 
medium (MEM) and Dulbecco’s modified Eagle medium (DMEM), respectively, supplemented 
with 10% (vol/vol) fetal bovine serum (FBS) and 1× antibiotic-antimycotic (Invitrogen, Carlsbad, 
CA). MEL cells were washed with Hanks’ balanced salt solution (HBSS) and cross-linked with UV 
(400 mJ/cm2) three times on ice. CLIP was performed according to previously published protocol 
[98, 171]. Briefly UV cross-linked MEL cells were lysed with 1x PMPG in the presence of RNase 1 
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(2.5 U, Promega, Madison, WI), DNAse I (Promega, Madison, WI) treated for 15 min. The lysates 
were ultra-centrifuged at 90,000g for 20 mins. Immunoprecipitation was performed with protein A 
Dynabeads coated with PABPC1 antibody (Abcam, Cambridge, MA). Following the wash steps 
radiolabeled 3’ adaptor was ligated to the complexes on the beads using T4 RNA ligase (Thermo 
Scientific) for 16 h at 16oC. The beads were then washed, treated with T4 polynucleotide kinase 
(NEB, Ipswich, MA), and the RNP complexes were eluted off of the beads. 90 % of the eluate 
were used for autoradiography and the remainder was used for immunoblotting. The RNP 
complexes were resolved on 4- 12 % NuPage gels (Invitrogen, Carlsbad, CA), transferred to 
nitrocellulose membrane, and then exposed to X-ray film. Using the X-ray film as a guide, the 
portion of the nitrocellulose membrane corresponding to PABPC1-RNA complexes was excised, 
Proteinase K (Roche, Basel, SUI) treated, and the RNA was Phenol extracted. The purified RNA 
was ligated to a 5’ adaptor, amplified, and sequencing libraries were constructed. Libraries 
generated from biological triplicates were individually bar coded, pooled, and sequenced on an 
Illumina HiSeq 2000 platform at the University of Pennsylvania Next Generation Sequencing Core 
(NGSC). 
 
CLIP-seq read processing and alignment 
Adapter sequences (GTGTCAGTCACTTCCAGCGGTCGTATGCCGTCTTCTGCTTG) 
were removed from raw reads and only trimmed reads were used for downstream analysis. 
Trimmed reads from each individual replicate CLIP-seq experiment were collapsed and mapped 
to the mouse genome (mm10) with Novoalign (Novocraft, Selagnor, MYS) with the parameters –t 
85 -l 15 –s 1 –o Native –r None. Replicate experiments were merged and only uniquely mapped 
reads were used for subsequent analysis. 
 
CIMS and Cluster analysis 
CIMS analysis was applied to identify single-nucleotide RBP-RNA interaction sites (as 
described; Moore et al. 2014). Briefly, deletion sites were extracted for each CLIP tag from 
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novoalign output and a negative binomial test was used to assess significance. Sites with FDR < 
0.001 were used for downstream analysis. To identify significant CLIP-seq clusters we used 
Pyicoclip [151] with an mFDR < 0.01. Gencode annotation vM2 was used for all analyses. 
 
mRNA-seq 
mRNA-seq was performed as previously described [172] . Briefly, total RNA was purified 
from the MEL cell cultures (miRNeasy; Qiagen, Valencia, CA). Poly(A)+ RNA was isolated using 
oligo dT beads (Life Technologies, Frederick, MD). RNA was fragmented for 7 minutes using 
Fragmentation Reagent (Life Technologies, Waltham, MA). mRNA-seq libraries were then 
generated using the Illumina smRNA-seq kit (illumina, San Diego, CA). Reads were trimmed with 
Cutadapt, mapped with Tophat2, and gene expression was quantified using HTseq [173-175]. 
Custom python scripts were used to calculate RPKM. 
 
Motif analysis 
Motif analysis was carried out by aligning CIMS sites and extracting sequences +/- 10nt 
from each site. A custom script was used to create a position-weight matrix and used the R 
package SeqLogo to generate motif logos [176]. For hexanucleotide enrichment analysis, the 
equally sized regions in the exonic portion of the mRNA transcriptome was shuffled10 times and 
the prevalence of each hexanucleotide was calculated and compared to the abundance in +/- 
15nt CIMS regions. A position weight matrix was created from the top 20 hexanucleotides. For de 
novo motif discovery, MEME was used with a maximum width of 12nt [135].  
 
Active polyadenlyation addition site identification 
To identify high confidence polyadenylation additions sites, we used a custom python 
script to filter raw mRNA-seq reads with at least 20 Adenines at the 3’ end. We then removed 
these poly(A) stretches, mapped the remaining sequence to the mouse genome with Tophat2, 
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and calculated the density of 3’ ends using bedtools genomecov [177]. Only sites with greater 
than 10 reads per million were considered bona-fide poly(A) sites. 
 
Luciferase assays 
5’ UTR or defined variants were cloned into a Firefly luciferase vector. These constructs 
were transfected into NIH-3T3 cells in 12-Well plate using Turbofect transfection reagent (Thermo 
Scientific). After 48h Luciferase activity was measured using Dual Luciferase assay kit (Promega, 
Madison, WI) and the corresponding mRNA levels were quantified by qPCR. 
 
CRISPR targeted deletion of PABPC1 5’ UTR region 
gRNA oligos (ATAAATGTGTGTTCCGAGCCCGG) and 
(TCGGTCTCGGCTGCTTCACCGGG) were designed using the Broad Institute CRISPR design 
tool (www.crispr.mit.edu). After restrictions digest with BbsI they were cloned into px330 vector 
and then transfected into C2C12 cells using Lipofectamine 3000 (Life Technologies, CA). After 72 
h, purmomycin was added at 1 mg/ml to and colonies with targeted 5’ UTR deletions were 
selected for gDNA PCR. 
 
Quantitative Western blotting 
Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer, and the following 
primary and secondary antibodies were used: rabbit anti-PABPC1 (Abcam), rabbit anti-actin 
(Bethyl), and goat-anti-rabbit IgG (Licor). Blots were visualized and scanned with Odyssey 
scanner and software (Li-Cor Bioscience).  
 
Re-analysis of Ribosome Profiling data 
Ribosome profiling data from harringtonin-treated mouse embryonic stem cells (mESCs) 
were obtained from GSE30839. We processed the ribosome profiling data as previously 
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described [178]. Briefly, reads were trimmed for adapter sequence 
(CTGTAGGCACCATCAATTCGTATGCCGTCTTCTGCTTGAA), filtered by mapping to mouse 
ribosomal RNA sequences. Filtered reads were mapped to the mouse transcriptome and genome 
using TopHat2 [174, 179]. Only mapped reads with no mismatches were used for further 
analysis. Aminoacyl-tRNA sites were identified as previously described [178]. 
 
Availability of supporting data: 
The data sets supporting the results of this article are available in the GEO repository, 
under accession number GSE69755. 
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This section refers to work from: 
• Silverman IM*, Gosai SJ*, Vrettos N, Foley SW, Berkowitz ND, Mourelatos Z, Gregory 
BD. Isolation and sequencing of AGO-bound RNAs reveals characteristics of mammalian 
stem-loop processing in vivo. In Prep 
 
Abstract: 
 MicroRNA precursors (pre-miRNAs) are short hairpin RNAs that are rapidly processed 
into mature microRNAs (miRNAs) in the cytoplasm. Due to their low abundance in cells, 
sequencing-based studies of pre-miRNAs have been limited. We successfully enriched for and 
deep sequenced pre-miRNAs in human cells by capturing these RNAs during their interaction 
with Argonaute (Ago) proteins. Using this approach, we detected > 350 pre-miRNAs in human 
cells and > 250 pre-miRNAs in a reanalysis of a similar study in mouse cells. We uncovered 
widespread trimming and non-templated additions to 3’ ends of pre-miRNAs and mature miRNAs. 
Additionally, we identified novel Ago2-cleaved pre-miRNAs and created an index for microRNA 
precursor processing efficiency. This analysis revealed a subset of pre-miRNAs that produce low 
levels of mature miRNAs despite abundant precursors, including an annotated miRNA in the 5’ 
UTR of the DiGeorge syndrome critical region 8 (Dgcr8) mRNA transcript. This led us to search 
for other Ago-associated stem-loops originating from mRNA species, which identified hundreds of 
putative pre-miRNAs embedded within mRNA sequences in both the mouse and human 
transcriptomes. Intriguingly, we found that iron responsive elements in ferritin heavy and light 
chain mRNAs are processed into Ago-associated stem-loops in both mouse and humans but do 
not produce functional small RNAs. In summary, we provide a wealth of information on pre-
miRNAs, and identified microRNA and microRNA-like elements in mRNAs. 
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Contributions: 
 The contents of this section were generated by in collaboration with Sager Gosai, 
Nicholas Vrettos, and Shawn Foley. I performed the initial experimental analysis with assistance 
from Nicholas Vrettos. Sager Gosai developed the computational pipelines and together we 
performed all bioinformatic analyses. Shawn Foley performed qPCR validation experiments. I 
drafted the manuscript with assistance from other authors. 
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4.1 INTRODUCTION 
MicroRNAs (miRNAs) are ~22 nucleotide (nt) small RNAs (smRNAs) that function in 
post-transcriptional gene regulation to repress translation or promote degradation of target 
messenger RNAs (mRNAs) [17, 180]. Animal miRNAs are generated in a two-step process, 
whereby miRNA precursors (pre-miRNAs) are first cleaved from their primary transcripts by the 
action of the DGCR8/DROSHA microprocessor complex [67, 68]. Alternative pre-miRNA 
biogenesis pathways have been described that bypass the microprocessor, for example mirtron 
loci generate pre-miRNAs in a splicing-dependent, DROSHA-independent fashion [70, 71]. Pre-
miRNAs are then transported into the cytoplasm by Exportin-5 for further processing [72, 73].  
Cytoplasmic pre-miRNAs are then matured by the miRNA loading complex (miRLC) 
which is composed the type III endonuclease DICER, the double-stranded RNA-binding protein 
TRBP, and the miRNA effector protein Argonaute (AGO) [74-76]. DICER cleaves the pre-miRNA 
to reveal a ~22 nt miRNA duplex, consisting of the upstream miRNA (denoted as the 5p miRNA) 
and downstream miRNA (denoted as the 3p miRNA). One of these strands is selectively loaded 
into AGO to form the RNA-induced silencing complex (RISC). Alternatively, AGO2 has been 
shown to directly cleave several pre-miRNAs, which are then further processed by the poly(A)-
specific ribonuclease (PARN) to give rise to mature miRNAs. This class of miRNAs is known as 
the AGO2-cleaved pre-miRNAs (ac-pre-miRNAs) [78-80, 181]. Such DICER-independent 
processing involves the pre-miRNA deposit complex (miPDC), which is composed of just AGO2 
and a pre-miRNA [77].  
 The biogenesis of miRNAs is further complicated by the fact that both pre- and mature 
miRNAs can be post-transcriptionally modified at the 3’ end by trimming or by non-templated 
addition of ribonucleotides, especially uridine and adenine [69, 182-185]. In general, mono-
uridylation is thought to re-establish a 3’-2 nucleotide overhang, which is required for efficient 
DICER cleavage. In contrast oligo-uridylation has been shown to be a signal for degradation and 
usually occurs after AGO2-mediated slicing of pre-miRNAs. However, most detailed studies of 
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pre-miRNAs have been performed on a small number of pre-miRNA sequences, thus our 
understanding of the overall landscape, and global function of these modifications remains 
elusive. 
High-throughput sequencing of total or AGO-bound smRNAs in numerous cells, tissues, 
and organisms has provided a wealth of information about miRNAs. In concert with bioinformatic 
approaches, these datasets have been leveraged to identify thousands of novel miRNAs [186, 
187]. In contrast, sequencing of pre-miRNAs has been challenging, due to the presence of other 
RNA species, including the highly abundant transfer RNAs (tRNAs) and small nucleolar RNAs 
(snoRNAs), that exist in the same size range as pre-miRNAs. Attempts to use size selection to 
sequence pre-miRNAs have achieved < 1% of total sequenced clones corresponding to pre-
miRNAs even after selective depletion of abundant species [188]. Alternatively, primer-based 
approaches have been applied, but these methods restrict analysis to known miRNA species and 
cannot be used for discovery [184, 185, 189]. Thus, there is a need for unbiased, sequencing 
based approaches to gain a more comprehensive understanding of pre-miRNA expression and 
sequence content. 
Leveraging the knowledge that AGO is an integral component of the pre-miRNA 
processing complexes (miRLC and miPDC) and the miRNA functional (miRISC) complex, our 
groups recently developed an approach to enrich for pre-miRNAs by immunoprecipitating AGO 
proteins and isolating RNAs from 50-80 nucleotides (nts) [183]. Using this approach, pre-miRNA 
libraries from mouse embryonic fibroblasts (MEFs) were generated with > 40% of reads mapping 
to miRNA loci. Thus, this strategy can be used to efficiently study pre-miRNAs globally without 
the need for primer-based approaches or depletion of abundant RNA species. Here, we applied 
this approach to isolate and sequence pre-miRNAs and mature miRNAs from human embryonic 
kidney (HEK293T) cells. We developed a bioinformatic pipeline to capture post-transcriptional 
modifications, which we applied to data generated in this study from human cells, as well as to 
previous data generated in MEFs. Our results provide global insights into pre-miRNA processing 
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and provide an alternative strategy for identifying pre-miRNAs and other AGO-associated stem-
loops in transcriptomes of interest. 
 
4.2 RESULTS 
4.2.1 Isolation and sequencing of pre-miRNAs 
To isolate and sequence pre-miRNAs we first immunoprecipitated AGO proteins from 
HEK293T cells with the pan-AGO-2A8 antibody [190] (Figure 4.1A). RNA was purified from AGO 
immunoprecipitates, dephosphorylated and labeled with P32-γ-ATP. Autoradiography of the RNA 
gel showed a major band at 20-25 nts, representing mature miRNAs, and several other prominent 
bands between 50-80 nts, corresponding to the size range of pre-miRNAs (Figure 4.1B). We 
excised gel slices from both of these regions and generated high-throughput sequencing libraries, 
referred to herein as miRNA-seq and pre-miRNA-seq libraries, respectively. Previous attempts to 
sequence pre-miRNAs have been unsuccessful due to the inaccessibility of the pre-miRNA 5’ 
ends. Therefore, we used a method that attaches the 5’ linker through CircLigase-mediated cDNA 
circularization step (see Methods) [13, 183].  
96	  
	  
  
Figure 4.1 Isolation and sequencing of AGO interacting pre-miRNAs and mature miRNAs. A) 
Western blot of AGO-IP from HEK293T cells. AGO-2A8 and none immune serum (NIMS) were 
used for immunoprecipitaiton. AGO-2A8 antibody was used for detection. *Radixin is known to 
cross-react with the 2A8 antibody. B) Autoradiography of RNA co-immunoprecipitated with AGO. 
Pre-miRNAs were excised from 50-80 nts and mature miRNAs were excised from 20-25 nts. C) 
Bioinformatics pipeline: Adapter sequences were trimmed and PCR duplicates were collapsed for 
efficiency. The first 35 nts of pre-miRNAs (18 nts of mature miRNAs) were mapped to miRBase 
(v20). Remaining bases were mapped with Smith-Waterman aligner.  
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Using this approach, we successfully generated high-throughput sequencing libraries for 
both pre-miRNAs and mature miRNAs. We obtained 27.8 and 9.8 million reads with sufficient 
adapter sequence from the pre-miRNA-seq and mature miRNA-seq libraries, respectively (Table 
4.1). Given that pre-miRNAs and mature miRNAs contain non-templated modifications at their 3’ 
ends, we reasoned that standard alignment pipelines would be limited in their ability to align these 
sequences to miRBase. Therefore, we developed an alignment pipeline that utilized the first 35 
nts of the pre-miRNA-seq (18 nts for miRNA-seq) reads for alignment (Figure 4.1C), followed by 
Smith-Waterman local alignment to extend the read as far as possible along the mapped miRNA 
sequence (see Methods) [191-193]. After all possible nucleotide matches were made, we 
selected alignments with the lowest mismatch rate and captured non-templated modifications at 
the 3’ end.  
We performed this analysis on pre-miRNA-seq, miRNA-seq, and smRNA-seq (without IP; 
Vandivier et al. Under Review) from human HEK293T cells as well as pre-miRNA-seq and mature 
miRNA-seq data previously generated using the same technique from MEFs [183]. We 
successfully aligned 10.8% of pre-miRNA-seq, 98.7% of miRNA-seq, and 52.4% of smRNA-seq 
reads to the human miRBase v20 annotation set (Figure 4.2 and Table S1). We were not 
surprised to find such high rates of mapping for mature miRNAs, however, a 10% mapping rate 
for pre-miRNAs is significantly higher than previous attempts to sequence pre-miRNAs without 
pre-miRNA specific primers (0.8%) [188]. Using the datasets previously generated from MEFs, 
we had a much higher rate of pre-miRNA-seq reads mapping (44%), but mapped fewer miRNA-
seq reads (90.3%) (Figure 4.2 and Table S1). These differences likely represent variable 
experimental conditions and amounts of starting material and/or biological differences in the 
smRNA populations between these two mammals.  
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Table 4.1 Summary of sequencing libraries and mapping statistics 
 
 
 
 
 
Figure 4.2 Percent of reads mapping to miRBase for pre-miRNA-seq, miRNA-seq and smRNA-
seq.  
 
Library
Trimmed+
(reads)
Mapped+to+
miRbase+(reads)
Mapped+to+
miRbase+(%)
Mapped+to+
RefSeq+(reads)
Mapped+to+
RefSeq+(%)
HEK293T(pre,miRNA,seq 27,836,261 3,009,275 10.81% 1,208,362 4.34%
HEK293T(miRNA,seq 9,862,300 9,731,649 98.68%
HEK293T(smRNA,seq 50,887,440 26,643,855 52.36%
MEF(pre,miRNA,seq 16,597,532 7,306,162 44.02% 368,200 2.22%
MEF(miRNA,seq 22,044,132 19,906,265 90.30%
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Figure 4.3 Size distribution of miRBase mapped reads. A-B) Size distribution of pre-miRNA-seq 
reads from HEK293T cells (A) and MEFs (B) mapping to miRBase. C-E) Size distribution of 
miRNA-seq reads from HEK293T cells (C) and MEF (D) and smRNA-seq reads from HEK293T 
cell (E). 
 
Overall, we obtained pre-miRNA-seq reads mapping to 367 annotated human miRNAs 
and 267 annotated mouse miRNAs. For libraries prepared from smaller RNA species, we 
mapped reads to 931 (HEK239T miRNA-seq), 567 (MEF miRNAs-seq), and 1,364 (HEK293T 
smRNA-seq) miRBase miRNAs. We examined the size distribution of mapped pre-miRNA-seq 
reads and found that they were distributed between 55-65 nts in both cell types (Figure 4.3A-B). 
MiRNA-seq reads, were tightly distributed between 21-24 nts, in both HEK293T AGO-bound and 
total cellular fractions, as well as in MEFs (Figure 4.3C-E). We determined the abundance, end 
concordance, and non-templated additions for all mapped miRNAs and generated coverage plots 
to represent these data, which are available for download at 
http://gregorylab.bio.upenn.edu/AGO_IP_Seq/ (examples in Figure 4.4). Together, our 
biochemical and bioinformatic approaches provide a data rich resource for the global and 
unbiased analysis of pre-miRNAs in two mammals.  
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Figure 4.4 Pre-miRNA-seq and miRNA-seq coverage of hsa-miR-16-2. A-B) Coverage plot of pre-
miRNA-seq (A) and miRNA-seq (B) reads mapping to hsa-miR-16-2 locus. White bars indicate 
templated nucleotides. Colored bars indicate non-templated additions. Dashed red and blue lines 
indicate boundaries of annotated 5p (blue) and 3p (red) mature miRNAs  
 
	  
4.2.2 Diverse ends of AGO-bound pre-miRNAs 
It is well established that pre-miRNA trimming and non-templated tailing (uridylation) is a 
mechanism of regulation [69, 182, 184]. However, most studies have investigated individual 
miRNAs or used targeted approaches to examine a predetermined subset of miRNAs. Using our 
novel datasets, we examined the end concordance of sequenced pre-miRNA-seq (Figure 4.5A-B) 
and miRNA-seq reads (Figure 4.5C-D), relative to high confidence human and mouse miRBase 
miRNA ends. We found that the majority (>90%) of 5’ read ends of pre-miRNAs coincided with 
annotated 5’ ends of 5p miRNAs for both human and mouse (Figure 4.5A-B). In contrast 3’ read 
ends of pre-miRNAs were highly variable, with only 40% and 20% of reads ending precisely at 
the annotated 3’ end of 3p miRNAs in HEK293T cells and MEFs, respectively (Figure 4.5A-B). 
Relatedly, mature miRNAs (Figure 4.5C-D) and smRNAs (Figure 4.5E) displayed higher variation 
in their 3’ ends relative to 5’ ends for both 5p and 3p miRNAs, but not nearly to the extent that 
was observed for pre-miRNAs (Figure 4.5A-B). Overall, these results reveal that 3’ end variation 
is more common in pre-miRNAs than in mature miRNAs.  
A
0 4 8 13 19 25 31 37 43 49 55 61 67 73 79 85 91
Position
C
ou
nt
s
0
20
00
40
00
60
00
80
00
A
T
G
C
0 4 8 13 19 25 31 37 43 49 55 61 67 73 79 85 91
Position
C
ou
nt
s 
(X
1,
00
0)
0
10
0
20
0
30
0
40
0
50
0
60
0
A
T
G
C
B
101	  
	  
 
Figure 4.5 Mapped read ends relative to miRBase miRNAs. A-B) Distribution of pre-miRNA-seq 
read ends for HEK293T cells (A) and MEFs (B) relative to annotated 5’ end of 5p and 3’ end of 3p 
miRNAs for high confidence miRNAs. Positive and negative values indicate trimming and 
extension of reads respectively. C-E) Distribution of miRNA-seq read ends for HEK293T cells (C), 
MEFs (D) and smRNA-seq read ends from HEK293T cells (E) relative to annotated ends of 5p 
and 3p miRNAs for high confidence miRNAs. Positive and negative values indicate trimming and 
extension of reads respectively. 
 
Pre-miRNAs and miRNAs are post-transcriptionally modified at their 3’ ends through the 
action of TUT4 and TUT7 terminal uriydyl transferases (TUTases) [69, 182, 194, 195]. We found 
that 14.5% of human and 17.4% of mouse pre-miRNAs contained single nucleotide additions to 
their 3’ ends, whereas 4.9% and 7.1% had more than two non-templated additions on their 3’ 
ends in human and mouse high confidence miRBase miRNAs, respectively (Figure 4.6). For 
mature miRNAs, we also found a large number of single nucleotide additions at the 3’ end; 8.4% 
of human and 12.5% of mouse mature miRNAs. However, tails greater than one nucleotide were 
much less frequent, with only 1.1% of human and 2.2% of mouse mature miRNAs containing long 
tails. For cellular smRNA-seq from HEK293T cells we observed a higher overall levels of 
modification than miRNA-seq with 4.0% and 3.3% of reads having single or multiple non-
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templated additions, respectively (Figure 4.6). These data demonstrate that non-templated 
additions are widespread in both pre-miRNAs and mature miRNAs, and that extended tails are 
more frequent in pre-miRNAs compared to mature miRNAs.  
 
Figure 4.6 Percentage of reads with mono-tails and oligo-tails for pre-miRNA-seq, miRNA-seq 
and smRNA-seq reads mapped to high confidence miRBase miRNAs. 
 
We also generated metaplots to analyze the sequence content of non-templated 
additions to the 3’ end of pre-miRNAs (Figure 4.7A-B) and mature miRNAs (Figure 4.7C-E). 
Uridine (denoted as T) was by far the most common addition to human and mouse pre-miRNAs, 
and was even more prevalent in positions past the first non-templated nucleotide (Figure 4.7A-B). 
For mature miRNAs, adenosine was the most common non-templated addition, with much lower 
levels of uridine as compared to pre-miRNAs (Figure 4.7C-E). When examining non-templated 
additions in total smRNA-seq data, we found that 2 nucleotide tails were much more common 
than in AGO-interacting miRNAs (Figure 4.7E). Collectively, these data show that mono- and 
oligo-tailing are widespread in human and mouse pre-miRNAs and mature miRNAs and that 
uridylation is more common in pre-miRNAs, especially after the first nucleotide, whereas 
adenylation is more common in mature miRNAs. 
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Figure 4.7 Non-templated 3’ end modifications. A-B) Non-templated 3’ end tail length and 
sequence content for pre-miRNA-seq reads from HEK293T cells (A) and MEFs (B) reads 
mapping to miRBase high confidence miRNAs. C-E) Non-templated 3’ end tail length and 
sequence content for miRNA-seq reads from HEK293T cells (C) and MEFs (D) and smRNA-seq 
reads from HEK293T cells (E) mapping to miRBase high confidence miRNAs. 
 
4.2.3 Identification of AGO2-cleaved pre-miRNAs 
 AGO2, is unique amongst the AGO proteins in that it has slicing activity [196-198]. In fact, 
AGO2 has been demonstrated to cleave a subset of pre-miRNAs (ac-pre-miRNAs), which are 
then trimmed by PARN into mature miRNAs [78-80, 181]. However, the extent to which this 
process occurs in mammalian pre-miRNA populations has not been determined. AGO2 cleavage 
events are known to occur around 10 nucleotide upstream of the 3’ end of the pre-miRNA and 
give rise to 5p miRNAs [78]. To search for these events, we calculated the percentage of pre-
miRNA-seq reads that were trimmed 8-15 nucleotide from the 3’ end of the 3p miRNA for each 
miRNA. In mouse, for which ac-pre-miRNAs are best characterized, we observed all previously 
identified ac-pre-miRNAs with the exception of miR-451, which is not expressed in MEFs (Table 
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4.2). In our human dataset, we also observed previously identified ac-pre-miRNAs, including 9 
members of the let-7 family and miR-9-2. From this approach, we identified 7 putative ac-pre-
miRNA candidates in humans and 37 in mouse, including hsa-miR-455 and mmu-miR-335 
(Figure 4.8A-B and Tables 4.2). 
 
Figure 4.8 De novo identification of AGO2-cleaved pre-miRNAs. A-D) Examples of novel ac-pre-
miRNAs identified from pre-miRNA-seq. hsa-miR-455 (A) and mmu-miR-335 (B) are novel ac-
pre-miRNAs with cleavage in the 3p miRNA. hsa-miR-140 (C) and mmu-miR-22 (D) are novel ac-
pre-miRNAs with cleavage in the 5p miRNA. White bars indicate templated nucleotides, colored 
bars indicate non-templated additions. Dashed red and blue lines indicate boundaries of 
annotated 5p (blue) and 3p (red) miRNAs. 
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Table 4.2 De novo identification of ac-pre-miRNAs in MEFs. Bolded rows indicate known ac-pre-
miRNAs 
 
Name Cleaved)Clones Total)Clones Percent)Cleaved 5p)miRNAs 3p)miRNA Percent)5p
mmu9let97a91 4943 78608 6.29% 227064 27133 89.33%
mmu9let97b 37000 68610 53.93% 139401 5988 95.88%
mmu#let#7c#1 241 5289 4.56% 296030 23 99.99%
mmu9let97c92 6913 173344 3.99% 166758 26178 86.43%
mmu9let97d 2665 12663 21.05% 364660 63447 85.18%
mmu#let#7e 242 1694 14.29% 20622 2712 88.38%
mmu9let97f91 25368 56223 45.12% 129389 4943 96.32%
mmu9let97i 1264 1795 70.42% 125465 11219 91.79%
mmu9mir9101a 558 879 63.48% 638 5105 11.11%
mmu#mir#106b 7784 100647 7.73% 160155 9516 94.39%
mmu#mir#10a 1134 34484 3.29% 85754 2319 97.37%
mmu#mir#125b#1 389 13989 2.78% 939092 45080 95.42%
mmu#mir#125b#2 2729 4277 63.81% 933810 2376 99.75%
mmu#mir#181a#2 627 35394 1.77% 62245 4109 93.81%
mmu#mir#181b#1 1342 51785 2.59% 23557 83 99.65%
mmu#mir#181b#2 272 6842 3.98% 28160 99 99.65%
mmu#mir#183 323 3156 10.23% 16348 220 98.67%
mmu#mir#1839 169 509 33.20% 3225 897 78.24%
mmu#mir#188 139 4641 3.00% 4085 98 97.66%
mmu#mir#18a 274 18156 1.51% 79317 4586 94.53%
mmu#mir#195a 147 2585 5.69% 1224 736 62.45%
mmu#mir#199a#2 271 25099 1.08% 148775 873207 14.56%
mmu#mir#26a#2 5060 124040 4.08% 238340 651 99.73%
mmu#mir#28a 25 703 3.56% 32209 3247 90.84%
mmu#mir#297a#4 184 185 99.46% 7607 3107 71.00%
mmu#mir#297c 168 169 99.41% 2412 3107 43.70%
mmu#mir#3079 25 110 22.73% 31 0 100.00%
mmu#mir#30e 62 3749 1.65% 69001 1428 97.97%
mmu9mir931 2161 40063 5.39% 449467 69169 86.66%
mmu9mir9322 835 1561 53.49% 22178 13211 62.67%
mmu#mir#335 1006 1141 88.17% 627 309 66.99%
mmu9mir9345 229 1798 12.74% 16236 434 97.40%
mmu#mir#374b 73 1125 6.49% 70335 423 99.40%
mmu#mir#449c 160 530 30.19% 100 25 80.00%
mmu#mir#452 219 549 39.89% 465 312 59.85%
mmu#mir#466c#1 159 312 50.96% 1424 4708 23.22%
mmu#mir#467b 1113 2775 40.11% 6330 45 99.29%
mmu#mir#467c 186 1644 11.31% 2763 342 88.99%
mmu#mir#467d 145 3557 4.08% 3200 2352 57.64%
mmu#mir#467e 184 4482 4.11% 4354 380 91.97%
mmu#mir#503 1816 71861 2.53% 13223 496 96.38%
mmu#mir#542 197 586 33.62% 271 623 30.31%
mmu#mir#669c 106 645 16.43% 336 50 87.05%
mmu#mir#669d#2 9 514 1.75% 4327 3 99.93%
mmu#mir#669h 54 262 20.61% 68 161 29.69%
mmu#mir#669p#1 5 122 4.10% 6091 325 94.93%
mmu#mir#7a#1 103 8399 1.23% 7386 3052 70.76%
mmu9mir9992 5453 9481 57.52% 29673 3426 89.65%
mmu9mir998 877 964 90.98% 7122 2399 74.80%
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All previous examples of ac-pre-miRNAs are cleaved in the 3p miRNA and generate 5p 
miRNAs. To identify putative ac-pre-miRNAs that are processed in the opposite directionality, we 
performed a parallel search for pre-miRNA-seq reads that were trimmed 8-15 nucleotide from the 
5’ end of the 5p miRNA. From this analysis, we found 3 candidates in humans and 5 candidates 
in mouse including hsa-miR-140 and mmu-miR-22 (Figure 4.8C-D). Importantly, these 5p cleaved 
ac-pre-miRNAs give rise predominantly to 3p miRNAs suggesting that cleavage in this region is 
not a degradation byproduct and is likely a competent mechanism for generating mature miRNAs. 
These results reveal a greater collection of ac-pre-miRNAs than previously appreciated and 
uncover a likely novel class of 5p cleaved ac-pre-miRNAs. 
 
4.2.4 Relating pre-miRNA and mature miRNA abundance 
Almost nothing is known about the relationship between pre-miRNA and mature miRNA 
abundance. In order to assess this, we first grouped miRNAs into their families and merged the 
mapped reads. This was necessary to avoid artifacts, given that multiple distinct precursors give 
rise to identical, or nearly identical mature miRNAs. We further refined our analysis by only 
focusing on high confidence miRNAs, which left us with 158 human and 159 mouse miRNAs with 
reads mapping from pre-miRNA-seq and/or miRNA-seq libraries. We analyzed the correlation 
between pre-miRNAs and mature miRNA levels expressed from these families (Figure 4.9A-B). 
We found a positive but modest correlation between pre-miRNA and mature miRNA expression in 
both humans (Spearman correlation R = 0.53, p-value < 6.635e-08) and mouse (Spearman 
correlation R = 0.52, p-value < 2.047e-07). We also assessed the relationship between smRNA-
seq and pre-miRNA-seq in HEK293T cells (Figure 4.9C). We found a strikingly similar correlation 
to that of miRNA-seq (Spearman correlation; R = 0.53, p-value < 4.331e-08), which is explained by 
the high correlation of smRNA-seq to AGO-IP-seq (Spearman correlation; R = 0.90, p-value < 
2.2e-16) (Figure 4.9D). Together, these results reveal that pre-miRNA and mature miRNA levels 
have a modest positive correlation in both mouse and humans.  
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Figure 4.9 Relating pre-miRNA and miRNA abundance. A-B) Correlation of pre-miRNA-seq and 
miRNA-seq for high confidence human (A) and mouse (B) miRNA loci (human: R = 0.53, p-value 
< 6.635e-08, mouse: R = 0.52, p-value < 2.047e-07; Spearman correlation coefficient). C) 
Correlation of pre-miRNA-seq and smRNA-seq for high confidence human miRNA loci 
(Spearman correlation R = 0.53, p-value < 4.331e-08). D) Correlation of miRNA-seq and smRNA-
seq for high confidence human human miRNA loci (Spearman correlation R = 0.90, p-value < 
2.2e-16). 
 
4.2.5 An index for miRNA precursor processing 
We reasoned that the ratio of mature miRNAs to pre-miRNAs represents a reasonable 
estimate for in vivo miRNA processing efficiency. As some miRNAs had no detectable pre-miRNA 
reads, we used a generalized log odds ratio of miRNA-seq to pre-miRNA-seq reads (see 
METHODS) to compute a miRNA precursor processing index (MPPI) for miRNAs expressed in 
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human HEK293T and mouse MEF cells. As expected, the majority of high confidence miRNAs 
from human and mouse cells exhibited MPPI values > 0 (Figure 4.10A-C), suggesting they are 
efficiently processed. Among the maximum scoring high confidence miRNAs in humans was hsa-
miR-338, which had no detectable pre-miRNA-seq reads and 1,358 reads per million (RPM) in 
miRNA-seq libraries (MPPI = 11.4). In contrast, we found a number of miRNAs that had many 
more pre-miRNA-seq reads than mature miRNA-seq reads. For example, the least efficiently 
processed high confidence miRNA in humans was hsa-miR-1296, for which we obtained 8,189 
RPM in pre-miRNA-seq libraries and only 30 RPM for miRNA-seq libraries, (MPPI = -8.1). For 
mouse, we found a similar range of MPPI scores with mmu-miR-214 being the most efficiently 
processed (MPPI = 16.1) and mmu-miR-3572 being the least efficiently processed (MPPI = -9.1). 
Thus, examining the ratio of mature to pre-miRNAs allows us to determine the efficiency of 
miRNA processing for hundreds of miRNAs at once. 
 
Figure 4.10 An index for miRNA precursor processing efficiency. A-B) Rank ordered list of miRNA 
precursor processing index (MPPI) scores for high confidence human (A) and mouse (B) 
miRNAs. C) Rank ordered list of MPPI for high confidence human miRNAs with smRNA-seq. 
 
4.2.6 Distinct processing of two pre-miRNAs from Dgcr8 mRNA 
The microprocessor complex (DGCR8/DROSHA) auto-regulates the expression of the 
Dgcr8 transcript by binding and cleaving two hairpins near the 5’ end of this mRNA [35, 199, 200]. 
We re-examined the abundance, modification status, and MPPI scores for the two annotated 
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miRNAs in this region (Figure 4.11). We determined that hsa-miR-3618, which is encoded in the 
5’ untranslated region (UTR) of Dgcr8, is inefficiently processed into mature miRNAs (MPPI = -
5.22), whereas hsa-miR-1306, which lies in the coding sequence (CDS), was matured efficiently 
(MPPI = 3.09) (Figure 4.11). Furthermore, we found that less than 10% of hsa-miR-3618 pre-
miRNAs contained non-templated tails, whereas 100% of the hsa-miR-1306 clones were mono-
uridylated, a signal that has previously been linked to efficient processing in some miRNAs [69]. 
Thus, divergent processing of two miRNAs from the same primary transcript underscores the 
selectivity of DICER processing, and suggests that these two hairpins likely have evolved distinct 
functions in post-transcriptional regulation. 
 
Figure 4.11 Two miRNAs embedded in the Dgcr8 mRNA are processed with highly divergent 
efficiencies. A-B) miRNA-seq reads mapping to hsa-miR-3618 in the 5’ UTR (A) or hsa-miR-1306 
in the CDS (B) of Dgcr8 mRNA. C-D) pre-miRNA-seq reads mapping to hsa-miR-3618 in the 5’ 
UTR (C) or hsa-miR-1306 in the CDS (D) of Dgcr8 mRNA. 
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4.2.7 Identification of AGO-associated stem-loops in mRNAs 
Given this observation, we examined our dataset for novel pre-miRNAs embedded in 
other mRNAs. To do this, we took a highly conservative approach, using pre-miRNA-seq reads 
that failed to map to miRBase, and filtering them by mapping to small nuclear RNAs (snRNAs), 
snoRNAs, tRNAs, ribosomal RNAs (rRNAs), and repeat-masked sequences (Figure 4.12, see 
Methods). Approximately 1.2 and 0.37 million clones passed our stringent filtering steps and 
mapped to human and mouse mRNAs, respectively (Table 4.1). To identify significant AGO-
associated stem-loops in mRNAs, we used a CLIP-seq peak calling approach to identify 
significant (modified false discovery rate (mFDR) < 0.01) read clusters in mRNAs [151]. We found 
a number of highly significant peaks that corresponded to nearly the full length of some highly 
expressed genes (e.g Actb). Therefore, we further filtered significant clusters based on their size 
(< 200 nt), then chose the top clone from each cluster, folded it using RNAfold, and captured 
clusters that had a minimum free energy (MFE) < -0.3 kcal/mol/nt and a minimum of 15 base-
pairs in the longest hairpin [201].  
This resulted in 403 AGO-associated stem-loops in human and 373 in mouse. We 
intersected our list of human AGO-associated stem-loops with recently identified miRNAs in 
humans from smRNA-seq and miRNA prediction or from DICER PAR-CLIP [187, 202]. In fact, 12 
of our AGO-associated stem-loops were annotated as novel miRNAs in these lists supporting the 
validity of our approach (Figure 4.12). Furthermore, 34 and 37 AGO-associated stem-loops 
overlapped with DICER and DGCR8 binding sites respectively, revealing that a number of the 
AGO-associated stem-loops interact with other components of the canonical miRNA processing 
pathway [89, 202]. 
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Figure 4.12 Bioinformatics pipeline for identification of AGO-associated stem-loops. Pre-miRNA-
seq reads that did not map to miRBase were filtered on ncRNA and repeat-masker (RMSK), 
trimmed to 35 nts and mapped to spliced mRNA sequences. These alignments were then 
extended to find all matching bases. AGO-associated stem-loops were identified using a CLIP-
seq peak caller (mFDR < 0.01) followed by filtering by length (< 200 nt), MFE (< -0.3 kcal/mol/nt), 
and paired bases ( > 15 bp/hairpin).  
 
unmapped pre-miRNA-seq reads
Filter reads that map to ncRNA or RMSK
Map first 35 nt to mature mRNA sequences
Map remaining bases with Smith-Waterman
Call Peaks with CLIP-seq peak caller 
(mFDR <0.01)
Filter by peak length: < 200 nt, 
MFE: < -0.3 kca/mol/nt, 
Paired Bases: >15 bp/hairpin
HEK293T:
 403 Putative Precursors
 12 Overlap with novel microRNAs
 34 Overlap with Dicer PAR-CLIP
 37 Overlap with DGCR8 HITS-CLIP
MEF:
 373 Putative Precursors
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 We next examined the distribution of AGO-associated stem-loops across mRNAs and 
found that they were equally present in all regions of mRNAs and similarly distributed between 
human and mouse (Figure 4.13A). When we normalized the distribution of AGO-associated stem-
loops by relative genomic coverage of each mRNA region and found that the CDS was 
underrepresented, whereas the 5’ UTR was enriched 2.5 fold for AGO-associated stem-loops in 
both organisms (Figure 4.13B). We also examined the size distribution of reads mapping to AGO-
associated stem-loops and found them to be similar in size in both mammals, between 55-75 nt in 
humans and 52-80 nt in mouse (Figure 4.13C-D). This size range was slightly broader than pre-
miRNA-seq reads mapped to miRBase (Figure 4.3A-B). 
 
Figure 4.13 Characterization of AGO-associated stem-loops. A) Distribution of AGO-associated 
stem-loops in mRNAs. B) Enrichment of AGO-associated stem-loops in mRNA regions relative to 
genomic coverage of mRNA regions. D-E) Size distribution of pre-miRNA-seq reads from 
HEK293T (D) and MEFs (E) mapping to AGO-associated stem-loops in mRNAs. 
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We also analyzed the non-templated 3’ additions to pre-miRNA-seq reads mapped to 
AGO-associated stem-loops in human and mouse mRNAs (Figure 4.14A-B). We found that pre-
miRNA-seq reads which mapped to AGO-associated mRNA stem-loops were enriched for 
uridylation events, and in fact a higher percentage were oligo-tailed (13.0% in human and 24.3% 
in mouse), compared to reads mapping to miRBase (Figure 4.6). This result suggests that the 
AGO-associated stem-loops in mRNAs identified by our approach undergo similar modifications 
as known pre-miRNAs. 
 
Figure 4.14 Non-templated 3’ ends of AGO-associated stem-loops in mRNAs. A-B) Non-
templated 3’ end tail length and sequence content for pre-miRNA-seq reads mapping to human 
(A) and mouse (B) AGO-associated stem-loops within mRNAs. 
 
Finally, we overlaid in vivo RNA structure-probing data from mouse embryonic stem (ES) 
cells generated with in vivo click selective 2’-hydroxyl acylation and profiling (icSHAPE) onto our 
AGO-associated stem-loops in mouse mRNAs (Figure 4.15). icSHAPE, chemically modifies the 
backbone of unpaired nts, causing early termination of reverse transcription [203]. Based on our 
RNAfold predictions, we examined the icSHAPE reactivity at paired or unpaired bases and found 
that icSHAPE reactivity was much higher at unpaired bases (Kruskal-Wallis one-way ANOVA; p-
value < 8.18e-133) (Figure 4.15A). This can been seen clearly when examining the RNAfold 
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structure diagrams of AGO-associated stem-loops with icSHAPE reactivity overlaid (Figure 
4.15B-D). Together, our analyses provide numerous candidate pre-miRNA-like elements that are 
processed into 50-80 nt AGO-associated stem-loops from mRNAs in mammalian cells.  
 
Figure 4.15 icSHAPE supports RNAfold structures of AGO-associated stem-loops in mRNAs. A) 
Violin plot of in vivo icSHAPE reactivity (top and bottom 10th percentile) for paired and unpaired 
positions in mouse AGO-associated stem-loops in mRNAs. Significance was assessed with 
Kruskal-Wallis one-way ANOVA; p-value < 8.18e-133. B-D) Examples of RNAfold predicted 
structures overlaid with icSHAPE reactivity for AGO-associated stem-loops in the 5’ UTR of 
Smarcd2 (B), CDS of Fam102a (C) and 3’ UTR of Grepl1 (D). 
 
4.2.8 Stem-loop containing mRNAs are regulated by DGCR8 and DROSHA 
 To assess whether AGO-associated stem-loop containing mRNAs are regulated by the 
microprocessor complex, we performed siRNA-mediated knockdown of DROSHA and DGCR8 in 
HEK293T cells and assessed changes in gene expression (Figure 4.16). We observed robust 
knockdown of both DROSHA and DGCR8 protein levels (Figure 4.16A). Consistent with the role 
of DROSHA in regulating DGCR8 expression, we found that knockdown of DROSHA increased 
DGCR8 protein and RNA expression (Figure 4.16A-B). Furthermore, RNA-seq data were 
consistent with RT-qPCR-based validation for both DROSHA (Pearson correlation R = 0.99, p-
value < 0.0097) and DGCR8 knockdown (Pearson correlation R = .87, p-value < 0.06) (Figure 
4.16B). We found that AGO-associated stem-loop containing mRNAs were significantly 
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upregulated after knockdown of either DROSHA (Wilcoxon rank-sum test, p-value < 1.55e-5) or 
DGCR8 (Wilcoxon rank-sum test, p-value < 0.00047) relative to all genes (Figure 4.16C).  
 
Figure 4.16 mRNAs that host AGO-associated stem-loops are regulated by the microprocessor 
complex. A) Western blot following siRNA knockdown of DGCR8, DROSHA and TUBB in 
HEK293T cells. B) Correlation of RT-qPCR and RNA-seq log2 Fold Change (log2FC) for selected 
genes. siDROSHA; Pearson correlation R = 0.99, p-value < 0.0097 and siDGCR8; Pearson 
correlation R = .87, p-value < 0.06. C) Cumulative distribution function plot of DROSHA and 
DGCR8 knockdown mRNA-seq log2FC for AGO-associated stem-loop containing mRNAs 
compared to all mRNAs. siDROSHA; Wilcoxon rank-sum test, p-value < 1.55e-5, and siDGCR8; 
Wilcoxon rank-sum test, p-value < 0.00047. 
 
4.2.9 Most AGO-associated stem-loops in mRNAs do not produce AGO-bound smRNAs 
We next calculated the miRNA-seq and smRNA-seq coverage at AGO-associated stem-
loops using a similar mapping pipeline as described above for miRNAs. We found that miRNA-
seq and smRNA-seq reads mapping to AGO-associated stem-loops were of a similar size as 
miRBase miRNAs and had non-templated additions to their 3’ ends (Figure 4.17). We calculated 
the MPPI for AGO-associated stem-loops and found them to be inefficient producers of mature 
AGO-bound smRNAs (Figure 4.18). This is in agreement with the finding that these elements are 
more commonly oligo-tailed compared to canonical pre-miRNAs. In fact, we only found a total of 
171 miRNA-seq reads mapping to AGO-associated mRNA stem-loops in humans and the 
majority of these reads mapped to the recently identified miRNAs embedded within the mRNAs; 
GNAS, GLUL, and E2F1 [187, 202] (example of E2F1 in Figure 4.19A-B). Additionally, we found 
a total of 2,240 smRNA-seq reads mapping to AGO-associated mRNA stem-loops, which in part 
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reflects the higher sequencing depth of these libraries. Some of putative pre-miRNAs with the 
most smRNA-seq reads, corresponded to previously identified novel miRNAs, including BRD2, 
GLUL and E2F1 (example in Figure 4.19C). However, we also noticed numerous reads mapping 
to putative pre-miRNAs that did not have binding evidence from miRNA-seq, including FTH1, 
FTL, SOX4, and KMT2C.  
 
Figure 4.17 Few AGO-associated stem-loops in mRNAs produce smRNAs. A-B) Size distribution 
of miRNA-seq reads mapping to human (A) and mouse (B) AGO-associated stem-loops in 
mRNAs. C) Same as in (A) except human smRNA-seq. D-E) Non-templated 3’ end tail length and 
sequence content for miRNA-seq reads mapping to human (D) and mouse (E) AGO-associated 
stem-loops within mRNAs. F) Same as in (D) except for human smRNA-seq 
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Figure 4.18 AGO-associated stem-loops are inefficient producers of smRNAs. A-B) Rank order of 
MPPI score for AGO-associated stem-loops from human (A) and mouse (B) mRNAs. Same as in 
(A) except with human smRNA-seq 
	  
 
Figure 4.19 pre-miRNA-seq identifies known and novel miRNAs. A-C) Coverage plot of pre-
miRNA-seq (A), miRNA-seq (B) and smRNA-seq (C) reads mapping to a human AGO-associated 
stem-loop in the 3’ UTR of E2F1. White bars indicate templated nucleotides, colored bars indicate 
non-templated additions. D-E) Coverage plot of pre-miRNA-seq (D) and miRNA-seq (E) reads 
mapping to a mouse AGO-associated stem-loop in the CDS of Rpl9. White bars indicate 
templated nucleotides, colored bars indicate non-templated additions. F) RNAfold predicted 
structure and icSHAPE reactivity for mouse AGO-associated stem-loop in the CDS of Rpl9. 
	  
M
PP
I
-10
-5
5
15
20
0
10
Rank
0 200100 400300
A
M
PP
I
-10
-5
5
15
20
0
10
Rank
0 100 200 300
M
PP
I
-10
15
20
Rank
0 100 200 300
10
-5
0
5
400
CB
118	  
	  
For mouse AGO-associated stem-loops we mapped 2,698 miRNA-seq reads, however 
71% of these mapped to a single locus in the CDS of Rpl9, which likely represents a novel 
miRNA (Figure 4.19D-F). Among other mature miRNA producing AGO-associated mRNA stem-
loops were regions of the Cyr61 5’ UTR, Asf1b 5’ UTR, and Klf9 3’ UTR (Figure 4.20). 
Collectively, these data suggest that pre-miRNA-seq uncovers AGO-associated mRNA stem-
loops, some of which are likely to represent novel miRNAs, but most of which are poorly 
processed into AGO-bound smRNAs. 
 
Figure 4.20 Novel miRNAs from AGO-associated stem-loops in mouse. A-I) Coverage plots of 
pre-miRNA-seq (A, D and G) and miRNA-seq (B, E and H) reads and RNAfold predicted 
structures overlaid with icSHAPE reactivity (C, F and I) for mouse AGO-associated stem-loops in 
the 5’ UTR of Cyr61 (A-C), 5’ UTR of Asf1b (D-F) and 3’ UTR of Klf9 (G-I) White bars indicate 
templated nucleotides, colored bars indicate non-templated additions. 
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4.2.10 Iron response elements are processed into AGO-associated stem-loops 
 The top AGO-associated mRNA stem-loop candidate in humans is localized in the 5’ 
UTR of Ferritin heavy chain (FTH1) (Figure 4.21A). We identified over 5,000 pre-miRNA-seq 
reads in this region, which had a strong predicted hairpin structure, clearly defined ends, and 
significant mono-tailing on the 3’ end. Intriguingly, this region of the FTH1 transcripts corresponds 
precisely to the iron responsive element (IRE), which is a well-studied structural element that 
regulates translation in an iron-dependent fashion [204] . We scanned our list of AGO-associated 
stem-loops for other IRE containing genes, and found Ferritin light chain (FTL1) was also 
producing AGO-associated stem-loops from its IRE region (Figure 4.21D)). Furthermore, we 
identified AGO-associated stem-loops supported by icSHAPE data from the mouse homologs of 
both of these genes, Fth1 and Ftl (Figure 4.22). Therefore, processing of IREs from ferritin genes 
into AGO-associated stem-loops is conserved in mammals. 
 To examine whether IRE-processed hairpins produce functional small RNAs, we 
examined miRNA-seq and smRNA-seq data from these regions. We did not find any AGO-
interacting small RNAs from human FTH or FTL1. We did however; observe cellular smRNAs 
from these regions in our smRNA-seq data (Figure 4.21 B,E). However, they were heterogeneous 
in size and only loosely reflective of DICER processing (Figure 4.21C,F). Therefore, these 
smRNAs appear to be the consequence of subsequent degradation of the processed stem-loops 
that are not loaded into AGO to make a functional RISC complex. In mouse, miRNA-seq data we 
were only able to find a small number of clones originating from the Fth pre-miRNA (Figure 
4.22D), further corroborating our results from human cells. Intriguingly, siRNA-mediated 
knockdown of DROSHA or DGCR8 in HEK23T cells had no affect on FTH1 or FTL mRNA 
expression levels (Figure 4.23). This suggests that processing of IREs into stem-loops is 
DROSHA-independent and may work through a different endonuclease. In total, these results 
demonstrate that mammalian IREs are processed into AGO-bound stem-loops through a 
microprocessor-independent mechanism, and that these stem-loops are not substrates for 
DICER. Whether cleaved IRE stem-loops are functional remains to be determined. 
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Figure 4.21 The IREs of human FTH1 and FTL are processed into AGO-associated stem-loops. 
A-B) Coverage plot of pre-miRNA-seq (A) and smRNA-seq (B) reads mapping to a human AGO-
associated stem loop in the 5’ UTR of the FTH1 gene. White bars indicate templated nucleotides, 
colored bars indicate non-templated additions. C) Size distribution of smRNA-seq reads mapping 
to the human AGO-associated stem-loop in the 5’ UTR of FTH1. D-E) Coverage plot of pre-
miRNA-seq (E) and smRNA-seq (F) reads mapping to a human AGO-associated stem loop in the 
5’ UTR of the FTL gene. White bars indicate templated nucleotides, colored bars indicate non-
templated additions. F) Size distribution of smRNA-seq reads mapping to the human AGO-
associated stem-loop in the 5’ UTR of FTL. 
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Figure 4.22 The IREs of mouse Fth1 and Ftl1 are processed into AGO-associated stem-loops. A-
F) Coverage plot of pre-miRNA-seq (A and D) and miRNA-seq (B and E) reads and RNAfold 
predicted structures overlaid with icSHAPE reactivity (C and F) for mouse AGO-associated stem 
loop in the 5’ UTR of the mouse Fth1 (A-C) and Ftl1 (D-F) mRNAs. White bars indicate templated 
nucleotides, colored bars indicate non-templated additions. 
 
Figure 4.23 IRE host genes are unaffected by knockdown of microprocessor components. RT-
qPCR analysis of DGCR8, DROSHA, FTH1 and FTL following knockdown of indicated mRNAs. * 
= p-value <0.05,** = p-value <0.01, *** = p-value<0.001; Students’ t-test. 
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4.3 DISCUSSION 
Here, we describe the application and further development of a methodology to enrich for 
and sequence AGO-associated pre-miRNAs in both human and mouse cells. This biochemical 
approach combined with custom bioinformatics pipelines, successfully enriches for and maps pre-
miRNAs in mammalian genomes (Figure 4.1-4.3). Using this approach, we detected 367 pre-
miRNAs in human and 267 in mouse cell lines, with ~ 28 and ~ 17 million raw sequencing reads 
in each experiment, respectively (Table 4.1). This gave us specific insights into the exact 
sequence and abundance of pre-miRNAs and miRNAs expressed in cells of two different 
mammalian organisms. We generated profiles to visualize coverage, trimming and non-templated 
tailing at each annotated miRNA expressed in either cell type, which is available for download at 
http://gregorylab.bio.upenn.edu/AGO_IP_Seq/ (Example in Figure 4.4).  
 
4.3.1 Insights into pre-miRNA processing 
Using these unique datasets, we uncovered widespread trimming and non-templated 
tailing in both pre- and mature miRNAs from human and mouse cells (Figures 4.5-4.7). We also 
identified known and putative ac-pre-miRNAs (Figure 4.8A-B and Table 4.2). The large number of 
ac-pre-miRNAs identified suggests that DICER-independent pre-miRNA processing may be a 
more commonly used mechanism than previously appreciated [77, 78, 183]. Furthermore, we 
identified putative ac-pre-miRNAs that cleave in the 5p arm of the pre-miRNA (Figure 4.8C-D), 
and thus are processed in the opposite direction of the currently known members of this pre-
miRNA class. This potentially novel pre-miRNA processing mechanism would require an 
alternative maturation process, with processive exonucleolytic nucleotide removal occurring step-
wise from the 5’ end. 
Given the unique nature of our datasets, we were able to make the first comprehensive 
analysis of the relationship between pre-miRNA and mature miRNA abundance in an unbiased 
fashion (Figure 4.9). Remarkably, we found very consistent relationships between human and 
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mouse for the processing efficiencies of miRNAs. Using this unique approach, we determined a 
microRNA precursor processing index (MPPI), allowing us to determine productive and 
unproductive miRNA maturation (Figure 4.10). We uncovered some pre-miRNAs that make 
surprisingly few mature species, despite abundance precursors. We also found that two miRNAs 
in Dgcr8 mRNA are processed with highly divergent efficiencies, suggesting distinct 
functionalities (Figure 4.11). 
 
4.3.2 Identification of Cleaved AGO-associated stem-loops in mRNAs 
From a further examination of pre-miRNA-seq reads that did not map to miRBase, we 
identified AGO-associated stem-loops that map to the exons of mRNAs (Figure 4.12). We found 
that these were enriched in the 5’ UTR of these transcripts, which suggests they may play a 
similar role to miR-3618 in the 5’ UTR of human Dgcr8 (Figure 4.13A-B). Furthermore, we found 
that these stem-loops had a broader size distribution than known miRNAs and were oligo-
uridylated, suggesting they are processed by TUTases (Figures 4.13C-D and 4.14). RNA 
structure prediction algorithms and in vivo structure probing data from mouse ES cells provide 
strong evidence that these regions of mRNAs form stem-loops (Figure 4.15). Furthermore, AGO-
bound stem-loop containing mRNAs were significantly upregulated following siRNA-mediated 
knockdown of components of the microprocessor complex (Figure 4.16). Collectively, our results 
strongly suggest the presence of AGO-associated stem-loops from mRNAs and that at least a 
subset of these interact with components of the miRNA biogenesis pathway. 
Interestingly, we found very few mature AGO-bound sequences coming from these 
regions and overall low MPPI scores (Figures 4.17-4.18). In human, the vast majority of AGO-
bound smRNAs from these regions can be explained by recently identified novel miRNAs [187, 
202]. In mouse, we uncovered a region in the Rpl9 CDS and a few other mRNA transcripts that 
account for most of the AGO-bound smRNAs from these regions (Figure 4.19). These findings 
indicate that our methodology uncovers novel miRNAs (Figure 4.20), but raises the question of 
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functionality of most of these stem-loops, which do not produce AGO-bound miRNAs, remains a 
mystery. 
4.3.1 IREs are cleaved and AGO-bound 
We also found that the IRE elements of human and mouse ferritin mRNAs are processed 
into pre-miRNA-like molecules, but not into mature AGO-bound miRNA species (Figure 4.21-
4.22). Moreover, knockdown of DROSHA or DGCR8 had no effect on the expression of IRE host 
genes (Figure 4.23). Then, what is the function of these pre-miRNA-like molecules? IRE hairpins 
may represent stable remnants of normal degradation of IRE containing mRNAs. However, given 
the conservation of AGO-associated stem-loops from IREs in both human and mouse cell, this 
seems unlikely. Alternatively, they may be processed from ferritin host genes by endonucleases 
other than the DGCR8/DROSHA microprocessor. This would be consistent with the inability of 
these pre-miRNA-like molecules to serve as substrates for DICER processing. However, these 
stem-loops could serve alternative roles, such as acting as a RNA-binding protein sink for IRE-
binding proteins. Undoubtedly, the biogenesis and biological relevance of these processed stem-
loops will be the subject of further investigation. 
 
4.4 METHODS 
Cell culture 
HEK293T cells were grown to 70-80% confluence in 15 cm tissue cultures plates with 
DMEM media supplemented with 10% FBS and 1X pen/strep at 37°C and 5% CO2. 
 
AGO-IP-sequencing 
Pre-miRNA-seq and miRNA-seq was performed as previously described [183]. Briefly, 
HEK293T cells were lysed in RSB 200 (20 mM Tris-HCl pH 7.4, 200 mM NaCl, 2.5 mM MgCl2, 
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0.5% NP-40) supplemented with 0.2 U/µl RNaseIN (Promega) and 1 tab/10 ml of protease 
inhibitor cocktail (Roche) with 1-3 10 second bursts of sonication. Cleared lysates were incubated 
with Agarose protein G beads (Life Technologies) conjugated to 12 µg of AGO 2A8 antibody or 3 
µl of non-immune serum (NIMS) per 1 ml of lysate. Conjugated beads were incubated with lysate 
for 1.5 h at 4°C on rotator and washed 4X with RSB 200. 500 µl of Trizol was added to washed 
beads and vortexed for 30 seconds. 150 µl of chloroform was added and the reaction and 
vortexed for 30 seconds followed by 20 min of centrifugation at 16,000 g. The supernatant was 
transferred to a new tube with 300 µl of isopropanol and 15 µg of glycogen. Pellets were 
recovered and RNA was dephosphorylated with phosphatase and labeled with T4 polynucleotide 
kinase and P32-g-ATP. 
5’ end radiolabeled RNA from AGO-IPs were resolved on a 15% denaturing PAGE gel 
with 7 M urea. Gel slices from 20-25 nt (miRNA-seq) and 50-80 nt (pre-miRNA-seq) were 
recovered and ligated to miRCat 3’ Linker (IDT) with T4 RNA Ligase 2 Truncated (NEB). Ligation 
products were resolved on a 15% PAGE gel with 7 M urea, size selected and purified. Reverse 
transcription was performed and product was purified from a 10% PAGE gel slice. cDNA was 
circularized using CircLigase I and PCR amplified. PCR amplicons were gel purified on a 3% 
Metaphor Gel, size selected and a second round of PCR was performed. Product was again size 
selected, purified, and submitted for sequencing. 
 
Mapping Pipeline 
The first 20 nt of the 3’ adapter sequence CTGTAGGCACCATCAATAGA was used to 
trim adapter sequence from the raw reads using cutadapt (v1.4.2). Identical reads were collapsed 
but clone information was retained to reduce computational time. Trimmed reads were 
sequentially mapped to miRBase (v20) and RefSeq annotated spliced transcript models (hg19 or 
mm10, downloaded on 06082015), with a two-stage alignment strategy with Bowtie2 and 
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EMBOSS-WATER. First, Bowtie2 was used to map the 5’ regions of reads to either miRbase 
(v20) primary miRNA sequences with a 50 nt extension on the 3’ end or RefSeq annotated 
spliced transcript models. For pre-miRNA-seq, the first 35 nt were used in the initial alignment 
step, whereas 18 nt were used for miRNA- and smRNA-seq. Following Bowtie2 alignment, reads 
were extended by local alignment with EMBOSS-WATER (with parameters: -gapopen 10.0 -
gapextend 0.5). Multimapped reads were partially resolved by selecting the longest, highest 
scoring alignments. Mismatches detected at the 3’ ends of reads were considered as non-
templated additions and analyzed separately. We filtered unmapped reads from pre-miRNA-seq 
for known rRNA, snoRNA, snRNA, tRNA, mitochondrial transcripts, and repeat-masked 
sequences before mapping to RefSeq. 
 
Analysis of miRNA trimming and non-templated tailing 
 We tabulated non-templated additions revealed by our mapping pipeline for reads, which 
mapped to high-confidence miRBase annotations. Additionally, we calculated templated-
extension and trimming by comparing mapped ends of pre-miRNA-seq, miRNA-seq, and smRNA-
seq reads against annotated 5p and 3p miRNA ends. 
 
Identification of AGO-2 cleaved pre-miRNAs 
For each miRBase miRNA, we calculated the percentage of trimmed pre-miRNA-seq 
reads that ended between 8-15 nts upstream of the 3’ end of the 3p miRNA or downstream of the 
5’ end of the 5p miRNA. We identified pre-miRNAs with >1% of such cleavage events in the 3p 
arm as putative ac-pre-miRNAs. For cleavage events in the 5p arm, we took a more conservative 
approach, requiring 5% of reads to terminate in this region and > 50% of mature miRNA-seq 
reads in the 3p arm compared to 5p arm. 
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Determination of MPPI  
We calculated the miRNA precursor processing index (MPPI) for miRBase miRNAs or 
AGO-associated stem-loops as the generalized log ratio (glog) [129, 205, 206] of miRNA-seq 
(smRNA-seq) to pre-miRNA-seq RPM coverage (nmi, npr) as follows: 
𝑀𝑃𝑃𝐼! = 𝑔𝑙𝑜𝑔 𝑛𝑚𝑖! −   𝑔𝑙𝑜𝑔 𝑛𝑝𝑟! =    𝑙𝑜𝑔! 𝑛𝑚𝑖! +    1 +   𝑛𝑚𝑖!! −    𝑙𝑜𝑔! 𝑛𝑝𝑟! +    1 +   𝑛𝑝𝑟!!  
Thus MPPI can be calculated for loci that are not represented in either the pre-miR-seq or miR-
seq library. Loci with no coverage in either sequencing library were omitted from this analysis. 
 
Identification of AGO-associated stem-loops in mRNAs 
Pre-miRNA-seq reads that failed to map to miRBase and were not removed by mapping 
to known rRNA, snoRNA, snRNA, tRNA, mitochondrial transcripts and repeat-masked sequences 
were we aligned to RefSeq transcripts with Bowtie2. After filtering for best matches for reads with 
less than 4 mismatches, we used Pycioclip to call significant peaks with a modified False 
Discovery Rate < 0.01 [151]. To remove abundant genes with high numbers of mappings but no 
local peaks, we filtered out peaks that were greater than 200 nt in length. We then chose the 
most abundant clone and predicted its secondary structure with RNAfold using standard 
parameters [201]. We again filtered clusters, requiring that they had greater than 15b p in the 
longest hairpin and a total MFE of less than 0.3 kcal/mol/nt. We analyzed non-templated tailing 
for reads mapping to these hairpins as described above. 
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icSHAPE analysis 
 In vivo icSHAPE data from mouse ES cells was downloaded from GSE60034. Only 
scores in the top or bottom 10th percentile were used for analyisis. icSHAPE reactivity scores 
were overlaid on RNAfold diagrams using RNAplot [201]. 
 
siRNA-mediated knockdown of DGCR8 and DROSHA 
 ON-TARGET plus siRNAs against Human Dgcr8 and Drosha were obtained from 
Dharmacon (J-015713-05-0002,	  J-015713-06-0002, J-016996-05-0002, J-016996-06-0002). 
siRNAs against luciferase were a gift from the Mourelatos lab. To knockdown endogenous levels 
of Dgcr8 or Drosha, we performed two sequential siRNA transfections 48 hours apart. To 
transfect these cells, we combined 45 pmol of siRNAs (22.5 pmol siRNA-1 and 22.5 pmol siRNA-
2), 125 mL Opti-MEM (Life Technologies), and 6 mL Lipofectamine 2000 (Life Technologies) per 
reaction. Reactions were incubated at room temperature for 20 minutes. During this incubation, 
we seeded 6.0x105 HEK293T cells per replicate in two wells of a 6-well plate (3.0x105 cells/well) 
in 2 mL media. We then added the siRNA mixture to each well dropwise, and allowed cells to 
incubate at 37ºC in 5% CO2 for 48 hours. After 48 hours we repeated the transfection, harvesting 
the two wells per replicate (~1.2x105 cells) and dividing them into four wells in a 6-well plate. We 
treated each well with 45 pmol of siRNAs, and allowed them to incubate at 37ºC in 5% CO2 for 
another 48 hours. Cells were then pooled and washed with PBS prior to storage at -80ºC. 
 
mRNA-seq 
mRNA-seq was performed as previously described [172] . Briefly, total RNA was purified 
from the MEL cell cultures (miRNeasy; Qiagen, Valencia, CA). Poly(A)+ RNA was isolated using 
oligo dT beads (Life Technologies, Frederick, MD). RNA was fragmented for 7 minutes using 
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Fragmentation Reagent (Life Technologies, Waltham, MA). mRNA-seq libraries were then 
generated using the Illumina mRNA-seq kit (illumina, San Diego, CA). Reads were trimmed with 
Cutadapt, mapped with Tophat2, and gene expression was quantified using HTseq [173-175]. 
DEseq2 was used perform differential expression analysis [207]. 
 
Data access 
 All sequencing data generated in this study has been deposited in GEO under the 
accession number GSE71710 (available at http://www.ncbi.nlm.nih.gov/geo/). RNAfold diagrams 
and coverage plots are available for download at http://gregorylab.bio.upenn.edu/AGO_IP_Seq/. 
MEF pre-miRNA-seq and miRNA-seq data were downloaded from European Nucleotide Archive 
(http://www.ebi.ac.uk/ena/) under the accession number PRJEB6756. HEK293T smRNA-seq 
data was obtained from GSE66224. 
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Abstract:	  
 
In this dissertation, I have covered a diverse array of topics connected by the common 
theme of RNA-protein interactions. In Chapter 2, we developed a novel methodology for 
uncovering RBP-RNA interaction sites throughout a transcriptome of interest. In Chapter 3, we 
generated a transcriptome-wide map of RNA binding sites for a single RBP, PABPC1. In Chapter 
4, we leveraged the interaction of pre-miRNAs with AGO proteins to sequence these transient 
intermediates and study them in two organisms. The variety of studies performed here 
underscores the range of biological pathways and regulatory roles for which RNA-protein 
interactions are key components. In this section, we will discuss the major advances provided by 
each of these studies and propose future experiments to address questions that have arisen from 
this work. 
 
5.1  A NOVEL APPROACH TO IDENTIFY RNA-PROTEIN INERACTION SITES 
In Chapter 2, we introduced a novel methodology, PIP-seq, to uncover RNA-protein 
interaction sites throughout a transcriptome of interest. This technique represents a significant 
advance over previous technologies, which only probe the RNA binding sites of a single protein at 
a time. PIP-seq is distinct from related techniques that were introduced concurrently because it 
does not rely on the use of synthetic nucleotides, which cannot be used in tissues or whole 
organisms [22, 106]. We applied PIP-seq to uncover protein-bounds sites in HeLa cells and 
provided multiple lines of evidence to support the accuracy and applicability of this novel 
methodology [208]. Importantly, we showed that PIP-seq is both reproducible and identifies 
previously identified sites of RBP interactions in mRNAs. Therefore, we now have a validated 
new tool in our arsenal to explore RBP binding sites on mRNAs.  
 
132	  
	  
5.1.1  RBP Occupancy Profiles on mRNA and lncRNA 
We used PIP-seq to investigate aspects of RNA-protein interactions that were not 
previously addressed due to limitations of earlier methods. First, we asked what the global 
landscape of RBP binding across mRNAs looked like. We found that the 3’ UTR and CDS were 
more bound than the 5’ UTR (Figures 2.12 and 2.15). Although we can’t distinguish PPSs within 
the CDS from ribosome occupancy, the increased binding in the 3’ UTR as compared to the 5’ 
UTR confirms years of evidence that most RBPs interact with regions in the 3’ UTR RBP 
‘sanctuary’. We also directly compared protein binding at long non-coding RNAs (lncRNAs) and 
expression matched mRNA 3’ UTRs (Figure 2.13). We found similar amounts of PPSs between 
these two RNA types when using formaldehyde as a cross-linking reagent. However, lncRNAs 
were depleted when using UV cross-linking, which only crosslinks direct RNA-protein contacts. 
This suggests that lncRNAs serve as platforms for RBP binding, but that these interactions may 
be relatively weak, consistent with the low sequence conservation observed across lncRNAs. 
Together, these results confirm previous narrowly focused studies and offer new insights into the 
mechanisms of lncRNA-mediated gene regulation, which have been thought to act as RNA 
scaffolds for protein and DNA interaction [209]. Future experiments will be focused on further 
characterizing lncRNA-protein interactions and understanding what distinguishes them from 
mRNA-protein interactions. 
 
5.1.2  Insights into RNA Regulons 
Using our PIP-seq data, we explored the post-transcriptional operon, or regulon 
hypothesis of mRNA regulation in eukaryotes. This hypothesis states that mRNAs involved in the 
same functional pathways are regulated by similar sets of RBPs, in a manner akin to prokaryotic 
operons [210, 211]. Our analyses demonstrated that certain putative RBP-interacting motifs 
tended to co-occur on the same transcripts, and that some of these groups of transcripts fell into 
pathways of immune regulation, RNA production, and cell death (Figure 2.16). It would be 
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interesting to take this work further by identifying putative-motif interacting RBPs by RNA affinity 
chromatography [108]. We propose performing this analysis in other cell lines or primary tissues 
to identify cell-type specific pathways that are controlled by regulons. Knockdown or knockout 
studies coupled to RNA-seq or phenotyping could be used to confirm that these RBPs are key 
regulators of predicted processes. 
 
5.1.3  Insights into Human Disease 
 We also used PIP-seq data to learn something about human disease. We found that 
disease-linked single nucleotide polymorphisms (SNPs) were enriched within PPSs (Figure 2.17). 
Furthermore, we found that synonymous SNPs, which change DNA/RNA sequence but not 
primary protein sequence, were enriched compared to nonsynonymos SNPs within PPSs. We 
validated the ability of two such SNPs to alter protein binding to specific mRNAs. These SNPs 
could impact on RNAs in numerous ways, including any of the post-transcriptional mechanisms 
described in the introduction. Collectively, these data suggest that disruption of RNA-protein 
interactions may be a more common mechanism for human disease than previously thought. We 
propose that PIP-seq could be performed in disease-relevant tissues to more accurately identify 
specific SNPs that disrupt RNA-protein interaction sites. Those interaction sites that overlap with 
disease-linked SNPs could be flagged as potential RNA-protein interaction disruptors, which 
would enable researchers to more efficiently investigate the mechanisms of some diseases. 
 
5.1.4  PIP-seq in Plants 
 Since the development of PIP-seq (Chapter 2), our laboratory has applied it to study 
RBP-interaction sites in the HEK293T transcriptome and nuclear RNAs in the flowering plant, 
Arabidopsis thaliana [108, 212]. Ongoing studies in our lab are also characterizing RNA-protein 
interaction sites in the bryophyte Physcomitrella patens (moss) and in Zea mays (corn). PIP-seq 
is of particular importance to the study of plants, for which RBPs remain relatively 
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uncharacterized. Performing PIP-seq on nuclear fractions was an advance over our original 
approach, because we could not previously distinguish between ribosome occupancy and RBP 
binding within the CDS.  
 
5.1.5  Dynamic RNA-Protein Interactions 
 One of the main advantages of PIP-seq is that it can monitor the expression of a large 
number of RBP binding sites in a single experiment. How do RBP-RNA interactions change over 
time in dynamic biological processes and how are these changes reflected in post-transcriptional 
regulation? The long-term goal of our lab is to answer these questions and PIP-seq offers us a 
means to address them. We are currently exploring this question in a mouse model of blood cell 
development. Erythropoiesis is an ideal system for this type of analysis because blood cells 
function without active transcription and rely exclusively on post-transcriptional controls [213]. We 
have performed PIP-seq on mouse erythroleukemia (MEL) cells at three time points during 
DMSO induction of differentiation; Day 0 (uninduced), Day 2 and Day 4. We have developed a 
computational pipeline to identify RNA-protein interaction sites that show significant changes in 
occupancy during the differentiation process, utilizing the DESeq package [214] applied pairwise 
(e.g 0 vs. 2, 2 vs. 4, and 0 vs. 4) to pseudo-read counts. These pseudo-read counts will be 
calculated in a manner to preserve the relative read ratios of the Footprinting (Fp) sample to the 
digestion control (Dc) samples within each time point. Specifically, we will compute pseudocounts 
for each j-th PPS under conditions a and b: Cja = [ria(Fp)/ria(Dc)] * Ri and Cjb = [rib(Fp)/rib(Ds)] * Ri where 
ria(Fp) are the read coverage from Footprinting (Fp) samples and ria(Dc) are the read coverage from 
the Digestion control (Dc) samples of the j-th PPS under condtion a. The ratio ria(Fp)/ria(Dc) is thus a 
vector (across replicates) of the relationship between the Footprint and Digestion control sample 
read coverage under condition a. rib(Fp)/rib(Dc) is a vector (across replicates) of the relationship 
between Fp and Dc read coverage under condition b, and Rj is the average read coverage across 
all Dc replicates in both conditions. We can then directly compare the pseudocount vectors Cja 
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and Cjb to identify differentiation-impacted RNA-protein interaction sites. This analysis pipeline will 
enable us to identify differentially bound regions during erythroid differentiation.  
 
 
Figure 5.1 Intersection of RNP expression profiles, motif libraries, and PIP-seq data. A) Heatmap 
showing dramatic shifts in the RBP profiles during MEL cell induction (Day 0 à 4). Hierarchical 
clustering analysis was performed on RBP expression changes (y-axis) to reveal distinct groups 
of similarly regulated RBPs. B) Example: PIP-seq data set (right circle) identifies complex 
enrichment at a site within an RNA 3’ UTR at Day 4. The core PPS at this site (center circle) 
matches the consensus motif for the RBP, ELAVL1. Expression of ELAVL1 is increased at Day 4 
of differentiation as inferred from RNA-seq analysis shown in A). These theoretical informatic 
comparisons identify ELAV1 as a candidate binding protein at this site.  
 
It will be interesting to identify shifts in protein occupancy on RNA using PIP-seq and the 
computational pipeline described above, in combination with other approaches to determine 
proteins responsible for these changes (Figure 5.1). For example, we propose using a 
combination of RNA-seq measurements with the RNAcompete compendium of RNA-binding 
motifs [94, 95] to predict which RBPs are responsible for interactions at each site. We can then 
identify RBPs, whose occupancy profile is most changed during differentiation and define their 
impacts on gene expression or other post-transcriptional processes through global 
measurements of alternative splicing, translation and/or RNA stability. We already know that the 
occupancy of PCBP2 within globin mRNA increases during differentiation and that this binding 
stabilizes globin mRNAs [215]. Thus, PCBP2 will serve as important positive control when 
performing such analyses. For novel candidates, CLIP-seq and/or RIP-qPCR could then be used 
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to validate these interactions and their dynamics in blood cell differentiation. Follow up studies 
using siRNA knockdown can also be used to evaluate the impact of loss of individual RBPs on 
blood cell development. Application of PIP-seq to erythropoiesis and other dynamic biological 
systems will likely uncover RBPs with important roles in these processes, which has remained 
difficult despite the number of technologies available.  
 
5.2  EXPANDING ROLES FOR PABPC1 IN GENE REGULATION 
	   In Chapter 3, we identified the genomically encoded RNA targets of mammalian PABPC1 
throughout the mouse transcriptome. This was the first high-resolution global analysis of the 
binding sites of any mammalian PABP. Using this approach, we uncovered three distinct modes 
of binding to mRNAs outside of its known role in poly(A) tail binding. First we revealed that 
PABPC1 binds directly to the polyadenylation signal (PAS) of thousands of mouse mRNA 
transcripts. We also found that PABPC1 binds to the start and stop codons of mRNAs, in the 
absence of any underlying sequence motif. Finally, we showed that PABPC1 binds to the A-rich 
elements in the 5’ UTR of numerous mRNAs and negatively regulates their translation. Here, we 
discuss the implications for these findings and delineate future experiments to address new 
questions that have arisen from these novel insights. 
 In our study, we found that CLIP tags were highly enriched in the 3’ UTR and specifically 
localized towards the 3’ terminus of mRNAs (Figure 3.3). Unfortunately, the length of the 
sequenced reads limits the resolution of CLIP-seq. Classically, peak identification is performed by 
identifying clusters of overlapping reads to define broad binding sites. However, it was recently 
noticed that CLIP tags are specifically enriched for deletion events relative to other types of 
sequencing technologies [146, 147]. It is thought that these deletions are a result of protein-
fragments that remain on the RNA following proteinase K treatment. Therefore, these deletion 
events can be leveraged to identify RNA-protein interaction sites with singe-nucleotide resolution. 
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We applied this approach, termed cross-link induced mutation site (CIMS) analysis, to precisely 
identify PABPC1 interaction-sites within the murine transcriptome (Figure 3.4). 
 
5.2.1  PABPC1 Binds Directly to the Polyadenylation Signal  
Using CIMS analysis, we found that PABPC1 binding events were most enriched 
approximately 20-25 nucleotides (nt) upstream of the poly(A) addition site (Figure 3.7). This 
region coincides with the precise location of the mammalian polyadenylation signal sequence 
(PAS), which functions in the nucleus to recruit CPSF, a core component of the polyadenylation 
machinery [216]. CPSF also binds to the PAS in the cytoplasm to execute a much less common 
mechanism of cytoplasmic polyadenylation [217]. We also performed motif enrichment analysis of 
sequences proximal to PABPC1 CIMS sites and found that the PAS sequence (AAUAAA) was 
the most enriched sequence motif (Figure 3.6). Finally, we demonstrated that active 
polyadenylation sites were ~25 nt downstream of CIMS sites, again supporting the notion that 
PABPC1 binds directly to these regions (Figure 3.7). This is the first report of mammalian PABP 
interacting with the PAS, however, a related interaction was observed at the yeast efficiency 
element, which also plays a role in polyadenylation [59, 61].  
 Given that PABPC1 has been previously shown to bind to A- and AU-rich sequences, it is 
not surprising that PABPC1 can bind to the PAS sequence [47]. This interaction would effectively 
extend the region of the mRNA protected by PABP further upstream from the poly(A) tail. We did 
not determine the functional consequences of this binding, but we hypothesize that it would 
increase the stability and translation efficiency of bound mRNAs. In order to test for functionality 
of this interaction, careful experimental design must be taken, given the defined roles of PABPC1 
in regulating translation and RNA stability, as well as the PAS in polyadenylation. To circumvent 
these problems, we propose directly transfecting pre-polyadenylated luciferase mRNAs with or 
without the PAS signal to bypass polyadenylation in the nucleus. Ideally, we would knockdown 
PABPC1 levels with siRNAs, however, the global affects of this loss may preclude identification of 
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the function of PABPC1-PAS binding. We would then assay mRNA stability and translation over 
time using the dual luciferase reporter system. We expect that additional PABPC1 binding to the 
PAS sequence would stabilize the mRNA and promote translation. Alternatively, binding of 
PABPC1 to the PAS in the cytoplasm may block binding by CPSF and subsequence cytoplasmic 
polyadenylation. Competition assays between CPSF and PABPC1 binding, or tethering of CPSF 
to mRNA 3’ UTR in the absence of the PAS could be used to address this question. 
 
5.2.2  PABPC1 at Translation Initiation and Termination Sites 
 We also observed that PABPC1 interacts with sites of translation initiation and 
termination in mRNAs (Figures 3.8-3.9). This was most dramatically observed in the replication-
dependent histone mRNAs, which are unique among mRNAs in that they lack a poly(A) tail. We 
were unable to identity an enriched sequence motif in these regions, suggesting that these 
interactions are sequence-independent. An explanation for the presence of PABPC1 at these 
regions may lie in its known interactions with other factors. Specifically, PABPC1 binds to EIF4G, 
which in turn binds to EIF4E, which interacts with the ribosome to activate translation [218]. This 
interaction can circularize the mRNA, however, it has not been clearly demonstrated that 
PABPC1 remains associated with this complex during active translation [53]. Furthermore, 
replication-dependent histone mRNAs lack a poly(A) tail and thus circularization would not be 
predicted to involve PABPC1 at these mRNAs. Our observations suggest PABPC1-EIF4G-
EIF4E-ribosome interactions are stable at both the start and stop codons. It’s possible that 
release factors would be required to break this interaction to begin translation or promote 
ribosome release.  
To experimentally address the mechanism of PABPC1’s interaction at translation 
initiation and termination sites, we propose genetic ablation of the PABPC1-EIF4G interaction 
domain and CLIP-seq on PABPC1. If peaks at the CDS start and stop codon are lost, this would 
suggest that these interactions are mediated through EIF4G. This assay may be challenging due 
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to global impacts on translation from loss of the PABPC1-EIF4G interaction. It would be 
interesting to compare the effects on translation due to loss of this interaction for histone mRNAs 
relative to polyadenylated mRNAs. If the role of this interaction is mRNA circularization, then 
histone mRNAs should be unaffected. 
  
5.2.3  PABPC1 Binds to and Regulates Specific mRNAs 
It has been previously observed that PABPC1 protein binds to an A-rich tract in the 5’ 
UTR of its own mRNA transcript and negatively regulates translation [41, 58]. Our CLIP-seq data 
strongly support this finding and also showed that PABPC1 interacts with another A-rich region 
downstream of the known regulatory element region in its mRNA (Figures 3.12-3.13). We used 
an in vitro luciferase assay to show that the known PABPC1 binding site in the 5’ UTR of Pabpc1 
mRNA acts as a negative regulator of translation. Surprisingly, we found the other A-rich region, 
with a more enriched binding peak, had no effect on mRNA translation or expression. This 
binding peak also happens to coincide with a predicted upstream open reading frame (uORF) 
with extensive experimental support from ribosome profiling with harringtonin treatment (Figure 
3.14) [159]. We hypothesize that interaction in this region may regulate expression of the uORF 
but not the downstream main ORF. We also used the CRISPR/Cas9 system to genetically ablate 
the PABPC1 binding site in the 5’ UTR of Pabpc1 mRNA, in cells (Figure 3.15). This analysis 
showed that this A-rich tract is a repressor of translation but does not affect mRNA levels in vivo. 
Thus, we have provided extensive supporting evidence for the role of PABPC1 in auto-regulation 
through the 5’ UTR of its own mRNA. However, our study further complicates this known 
interaction due to the presence of another more enriched PABPC1 binding site with an undefined 
function. 
 In addition to its interaction with the 5’ UTR of Pabpc1, we also found that PABPC1 binds 
the 5’ UTR of numerous other cellular mRNAs. This is the first such report of additional 5’ UTR 
targets for a mammalian PABP. We performed luciferase reporter assays for 5’ UTR target genes 
(Ccnd2, Safb, and Amd1), and found that the presence of PABPC1 binding sites has repressive 
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effects on translation (Figures 3.16-3.17). This is consistent with our studies of PABPC1 binding 
sites in the Pabpc1 5’ UTR. However, we have now expanded this regulatory affect to multiple 
mRNA targets. There are hundreds of other mRNAs with PABPC1 binding sites in their 5’ UTRs, 
and thus it is likely that PABPC1 also negatively regulates their translation.  
One important caveat to these studies is that we showed that the PABPC1 binding sites 
and not PABPC1 itself is responsible for the translation inhibitory effects. Ideally, we would 
knockdown PABPC1 expression and assay for effects on translation of target genes, in vivo. 
However, we were not able to achieve PABPC1 knockdown without significant levels of cell 
death, and there are no reported PABPC1 KO mice to study. This is likely due to the global role of 
PABPC1 in mRNA stability and translation. Therefore, titrating knockdown conditions such that 
PABPC1 levels are reduced just ~10% could alleviate some of these problems. If we could 
achieve this, we would also perform a global assay for translation (ribosome profiling), so that we 
could assess ribosome occupancy on thousands of mRNAs simultaneously. We would expect 
that overall translation rates for PABPC1 5’ UTR target genes would be increased. Despite lower 
overall translation in the system. 
 A recent study from the Liebhaber lab suggested that depletion of a minor PABP isoform, 
PABPC4, impacted on the maturation of erythoid cells in vitro [219]. We also performed CLIP-seq 
on PABPC4 and found that it shared the majority of its targets with PABPC1. PABPC4 is 
expressed at about 10% the levels of PABPC1 and therefore, it is reasonable to hypothesize that 
depletion of PABPC4 may be equivalent to a small reduction of PABPC1. Thus, defects in 
erythroid differentiation may be due to loss of PABP binding activity. PABPC4 knockdown does 
not result in cell death, thus, future studies will examine the impact of PABPC4 depletion on the 
translation of genes with PABPC1/C4 5’ UTR binding sites.  
 
5.3 NEW INSIGHTS INTO MICRORNA STEM-LOOP PROCESSING 
 In Chapter 3, we used a recently developed technique to isolate and sequence microRNA 
precursors (pre-miRNAs) in human HEK293T cells. We then developed a computational pipeline 
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to handle mapping of these highly modified RNA molecules which we applied to our data as well 
as data from mouse embryonic fibroblasts (MEFs), recently published by our lab [183]. Using 
these datasets we uncovered novel insights into the processing and post-transcriptional 
modification of pre-miRNAs. We also uncovered numerous AGO-associated stem-loops 
embedded within mRNAs, which are poorly processed into mature miRNAs. Here, we discuss the 
most important findings from our study and outline future experiments to better understand these 
results. 
Our enrichment and sequencing strategy for pre-miRNAs represents a significant 
advance over earlier methods, which utilized size selection or primer-based amplification to 
sequence pre-miRNAs. Previous studies were unable to enrich pre-miRNAs to greater than 1% of 
sequenced RNA [188, 220]. Alternatively, primer-based approaches suffer from inherent bias and 
cannot be used for discovery [184]. In our study, pre-miRNAs represented ~10% of human and 
~40% of mouse pre-miRNA-seq reads, providing detailed information on >600 mammalian pre-
miRNAs (Figure 4.2). These data provide a wealth of novel information about the sequence and 
abundance of pre-miRNAs, which improve our understanding of these understudied 
intermediates. Application of this technique to other cell types, tissues and organisms could 
greatly enhance our annotations of miRNAs. 
 
5.3.1 Diversity of pre-miRNA 3’ ends 
One of the most surprising results from our study was that the majority of pre-miRNA-seq 
reads did not map to the annotated 3’ end of the pre-miRNAs. In MEFs only 20% of reads ended 
at the annotated terminal 3’ position of mouse pre-miRNAs, while in HEK293T cells just 40% of 
reads ended at the expected 3’ position (Figure 4.5). In contrast, >90% of pre-miRNA-seq 5’ ends 
corresponded to the annotated 5’ end of the pre-miRNA. We also found that 3’ end trimming was 
more common than templated extension. These results demonstrate that pre-miRNAs in cells 
rarely end at the predicted 3’ end position. There are several explanations for this finding. For 
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instance, Drosha cleavage could be more heterogeneous than previously thought, or other 
nucleases could “nibble” at pre-miRNA ends similar to what has been observed for mature 
miRNAs and ac-pre-miRNAs [181, 221]. Alternatively, pre-miRNAs with appropriate 3’ ends may 
be rapidly processed into mature miRNAs, and therefore do not accumulate in AGO proteins. 
Regardless of the explanation, these results show that we still have much to learn about pre-
miRNA processing in vivo. 
 
5.3.2 Identification of Novel ac-pre-miRNAs 
 We also leveraged our dataset to identify novel ac-pre-miRNAs, which are directly 
cleaved by AGO2 and subsequently turned into mature miRNAs by PARN [78-80, 181]. We 
identified all known ac-pre-miRNAs, with the exception of pre-miR-451, which was not expressed 
in either of the cell lines used in our study (Table 4.2). Furthermore, we identified numerous 
candidate ac-pre-miRNAs, which show similar 3’ cliff patterns (Figure 4.8). Follow up studies 
could be performed to demonstrate that these pre-miRNAs are indeed ac-pre-miRNAs. To do 
this, cells would be co-transfected with pre-miRNAs of interest, and AGO2 overexpression. 
Northern blots would be used to confirm that increasing levels of AGO2 results in increased levels 
of mature miRNAs. These results show that ac-pre-miRNAs are more widespread than previously 
thought. 
 To date, all known ac-pre-miRNAs are cleaved in the 3p miRNA to produce mature 5p 
miRNAs. We performed a parallel search for ac-pre-miRNAs that cleave in the 5p miRNA to 
produce 3p miRNAs. We found several candidates that show striking 5p cliffs and produce 
predominantly 3p mature miRNAs (Figure 4.8). To validate that these are 5p-ac-pre-miRNAs, we 
would perform the same validation assay described for novel 3p-ac-pre-miRNAs. If indeed these 
candidates are AGO2 cleaved, their maturation would require a distinct mechanism from what 
has been proposed for known 3p-ac-pre-miRNAs. A 5’ to 3’ exoribonuclease, for example XRN1 
or XRN2, would be required for maturation from the 5’ end. I hypothesize that XRN1 is the likely 
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nuclease because XRN1 is cytoplasmic and AGO2 and XRN1 have already been shown to 
interact within cytoplasmic processing bodies [18, 222]. To test this hypothesis, XRN1 could be 
knocked down with siRNAs and the levels of mature miRNA assayed for the putative 5p-ac-pre-
miRNAs. From these experiments, I expect that mature levels would decrease in the absence of 
XRN1. In total, our studies have revealed a more complex landscape of AGO2-mediated miRNA 
maturation. 
 
5.3.3 Insights into pre-miRNA Processing Efficiency  
 Given the comprehensive nature of our data, we were able to ask an additional basic, but 
unanswered question in miRNA biology; what is the relationship between pre-miRNA and mature 
miRNA abundance? One important caveat to this analysis is that numerous pre-miRNAs can give 
rise to the same mature miRNA species. Therefore, we took a conservative approach by first 
grouping miRNAs by family and then assessing the ratio of pre-miRNA and mature miRNA. We 
found a modest positive correlation (R = 0.53) that was surprisingly consistent between mouse 
and human annotated miRNAs (Figure 4.9). This suggested that while pre-miRNA and mature 
miRNA expression are related, that a significant amount of variation in this relationship exists 
between different miRNAs. To further explore this variation, we created an index based on the 
ratio of mature miRNAs to pre-miRNAs (MPPI). We observed that the majority of high confidence 
miRBase miRNAs scored greater than 0 on this scale. However, we identified some interesting 
outliers, defining efficiently and inefficiently processed miRNAs (Figure 4.10). Further 
investigation as to what differentiates these outliers from other miRNAs will likely lead to a better 
understanding of miRNA processing. 
Among the poorly processed miRNAs was a miRNA encoded in the 5’ UTR of the 
DGCR8 mRNA. In fact, an adjacent pre-miRNA encoded in the CDS of DGCR8 is efficiently 
processed into mature miRNAs (Figure 4.11). Collectively, these miRNAs have been 
demonstrated to negatively regulate the expression of DGCR8 mRNA abundance through 
microprocessor-mediated cleavage [35, 199, 200]. However, it has not been investigated which 
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miRNA imparts this auto-regulatory function. To test this, I would generate luciferase reporter 
mRNAs with either miRNA inserted in the 5’ UTR and assay for luciferase protein and mRNA 
levels. I expect that the poorly processed 5’ UTR miRNA will impart the major regulatory potential, 
given that it appears to have no other function. However, the in vivo relevance remains 
convoluted, given that cleavage of either miRNA would lead to degradation, and likely cleavage of 
the other pre-miRNA.  
 
5.3.4 Identification of pre-miRNA-like Elements in mRNAs 
 We further explored our dataset to identify other mRNAs with pre-miRNA-like sequences 
embedded in their exons and identified ~400 AGO-associated stem-loops in both mouse and 
human mRNAs. We provided compelling support with multiple lines of evidence for the validity of 
these elements (Figures 4.13-4.16). Furthermore, 12 of AGO-associated stem-loops have been 
recently identified as novel human miRNAs [187, 202]. However, beyond a few cases most AGO-
associated stem-loops in human and mouse mRNAs did not produce AGO-bound smRNAs 
(Figure 4.18). Furthermore, these elements were highly enriched within the 5’ UTR, suggesting 
they may be related to the DGCR8 5’ UTR hairpin (Figure 4.13). Collectively, we have identified a 
set of stem-loop elements in mRNAs that are processed into AGO-associated pre-miRNA-like 
molecules, but fail to mature along the canonical pre-mIRNA pathway. 
 The most abundant AGO-associated stem-loop in our human dataset corresponded to 
the iron response element (IRE) of ferritin heavy chain (FTH1). Further investigation revealed that 
the IRE of ferritin light chain (FTL), as well as the mouse homologs of both of these elements are 
processed into AGO-associated stem-loops (Figure 4.21-4.22). We found that these elements do 
not produce AGO-bound smRNAs, but do produce a small number of cellular smRNAs. However, 
these unbound smRNAs were not arranged in a clean double stack and their size distribution did 
not correspond to Dicer cleavage. Finally, FTH1 and FTL mRNA levels were not affected by 
DROSHA or DGCR8 knockdown. These data suggest that IREs are cleaved in a microprocessor-
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independent fashion into AGO-associated stem-loops, and thus are poor substrates for miRNA 
maturation.  
 What could be the function of these AGO-associated stem-loops, and specifically IRE-
derived AGO-associated stem-loops? One possibility is that they are degradation products. The 
inherent stability of the stem-loop and perhaps AGO’s affinity for it may lead to stabilization of this 
product after degradation. Alternatively, these may function as RBP sinks, interacting with and/or 
buffering the amount of specific RBPs available. In the case of IREs, this would correspond to the 
IRE-binding protein (IRE-BP), which mediate translation regulation through interaction with IRE 
elements [223]. The function of IRE-derived AGO-associated stem-loops could be investigated 
using several approaches. For instance, one could alter iron concentrations and assay for 
changes in levels of IRE-derived AGO-associated stem-loops by northern blot. Alternatively, 
these RNAs could be transfected directly into cells and affects on iron metabolism could be 
assayed. Given the importance of the IREs to iron metabolism, it will be important to fully 
understand the function(s) of these elements during iron metabolism. Extrapolation of this 
function to the broader repertoire of AGO-associated stem-loops derived from mRNAs, will 
enhance our understanding of the function of these novel elements. 
 
5.4 CONCLUDING REMARKS 
RBPs and their RNA targets lie at the heart of post-transcriptional gene regulation. In this 
dissertation, I have described three projects connected by the common theme of RNA-protein 
interactions. While these studies are diverse, they each demonstrate that new insights can be 
gained from global studies of proteins and their RNA target sites. In Chapter 2, we developed a 
new method to profile RNA-protein interaction sites throughout a transcriptome of interest, laying 
the groundwork for future studies. In Chapter 3, we identified the genomically encoded target 
sites of PABPC1, revealing a broader role for this important RBP. Finally, in Chapter 4, we 
leveraged the interaction of AGO with pre-miRNAs to obtain unprecedented coverage of pre-
miRNAs in human and mouse transcriptomes, detailing known miRNAs and identifying novel 
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cleaved elements in mRNAs with unknown functions. In each of these projects, we have 
confirmed previous evidence and uncovered novel unexpected findings, opening up new avenues 
of investigation. Fortunately, these studies detailed molecular maps, which can guide future 
explorations of these important mediators of post-transcriptional gene regulation. 
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